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Almost everyone is susceptible to motion sickness, and around one in three people are known to be 
highly susceptible. It has been argued that the use of automated vehicles will increase motion sickness 
severity and onset frequency for those who already regularly suffer from it, as well as for those who are 
susceptible, but don’t regularly get motion sick in traditional vehicles. This is primarily due to the 
engagement with non-driving activities which cause sensory conflict, the relinquishing of control which 
prevents apprehension of current and upcoming motion, and the limited ability to self-mitigate due to 
potential vehicle designs and the inability to take control of the dynamic driving task in a fully 
automated vehicle. This research first contextualised the relationship between motion sickness and 
future automotive technologies – covering both research focused driving simulators as well as ‘real-
world’ use cases for on-road partially to fully automated vehicles. A framework for future research was 
developed and three core projects were established, positioned to cover the breadth of the field. 
Following this framework, the first project explored the impact of motion sickness on human 
performance, this was followed by the development of a method of reducing susceptibility to motion 
sickness and finally, objective measurements of motion sickness were explored.  
Motion sickness is a consideration for not only the day-to-day utility of future automated vehicles, but 
also within the development and simulator-based testing of such technology. Despite the myriad 
benefits of driving simulators for developing future technology, one significant side effect is simulator-
induced motion sickness or ‘simulation sickness’. The first project, using both simulator-based and real-
world experimentation, explored the effect of motion sickness on human performance – informing our 
understanding about transferability of simulator data to ‘real-world’ as well as providing insights into 
the relationship between motion sickness and productivity for future vehicles.   
The second research project proposes, develops, tests and validates a novel method of reducing motion 
sickness susceptibility by way of specific visual-cognitive training activities. Experimentation began using 
a high fidelity driving simulator where it was first shown how it is possible to increase visuospatial skills 
through a novel assimilation and application of a pen-and-paper training pack. Subsequently, this 
increased visuospatial skill reduced both subjective simulator sickness by 58%, and dropouts due to 
severe motion sickness by 60%. This simulator-based study was followed up with an on-road study 
where the visuospatial training pack was further validated for ‘real-world’ utility and was shown to be 
responsible for a reduction in motion sickness by 52% across the experimental group. Further to the 
core findings presented, an industry-focused workshop identified ways in which this new knowledge can 
be exploited for consumer-focused utility. This research also contributes to the fundamental 
understanding of the relationship between visuospatial ability and motion sickness susceptibility.  
Through extensive simulator-based and on-road motion sickness experimentation, the third research 
project pulls together physiological and subjective motion sickness data to explore concepts for 
objectively measuring and detecting motion sickness in real-time. Building upon literature from both 
motion sickness and machine learning fields, a wide range of data types, from demographics, to vehicle 
conditions, to occupant activity and route design are highlighted to be potentially useful in future 
objective motion sickness studies. Based on these sources of data, and many more, a new model is 
proposed through which motion sickness related data can be collected to aid in the objective 
measurement of motion sickness.  
The research conducted here provides a novel contribution in understanding motion sickness related 
human performance degradation and provides an interesting discussion about the impact this may have 
for both simulator trials, and automated vehicle utility. Through the design and validation of a novel 
training tool for reducing motion sickness susceptibility (in simulators and ‘real-world’) this research 
adds to the knowledge about our fundamental understanding of motion sickness and provides an 
innovative solution to address the issue of motion sickness. Further contributions are found within the 
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1 SETTING THE SCENE –  A BACKGROUND TO AUTOMOTIVE 
 
Over 100 years ago, in 1916, the American automaker Cadillac introduced the ‘Type 
53’ motor vehicle. This particular vehicle is of significance to the world of automotive 
human factors, where for the first time this car featured the controls of ignition, 
steering wheel, three pedals (brake, clutch, accelerator) and handbrake in the layout 
as is familiar in vehicles today. There has been great progress in many aspects of 
transportation since then and a host of new in-vehicle technologies have emerged. 
However, the fundamental concept of what it means to drive a vehicle has not 
changed – people are still fundamentally required to interact with vehicles in the same 
way in 2019 as they were in 1916. Just nine years after the launch of the Type 53, 
technology challenging this concept of ‘driving’, was already emerging in the form of 
‘driverless cars’. In 1925 the Houdina Radio Control company demonstrated a radio-
controlled Chandler automobile driving through the streets of New York City (USA) 
with no driver present - hence the term ‘driverless car’ was coined. This 
demonstration, although significantly abstract from our current understandings and 
objectives of automation in vehicles, stands as the first step in revolutionising the 
concept of driving a car. Since then, many significant steps have been made to 
progress automated technology where the overall goal is to remove the need for a 
human driver from a car and have the vehicle drive by itself. This concept, when 
requiring no human interaction at all is commonly referred to as autonomous driving, 
although the agreed definition is generally ‘fully automated’ (SAE International, 2018). 
To contextualise the envisaged future of the automotive industry, the four key factors 
of future automotive trends are believed to be of most significance as presented in a 






Figure 1 – Four Factors for the Automotive Revolution 
It is believed these four ‘factors’ are of the most significance for the future of the 
automotive industry, and society as a whole. Each of them bring their own benefits 
and challenges. However, this report will be focusing primarily on ‘autonomous 
driving’ as a consideration. With increasing automation comes many potential benefits 
to mobility including that of traffic management, access to mobility for the disabled 
and above all, safety. Technological developments including various Advanced Driver 
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Assistance Systems (ADAS) and vehicle crash protection systems can be associated 
with an increase in vehicle safety and a decline in road related injury and fatalities 
observed over the years. However, there are still an astonishing number of crashes, 
injuries and fatalities recorded every year. The chart below in Figure 2 illustrates the 









Figure 2  Reported Road Casualties by Severity and Motor Vehicle Traffic: Great Britain 1950 to 2017 
(Department for Transport, 2018) 
Figure 2 shows a general trend of a reduction in both injuries and fatalities over the 
recent years, despite an increase in traffic. However, with 144,369 people slightly 
injured, 24,831 seriously injured and 1,793 killed in 2017 on UK roads in 2018 
(Department for Transport, 2018), there is still great incentive to further increase road 
safety and bring these figures down. The goal of fully autonomous vehicles is to bring 
down road deaths to zero - it is not uncommon to see predictions for up to and beyond 
a 90% reduction in road traffic collisions (Fagnant & Kockelman, 2015). An 
independent research group at Morgan Stanley estimate the US economy would save 
US$488 billion per year due to the ability of fully autonomous vehicles to reduce road 
accidents (Morgan Stanley, 2013). 
Aside from safety, increasing levels of automation bring many more benefits from a 
consumer perspective. Almost as soon as these original ‘driverless car’ prototypes 
were conceived, people have been envisaging how they will spend their time whilst 
traveling on the road – given that they no longer need to engage in the dynamic 
driving task (DDT). In 1956, America’s Independent Electric Light And Power 














Figure 3  Automated Advertisement (America’s Independent Electric Light And Power Companies , 
1956) 
The advertisement in Figure 3 depicts a family scene playing a game together whilst 
the two front seats have rotated to create a communal space within the vehicle. In this 
image, no occupant is required to monitor the road or interact with the vehicle 
controls. Jumping forward to the modern day and it is interesting to see this concept of 
occupant activities has remained relatively consistent. In 2017 Mercedes-Benz 
released their concept of a highly automated vehicle (the model F 015) depicting a 
similar scene to that of the scene from 1956, although bringing in more modern 








Figure 4  The Mercedes-Benz F015 (Eliot, 2019) 
2019 is a pivotal point in time for the development of automated vehicles, where there 
is great support for the technology (evidenced by substantial financial investment from 
both the private and public sector) and a rapidly growing consumer desire for vehicles 
with various levels of automation. However, perhaps overshadowed by the potential 
safety benefits, there is still a great deal of uncertainty around the human as a 
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consideration in automated vehicles. There are a many challenges which face the 
automotive industry as drivers become vehicle occupants and relinquish control of the 
vehicle to automated systems. Some challenges are found within the subjects of 
information requirements, control handover, trust, acceptance etc. Many of these 
areas have had a significant research effort evidenced in the literature. However, one 
concern that has seen less attention is that of motion sickness. The US National Library 
of Medicine reports how one in three people are considered highly susceptible to 
motion sickness  (U.S. National Library of Medicine, 2019), and goes on to explain that 
almost everyone can become motion sick depending on the severity of the scenario. 
Motion sickness onset, frequency and severity is expected to increase significantly with 
the introduction of automated vehicles due to a number of factors including the loss of 
vehicle control (Rolnick, 1984), propensity to engage in non driving related activities 
(Diels C. , 2014) and vehicle design (Diels & Bos, 2015). There has been little motivation 
or incentive to develop an understanding of motion sickness thus far. However, this is 
no longer the case – increased automation is growing rapidly and consumer vehicles 
are already on the road with various automated features. Considering those with 
higher levels of autonomy it has been reported that Audi aims to have a highly 
automated car on the road by 2020, General Motors by 2020 or sooner and BMW by 
2021 (Driverless Future, 2017). If people are likely to get motion sick in automated 
vehicles, there is a pressing need to understand the impact, implications and 
mitigation strategies of this, to enable the successful rollout and adoption of 
automated vehicles. 
 
1.1  AIMS AND OBJECTIVES 
 
The aim of this research project is therefore to explore the relationship between 
motion sickness and future automotive technologies to gain an enhanced 
understanding of both the impact and management of motion sickness for the 
automotive industry. 
Objectives: 
1. To critically review the body of literature covering motion sickness with an 
emphasis on impact to automotive applications 
2. To explore the impact of motion sickness on human performance to inform 
transferability of simulator data to real-world 
3. To advise on the most appropriate way to conduct user trials for future 
simulator-based experimentation (including that of motion sickness 
management) to inform ‘best practice’ of vehicle simulator trials. 
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4. To consider the impact motion sickness may have on the utility of future 
automated vehicles 
5. To detail state of the art methods for managing motion sickness in vehicles 
6. Design, test and validate a method of reducing personal susceptibility to 
motion sickness 
7. Provide information on the ways through which a motion sickness 
management method could be implemented in production vehicles 
8. Explore methods for the measurement and detection of motion sickness 
9. Explore the feasibility of physiological data as objective measures of motion 
sickness and provide information about useful metrics through which motion 
sickness may be measured objectively.  
 
2 AN INTRODUCTION TO THE INNOVATION REPORT 
 
From September 2015 to September 2019 the British automotive manufacturer Jaguar 
Land Rover (JLR) sponsored this Engineering Doctorate (EngD) to help develop 
competency in human factors concerns related to future vehicles. This project sat 
within the RACeD project (Research for Advanced Concept Development) at the 
University of Warwick and was fully funded by JLR. As required by the University of 
Warwick’s EngD student handbook this Innovation Report will, along with presenting 
the research, discuss “the value and implication of the research work to the wider 
world” (WMG Reserach Degrees Office at the University of Warwick, 2018), and the 
sponsoring company. This report will therefore contain a summary of the work 
completed over this four-year period and pull out the key findings, impact to the 
sponsoring company, contributions to the field, and innovations.  
Considering the broad nature and size of the EngD as a project, an explanation is first 
given into how this Innovation Report is formed and what to expect from the various 
sections. To begin, an explanation of the portfolio plan is presented – containing an 
insight into all of the submissions made over the 4-year EngD and providing a visual 
representation of how this Innovation Report sits as an overall summary. The 
methodology of the project is highlighted within the explanation of this portfolio plan. 
This tells the story of this research and demonstrates the EngD’s inherent positioning 
between fundamental research and industry-focused outputs. The sponsoring 
company (JLR) is then presented as a case study establishing the state of competency, 
knowledge and influence of the company on this research. This introduction to the 
sponsoring company helps illustrate how this project was able to address the aims 
from the business, which in turn helped fuel this project. In summary of the 
requirements from JLR, and with an anticipation of the demands from the literature, 
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the broad research themes can be set out, which capture all the objectives of the 
research.  
With the introductory sections complete, a formal introduction to the two subjects of 
automated vehicles (AVs) and motion sickness (MS) will be presented – bringing the 
reader up to date with the state of the art (SOTA) for each subject. Evidencing the 
‘sustaining innovation’ approach, these two subjects of motion sickness and 
automated vehicles are brought together and the challenges that arise within the 
marriage of the two fields of study are explored. The combination of these two 
subjects is key for this Innovation Report, and provides an understanding into where 
the true challenges lie for this research. The three key projects, which make up the 
main body of this Innovation Report are then presented. Looking back on the three 
core projects, it will then be possible to revisit, in the closing sections, how this 
research has addressed the challenges, aims and objectives set out early on in this 
Innovation Report. Concluding, it is then possible to summarise the impact this work 
has had on the case study of Jaguar Land Rover as the sponsoring company.  
 
2.1 PORTFOLIO PLAN AND REPORT STRUCTURE 
 
As part fulfilment of this EngD, submissions have been made along the way to 
document and present distinct sections and/or research projects completed. Although 
this Innovation Report stands as the overall summary of these submissions, these 
documents hold within specifics and in-depth details of the work presented and 
discussed here. It is advantageous to present the structure of these submissions to 
provide a context to each submissions’ research contribution, which combined, make 
up this EngD. Figure 5 below shows how the research took place chronologically and 







Figure 5 Portfolio Plan Version 1 
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Viewing the portfolio in chronological order helps in understanding how this project 
developed. Initially, work began within the Self-Learning Car (SLC) team at Jaguar Land 
Rover. However soon after starting research, the business decided to progress the SLC 
project from research to ‘mainstream engineering’ – thus the project, which initially 
enabled this EngD, was dissolved. This led to a period of, futurescaping and problem 
identification to find a new scope for research to address the overall aims and 
objectives of this EngD. Moving away from automating in-vehicle features, this 
research moved towards the subject of motion sickness. Submission 2 was the first 
submission made in this new direction and contains an in-depth and critical review of 
the literature surrounding motion sickness and automated vehicles.  From then, each 
submission ran relatively consecutively and demonstrates a logical progression of the 
project. Considering the change in direction of the research stemming from the 
disbandment of the SLC team, this EngD portfolio plan is reordered, moving away from 
a chronological timeline, but instead to reveal the true story of this EngD as three core 







Figure 6 Portfolio Plan Version Finalised    
Figure 6 above, presents the portfolio plan for the structure of this EngD and 
Innovation Report. There are a few notable differences from the original chronological 
plan set out in Figure 5, which will be explained along with a brief overview of the 
submissions to give an appreciation for the overall methodology of this project.  
Submission 2, setting the scene for this motion sickness research was a literature 
review focused on motion sickness with an emphasis on the automotive industry. This 
review provided the background learning and understanding of many concepts of 
motion sickness, covering a wide range of fundamental literature ranging from 
biological explanations of the condition to discussing design recommendations for the 
management of motion sickness. This literature review was strategically kept broad so 
that this submission could stand as the backbone behind subsequent research 
projects. The problem of motion sickness and automated vehicles at the time of this 
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report was still ill-defined within the published literature and in general understanding.  
Therefore covering a wide range of subjects allowed for the opportunity to scope this 
EngD in such a manner to ensure maximum validity for future projects and not limit 
future work by way of omitting various areas of the literature. The outcome of this 
literature review evidenced innovation in the contextualisation of existing literature 
surrounding motion sickness as a specific subject, and expectations for future 
automotive trends (e.g., automated vehicles and driving simulators). This literature 
review also served as the reference for the problem identification carried through this 
EngD research. The conclusion of Submission 2 presented a series of challenges and 
research questions on which the subsequent EngD projects could be based.  
The challenges and research areas from Submission 2 were developed into a 
framework of future research which highlighted three distinct areas of recommended 
motion sickness future research. These categories were identified to be of most utility 
to explore for this EngD considering the state of the literature and the demands from 
industry. The framework loosely follows the same linear style progression of the 
Technology Readiness  Level (TRL) (NASA, 2012) scale where fundamental research 
tends to sit to the far left of the framework, and applications to the right. A modified 
version of this framework is presented below in Figure 7, where the original version 





Figure 7 Modified Framework of Identified Future Research 
The framework above differs somewhat from that presented in the literature review 
summarised in Submission 2, as both the field and this research project have 
developed since its initial conceptualisation. Figure 7 helps to present and justify the 
scope for this EngD project – sitting in-between theory and application. The theory 
based fundamental research can be more exploratory in nature and tends to be 
associated with academic research. Whereas the applications traditionally tend to be 
more where industry focused research and development lies. The scope of the EngD is 
therefore represented by the grey diamond, where the bulk of the effort is in 
understanding and contextualising the impact of motion sickness and future 
automotive technologies. This positioning also allows for some significant work to be 
carried out either side of this centre point - both adding to the fundamental knowledge 
as well as the application of knowledge to industry. The six submissions (besides 
Submission 2 – the literature review) can be mapped onto this framework presented in 
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Figure 7 where they form three Projects - A, B and C as per Figure 6. A brief overview 
of the portfolio of submissions is given.  
2.1.1 PROJECT A –  MOTION SICKNESS AND HUMAN PERFORMANCE 
(SUBMISSIONS 3 AND 4) 
Project A looks at motion sickness and human performance, it sits within the category 
of ‘impact of motion sickness’ as defined in the framework presented in Figure 7. One 
of the immediate concerns highlighted within the literature review (Submission 2) was 
the relatively undefined extent to which motion sickness affects human performance. 
This was of concern due to the nature of simulator-based user trials, and the 
propensity for driving simulators to induce motion sickness for some users. Submission 
3 looked to see how motion sickness affects various areas of human performance and 
looked to conclude on how performance, and therefore user trial results, may be 
impacted if motion sickness is a factor for participants. An experiment was devised 
using 51 participants, each using a simulator for up to 30 minutes and the impact of 
motion sickness on various areas of human performance was measured. The outcomes 
for Submission 3 were very interesting for understanding the transferability of 
simulator data to the ‘real-world’. Following up on the simulator study, a ‘real-world’ 
study using the pods from the UK AutoDrive project was devised, and this is presented 
in Submission 4.  
Within Submission 4, the same experimental procedure is followed as in Submission 3 
– the simulator study, although this time a further 17 participants were assessed whilst 
taking part in a ‘highly automated’ driving ‘pods’ trial, rather than a driving simulator 
study. This trial confirmed that the pods did not induce any significant motion sickness 
(in this trial) – and as a validation for results in submission 3 where performance was 
affected by motion sickness – no decrement to performance was observed following 
the pod trials. 
The summary of the two trials which make up Project A, provide insights into the 
transferability of simulator-based user trial data to real-world as well as bring into 
context the effect of motion sickness on human performance. This brings with it 
interesting considerations for automated vehicles and performance degradation 
because of motion sickness in an automated vehicle is discussed. 
2.1.2 PROJECT B – REDUCING MOTION SICKNESS SUSCEPTIBILITY 
(SUBMISSIONS 4 AND 5) 
Project B looks at a new method for reducing susceptibility to motion sickness, is 
comprised of Submission 4 and 5, and primarily sits within the category of 
‘applications’ as defined in the framework presented in Figure 7. However, this project 
also contributes significantly to the scientific literature through the more fundamental 
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understandings of motion sickness, which sits further to the left of Figure 7. One of the 
interesting findings presented in Submission 3 was the relationship observed between 
motion sickness and visuospatial skills. Upon examination of the data, and building 
further on the literature already discussed in Submission 2, it was hypothesised that 
motion sickness susceptibility could be reduced through improving one’s visuospatial 
skills. Project B set out to explore this hypothesis with a two-part experimental design. 
Submission 5 explores, through a simulator study, if through training visuospatial skills 
it is possible to reduce motion sickness susceptibility, a first for the academic 
literature. Submission 5 presents a novel visuospatial training tool, and shows how 
using this training tool participants (n=20) were able to improve visuospatial 
performance. Subsequently, and most significantly, it was shown how this increased 
visuospatial performance was responsible for a significant reduction in motion sickness 
susceptibility experienced within the driving simulator (measured as simulation 
sickness).  
Considering the importance of the findings presented in Submission 5, both for the 
fundamental understanding of motion sickness and the industry application of a 
potential motion sickness management method, Submission 6 looked to replicate this 
study in the ‘real-world’. Using a further 22 participants, a user trial was designed to 
mimic that of the trial presented in Submission 5, but using an on-road driving task as 
the motion sickness inducing task. This study somewhat mimicked the conditions of a 
fully automated vehicle where the occupant sat as a passenger whilst being driven. 
This user trial again showed how the novel visuospatial training tool was successful in 
improving visuospatial performance, and importantly showing how this improved 
visuospatial performance was responsible for a significant reduction in motion sickness 
severity for participants. Submission 6 therefore validated the findings presented 
within Submission 5 and showed the real-world application for a visuospatial training 
tool for the management of motion sickness. Further data was presented within this 
submission around the effect this reduced motion sickness had on cognitive workload 
when completing a basic reading task.  
Project B concludes on these two user trials, presents the data as well as a discussion 
about the implications of this finding. Further, an ideation workshop was conducted 
and methods of exploitation of this new knowledge have been presented – adding to 
the business case support for this project. 
2.1.3 PROJECT C – THE MEASUREMENT OF MOTION SICKNESS 
(SUBMISSIONS 7 AND 1) 
Project C primarily sits within the category of ‘measurement / detection/prediction’ as 
defined in the framework presented in Figure 7, and combines outputs submitted at 
the beginning and the very end of this EngD portfolio.  
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The roots of Submission 7 were again based upon the findings presented in the 
literature review (Submission 2), where this project looked to see the extent to which 
the physiological measures of Electro Dermal Activity (EDA) and skin temperature were 
useful as a measure of real-time motion sickness severity. This project idea stemmed 
from the confusion evidenced within the literature presented in Submission 2 where 
the utility of objective motion sickness measures was often argued. Using the user 
trials presented in submissions 3, 5 and 6 physiological data was collected for later 
analysis – hence it is presented at the end of the portfolio, upon completion of all 
these trials. There was a significant interest from the sponsoring company (JLR) to 
identify useful physiological metrics on which motion sickness can be inferred where at 
that time, JLR researchers were planning on using EDA and skin temperature to 
measure motion sickness. This submission looked at real-time measurement of motion 
sickness (objectively and subjectively) and showed that it is impractical to use these 
physiological measures as real-time motion sickness measures by themselves. Within 
submission 7, recommendations were made on how motion sickness could perhaps be 
measured using a mixed-methods approach, where this allowed for the re-
consideration of the data collection model presented in Submission 1. 
Submission 1, was completed at the beginning of this EngD, and looked at problems 
within JLR’s Self-learning  Car (SLC) project. This submission summarised the issues 
which were being experienced with the SLC system and proposed a new model 
through which data can be collected to better inform a machine learning system to 
enable reliability. The SLC team was disbanded soon after the completion of this 
submission and therefore the context in which the model was developed is less useful 
for this theme of motion sickness. However, the model itself remains relevant and is of 
testament to the appropriately scoped research in that its utility goes beyond its 
original purpose. This model may be applied to the measurement and perhaps 
prediction of motion sickness onset – exemplifying ‘architectural innovation’. The 
model is extracted and its implementation is discussed and explored  within this 
project.   
2.1.4 SUMMARY OF THE PORTFOLIO PLAN 
In summary of the portfolio plan, it is possible to revisit the frameworks presented in 
Figure 6 and Figure 7, combining the two to conclude upon the scope of this EngD. This 














Figure 8 Innovation Report Summary of Scope 
No individual project is constrained to just one area in the scope of motion sickness 
research, where all span the spectrum from fundamental theory-based research to 
industry-ready applications in some manner. However, the three projects presented 
within this Innovation Report do lend themselves to be mapped loosely within the 
framework and evidence how this research has attempted to cover the spectrum of 
research opportunities. The purpose of Figure 8 is to show the scope of the research 
conducted for this EngD, with a fundamental aim to bridge the gaps between 
academia and industry. The section highlighted in blue on the left of Figure 8 
(measurement / detection / prediction) encompasses the study of physiological 
measures and their correlation to motion sickness. In the middle (orange), is the 
impact of motion sickness, and is focused on the performance and subjective 
discomfort that motion sickness brings. Finally, mitigation solutions to the right (green) 
covers strategies for reducing motion sickness without drug or hormonal manipulation 
(i.e., non-invasively). All of these themes will be explored primarily in an automotive 
context, but each offer transferability for their application to the wider field. 
As more of a point of interest, two further scales have been added to the bottom of 
the framework presented in Figure 8. In general, it is understood that the research 
topics towards the left of the spectrum lend themselves to academic research, and to 
the right, industry research – as previous explained. But also interesting for this EngD is 
the applicability of simulation as a research method for studies further to the left of 
the spectrum, where real-world studies are more suited to those further to the right. 
This is of consequence for this EngD project, which looks to cover simulator-based 






2.2  AN INTRODUCTION TO THE PROJECT SPONSOR 
 
Jaguar Land Rover (JLR) are a British automotive OEM (Original Equipment 
Manufacturer) and home of the two previously independent brands of Jaguar and Land 
Rover. The two brands both strongly target the luxury / premium car market. Although 
the traditional primary focus of the two brands has been sports cars (Jaguar) and off-
road capable vehicles (Land Rover), the defining characteristic of their overarching 
business model is certainly one of luxury and quality. More recently, it seems JLR are 
positioning themselves as a lifestyle company, whereby you might ‘buy in’ to the brand 
for the overall experience rather than just the product, their 2019 tag line on their 
company website speaks to this ambition:  
Jaguar Land Rover: “Creating experiences people love for life” (Jaguar Land Rover, 
2019) 
It is this focus on the premium/luxury market and experience ‘creation’ around their 
brand that helps define the scope set out for this EngD. It also uncovers the driving 
force behind this research project, which looks overall to make the JLR experience the 
best it can be for its customers. 
When this EngD began in September 2015, JLR were attempting the development of a 
Self-Learning Car (SLC) system, which aimed to learn user engagement patterns with 
distinct in-vehicle systems (such as heated seats, radio media and climate control). 
There were no new features within the vehicle, but rather the automation of these 
existing features was the innovative step JLR were making to continue their premium 
vehicle development, and create the new experience for their customer. The challenge 
faced by JLR at the time was in finding a way to accurately predict the users’ routine 
based on data it could collect from the user. This challenge was the primary aim of this 
initial EngD conception. The SLC project was taken away from the research department 
and handed over to mainstream engineering, the SLC research team was disbanded 
and the scope of this EngD project therefore adapted and changed. 
Looking towards the future of the automotive industry, with increasing levels of 
automation on the horizon, JLR were keen to better understand some of the human 
factors concerns with automation within vehicles. At the time, the scope from JLR was 
broad with no fixed direction to research. This played to the strengths of the EngD aim 
and the challenge was, considering future mobility, to create a meaningful impact to 
JLR’s future vehicles whilst enabling the ethos of “creating experiences people love for 
life”. An initial consideration from the original SLC project was to explore the possibility 
of driving simulator-based SLC user trials, and how transferable these studies would be 
to real-world applications. One consideration from this was the propensity for people 
to become motion sick during studies (specifically, simulator sick) which gave the 
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consideration for the first project looking to understand if there was a human 
performance consideration. Expanding this line of study, it was conceived that motion 
sickness could be an issue for current, and certainly future automated JLR vehicles. The 
concept of motion sickness was discussed with JLR, and it was agreed that there was 
good scope to help shape their future vehicles by better understanding the 
relationship between motion sickness and future automotive technologies. Such a 
project is well suited to JLR as a car company who are keen to develop value-adding 
and experience enabling technology for their target market in the premium 
automotive sector. When this project began, the JLR research department had limited 
competency within the field of motion sickness management for driving simulators or 
automated vehicles. 
 
3 REVIEWING THE SUBJECTS OF AUTOMATED VEHICLES AND MOTION 
SICKNESS 
 
Although the research aims, objectives and themes have already been presented – to 
enable clarity of this Innovation Report, the aims and objectives were primarily 
concluded upon after the initial literature review (Submission 2). The literature 
covering motion sickness, automated vehicles and the combination of the two was of 
significant interest and importance for this EngD and an introduction to the subjects 
are now presented where the aims and objectives are further justified. This literature 
has been explored in greater detail in Submission 2, and as a result of this 
contextualisation and exploration of the subject a publication was created looking at 
the potential disparity between automated vehicle expectation and realistic outcomes 
(Smyth, Jennings, & Birrell, 2019). 
3.1 AN INTRODUCTION TO AUTOMATED VEHICLES 
 
The premise of increasing automation within a vehicle is to reduce the requirement for 
manual driving interaction from a human driver. Common lay phrases used to refer to 
automated vehicles include ‘self-driving vehicle’, ‘driverless vehicles’ and ‘autonomous 
vehicles’. 
3.1.1 TERMINOLOGY 
There are different levels of automation to classify automated vehicle technologies 
and the most recent, and most useful, scale is supplied by the Society for Automotive 

















Figure 9 Summary of Levels of Driving Automation (SAE International, 2018) 
‘DDT’: Dynamic Driving Task.  
‘OEDR’: Object and Event Detection, Recognition, Classification, and Response 
‘ODD’: Operational Design Domain 
For the purposes of this research and Innovation Report, SAE Levels 2 to 5 (as per 
Figure 9) are of most interest and will further be discussed:  
At SAE Level 2 (partial automation), in defined scenarios the vehicle will allow the 
driver to relinquish control of both lateral and longitudinal driving inputs to the 
automation system. However the driver must remain attentive to the driving task at all 
times, and overall, responsibility for the vehicle still lies with the driver.  
At SAE Level 3 (conditional automation) the vehicle can take control of all aspects of 
driving in defined scenarios (or ODD’s), however, the system requires the user to 
regain control of the vehicle at any time, following a notice period. 
At SAE Level 4 (high automation) the vehicle can control all aspects of the driving task 
within specific ODD’s but will allow the user to take control of the vehicle if they so 
choose – although there is no requirement to do so. This is where the line between 
‘driver’ and ‘passenger’ begins to blur as the user can choose to be either.  
At SAE Level 5 (full automation), the vehicle will control all aspects of the driving task 
and there will be no availability for the occupant to take over the DDT. In such a 
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vehicle, there would not be any traditional driving controls such as a steering wheel or 
pedals.   
As somewhat of a summary to the definitions above, the term Autonomous Vehicle 
(sometimes abbreviated to ‘AV’) relates to an SAE Level 5 full driving automation 
vehicle. Pods, such as the ones created by RDM group (RDM Group, 2017) and as used 
in recent research (Burns, Oliveira, Hung, Thomas, & Birrell, 2019) look physically like a 
Level 5 vehicle (with no manual driving controls), although they are designed to 
operate in specific ODD’s therefore they are classified as Level 4 vehicles according to 
the SAE. The term ‘Automated Vehicle’ relates to vehicles with Level 3, 4 or 5 capability 
(i.e., conditional to full automation). Other commonly used terms such as ‘self-driving’ 
vehicle and ‘driverless’ vehicle, whilst presumably refer to a Level 5 fully autonomous 
vehicle, have fallen into disuse in recent academic literature due to their lack of 
specificity and should therefore be avoided. 
3.1.2 CURRENT STATE-OF-THE-ART 
Although the overall goal of many automotive OEMs is full driving automation (SAE 
Level 5) there are a number of technical and legislative barriers to cross before this 
technology is ready. Until then it is likely vehicles will be released with increasing levels 
of automation, until full autonomy can be achieved. As of 2019, there is already 
evidence of this path to full automation with companies such as Tesla (AutoPilot), 
Cadillac (Super Cruise), Volvo (pilot Assist) and Nissan (ProPilot Assist) amongst others 
all releasing SAE Level 2 vehicles. A subjective review of these current systems has 
been published (Olsen, 2018) and presents a good overview of the various systems and 
implementations of this technology. A key thing to note about Level 2 vehicles is the 
responsibility for the driver to remain attentive to the driving task at all times. The way 
in which this is executed differs between vehicles where, for example, Tesla requires 
hands on the steering wheel at all times and Cadillac monitors eye fixation behaviour. 
Looking at SAE Level 3 systems, Audi has released their ‘Traffic Jam Pilot’ system in 
their 2019 A8 model vehicle, which claims to operate under the defined requirements 
for a Level 3 system and can control all aspects of the driving task (DDT) up to a speed 
of 37mph. As of 2019 there are no commercially available Level 4 or 5 vehicles on the 
market.  
3.1.3 UTILITY OF AUTOMATED VEHICLES 
There are myriad benefits to automated driving systems, and the increased safety that 
these technologies are likely to bring is possible even in the lower levels of 
automation. Initial estimates studying ADAS systems and ‘low levels of automation’ 
show the potential for this technology to reduce light vehicle crashes by at least 
32.99% per year and crashes for heavy trucks by at least 40.88% per year (Yue , Abdel-
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Aty, Yina , & Ling, 2018).  However, considering Levels 4 and 5 it is expected this 
reduction in collisions would be drastically greater. Morgan Stanley have previously 
predicted a US$488 billion saving per year for the US economy due to the reduction in 
road traffic accidents due to Level 4 or Level 5 vehicles (Morgan Stanley, 2013). They 
based this figure on the reporting that 90% of road traffic accidents are related to 
human error (World Health Organisation, 2004 ) (p.10) – so without the driver, they 
expect a reduction of 90% in road traffic accidents. The logic behind this calculation 
may be disputed, but the argument for increased safety is established enough and the 
specifics of exact figures is not necessary for this EngD research. 
Looking past safety, there are many more benefits to this technology, particularly at 
the higher levels (SAE Levels 4 and 5) where the driver can relinquish control to the 
automated system completely. Such systems will enable transportation for those who 
cannot drive a traditional vehicle due to age, health, disability etc. and thus has the 
ability to significantly enhance inclusivity in mobility. Also within these vehicles (SAE 
Levels 4 and 5) comes the ability to engage in non-driving related tasks for extended 
periods. A Level 3 vehicle may also allow for some engagement – although tasks may 
be restricted by the requirement to regain control of a vehicle if needed. Some tasks 
often envisaged for these vehicles include reading, watching films, working and 
socialising, amongst others. A survey conducted by insurance company StateFarm in 
2016 (State Farm, 2016) looked to understand what people want to do within a vehicle 
that can drive itself (referring to SAE Levels 3, 4 and 5), given the premise that self-
driving technology would free up their time to engage in other activities. With a 
sample size of 961 they reported 45% of people would be more willing to read texts, 
36% would be more willing to access the internet, 21% would be more willing to watch 
movies and 19% would be more willing to read a book (StateFarm, 2016). Findings are 
also reported around the trust of automated vehicles, and it is expected that these 
figures presented above would likely increase as trust in the technology and 
willingness to ride in such Level 3, 4 and 5 vehicles increases. The breakdown of 









Figure 10 What People Want to Do in a Level 3, 4 or 5 Automated Vehicle. 
This concept of productivity in vehicles is well supported by automotive OEM’s, many 
of whom have published concepts of what they believe are possible use cases for self-
driving vehicles. The image previously presented in Figure 4 which showed Mercedes-
Benz’s F015 automated vehicle speaks to this consideration and expectation for 
increased productivity in vehicles with all occupants engaging in a work based task. 
Many others are also advertising similar possibilities for future automated vehicles – 




















Figure 12 Volvo Automated Vehicle Prototype (Volvo, 2019) 
As proposed in these concepts, there appears to be a great opportunity to transform 
driving time into time spent doing many other activities when riding in an automated 
vehicle. Further to these leisure activities presented above, there is also scope for 
vehicles to become mobile offices as people can complete work-based activities whilst 
in their automated vehicle. This is particularly true for Levels 4 and 5 automated 
vehicles, but may also be possible, to some extent, for Level 3 vehicles. A recently 
OnePoll survey with a sample size of 2000, revealed how 27% of  the population would 
want to engage with work related activities whilst commuting in an automated vehicle 
(Lofthouse, 2017), although the full research article has not been published. Again, this 
figure is likely to increase as trust and willingness to ride in such vehicles increases. 
Further to this consumer pull, there may also be an industry push for work-orientated 
productivity in future automated vehicles. Morgan Stanley have estimated that the 
ability to work within an automated vehicle could bring US$508 billion per year to the 
US economy (Morgan Stanley, 2013) (p.50). A smaller figure, but again in support of 
the concept of completing work-based tasks in automated vehicles predicts a potential 
US$220 billion per year benefit to the US economy linked to increased productivity 
(Montgomery, 2018). 
 
3.2 AN INTRODUCTION TO MOTION SICKNESS 
 
Humans have been documenting motion sickness as early as 800 BC according to one 
text (Huppert, Benson, & Brandt, 2017) which explores the historical documentation of 
the condition. It is still a condition which humans suffer from today. Motion sickness, 
or ‘kinetosis’ can be experienced in a broad array of scenarios, such as on a boat 
(seasickness), in a car (car sickness), in a simulator (simulator sickness), or on a plane 
(airsickness) etc. Many of these definitions include motion sickness experienced when 
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in a mode of transport, therefore another common phrase covering these is ‘travel 
sickness’. Although all of these terms and more fall under the umbrella term of motion 
sickness (MS). 
3.2.1 THEORIES OF MOTION SICKNESS 
The cause(s) of motion sickness are still, to this day not fully agreed upon, with even 
the most established theories sometimes disputed. The most commonly referenced 
theory of motion sickness is the Sensory Conflict Theory (Reason & Brand, 1975). To 
understand this theory, it must first be understood that there are three primary ways 
of perceiving motion: 
 The Visual system –a person can infer motion using their eyes to track 
movement, light or parallax 
 The Vestibular system – balance organs within the inner ear which are 
responsible for sensing self-motion 
 The Somatosensory system – an area and therefore function of the brain which 
can infer motion based on movement of limbs and pressure on the body etc. 
The sensory conflict theory argues that mismatches between or within visual, 
vestibular or somatosensory inputs cause motion sickness. This theory holds the most 
weight in our present understanding of motion sickness where nearly all motion 
sickness incidences involve at least some form of conflict between these senses (Bles, 
Bos, de Graaf, Groen, & Wertheim, 1998) and therefore, it is most commonly 
observed. Some criticism of this theory is found within the literature, where it is 
argued that because “only a small subset of intermodal patterns of stimulation is 
associated with motion sickness” sensory conflict cannot necessarily predict motion 
sickness (Stoffregen & Riccio, 1991) (p.188).  
As somewhat of a response to the criticism of the sensory conflict theory, a new 
theory of motion sickness was proposed - the Postural Instability Theory (Riccio & 
Stoffregen, 1991). This theory explains how motion (physical or perceived) can disrupt 
the natural postural sway pattern of an individual, resulting in the inability to 
accurately understand ‘centre of gravity’ and therefore inability to maintain postural 
control. This theory was proposed as an alternative to sensory conflict theory and is 
presented as a challenge to the sensory conflict theory (Stoffregen & Riccio, 1991) 
where they argue that prolonged postural instability is the cause of motion sickness 
(Riccio & Stoffregen, 1991) (p. 205). This theory was investigated initially by (Warwick-
Evans & Beaumont, 1991) through a comparison of the postural instability theory to 
sensory conflict theory. Through attempting to remove postural control as a factor of 
the experimental design, the results of their study (where all participants became 
motion sick) indicated that reducing demands of postural control did not reduce 
motion sickness onset or severity. This study provided evidence on which to debate 
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the validity of the postural control theory. A further study using two conditions to 
control postural stability further disproves the hypothesis of the postural stability 
theory (Warwick-Evans, Symons, Fitch, & Burrows, 1998) whilst providing further 
evidence to support the sensory conflict theory.  More recently, the theory of postural 
control is  being considered less of a cause of motion sickness, and more as a precursor 
to motion sickness (Stoffregen, Hettinger, Hass, Roe, & Smart, 2000) (Stoffergen & 
Smart Jr., 1998) (Guerraz, Gianna, Burchill, Gresty, & Bronstein, 2001). It may not be 
postural instability that is necessarily causing motion sickness, but it does often 
precede motion sickness, agreeing there is a relationship between motion sickness and 
postural instability – but not a direct causation. 
Sopite Syndrome (Graybiel & Knepton, 1976) is also commonly discussed in relation to 
motion sickness subjects. Sopite syndrome is a condition related strongly to sensations 
of fatigue and mood changes in relationship to motion (observed and perceived). One 
of the subcategories of the MSAQ is sopite-related symptoms, again attesting to the 
link between this and motion sickness. However, sopite syndrome is not a causal 
theory of motion sickness, rather their relationship is such that they occur due to 
similar stimuli (motion), therefore in similar domains and at similar times.  
3.2.2 CLASSIFICATION OF MOTION SICKNESS TYPES 
Considering the various reference terms for motion sickness (car sickness, seasickness, 
virtual reality sickness etc.) along with the explanation of motion sickness theories it is 
useful to classify motion sickness states based on the presence of physical motion. The 
presence of motion and different motion cues are argued to be of importance in the 
understanding of motion sickness onset (Stoffregen & Riccio, 1991). A useful 
differentiating characteristic of motion sickness-inducing scenarios is those which 
involve ‘afferent’ and ‘efferent motion’. Where afferent motion accounts for when 
“objects are moving in the environment” (i.e., when observing object movement) and 
efferent motion accounts for “movements of the eyes, body or head” (i.e., self-
movement) (Kapoula & Thanh-Thuan, 2006) (p.438). It is afferent motion which also 
leads to the concept of ‘vection’ or the self-illusion of motion which is of consequence 
for sensory conflict theory and therefore motion sickness (for more on vection see 
(Palmisano, Allison, Schira, & Barry, 2015)). Given this reliance on motion (or lack 
thereof) for identifying motion sickness ‘type’, it is useful to categorise the three 







Table 1 Classification of Motion Sickness ‘States’ Based on Motion 
Classification  Examples of motion sickness state 
1. Motion is seen but not felt (afferent 
motion present) (referred to as VIMS) 
 E.g., Space-sickness, virtual reality (VR) 
sickness, simulator sickness (fixed base) 
2. Motion is felt but not seen (efferent 
motion present) 
 E.g., Car sickness, seasickness, airsickness 
3. Motion is seen (efferent) and felt (afferent) 
but the two do not correlate  
 E.g., Simulator sickness (moving base) or when 
using VR equipment or watching a film in a 
moving environment 
 
3.2.3 MOTION SICKNESS SYMPTOMOLOGY 
The subjective sensations of motion sickness are uncomfortable and undesirable, 
where common symptoms include nausea, sweating, headaches and, in severe cases, 
vomiting. The symptomology is somewhat explained through the evolutionary 
hypothesis (Treisman, 1977) which explains how the brain rationalizes the conflict in 
sensory inputs (as per sensory conflict theory) to be the result of ingesting a poison. 
Therefore evolutionary responses to self-sustain result in the characteristic sweating, 
burping and vomiting which are used to push toxins out through the skin, get rid of gas 
build up, and empty the stomach contents in case poison has indeed been ingested. 
The symptomology of motion sickness is somewhat dependent on the incidence of 
onset, where VIMS (visually induced motion sickness) related cases result in more 
visual discomfort, but afferent motion scenarios tends to result in more nausea related 
conditions. As a good explanation of this, two widely used subjective grading criteria 
for motion sickness - the Simulator Sickness Questionnaire (SSQ) by (Kennedy, 
Norman, Berbaum, & Lilienthal, 1993) and the Motion Sickness Assessment 
Questionnaire (MSAQ) (Gianaros, Muth, Mordkoff, Levine, & Stern, 2001) measure 
many motion sickness symptoms and therefore provide a good insight into the types of 
symptoms related to motion sickness. Where the SSQ is more useful for afferent 
motion environments, it is interesting to see a greater emphasis on visual system-
related symptomology, compared to the MSAQ.  
3.2.4 WHO IS AFFECTED BY MOTION SICKNESS 
It is understood that everyone is susceptible to motion sickness except those with 
complete loss of labyrinth function (i.e., those who are completely deaf or have a 
vestibular dysfunction) (Chung, Howard, & Money, 1991) (Kellogg, Kennedy, & 
Graybiel, 1965). The U.S Library of Medicine report that as many as one in three 
people are highly susceptible to motion sickness (U.S. National Library of Medicine, 
2019). Looking at car sickness specifically it is understood that around 60% of the 
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population has experienced some nausea from car travel, whereas about a third has 
vomited in cars before the age of 12 (Griffin, 1990). 
Motion sickness severity and onset frequency vary between demographics also, where 
it is known females are more susceptible than males (Jokerst, et al., 1999) (Flanagan, 
May, & Dobie, 2005) where the effect is even more pronounced when menstruating or 
pregnant. Because of this, and other factors, it is understood that the main reason for 
the gender difference in motion sickness susceptibility is related to sex hormones 
(Matchock, Levine, Gianaros, & Stern, 2008) where those with higher androgen levels 
report fewer incidents of motion sickness and those with higher levels of oestrogens 
report more motion sickness incidences (Hausmann, Slabberkoorn, Van Goozen, 
Cohen-Kettenis, & Gunturkun, 2000). There is also some differentiation between 
mechanisms for visually determining motion between the genders (Schouten, Troje, 
Brooks, Van Der Zwan, & Verfaillie, 2010)  which can result in higher motion sickness 
for efferent motion scenarios (VIMS) for women.  
There is also evidence to suggest that ethnicity has a role to play in susceptibility, 
where in general “Asian people are more susceptible than those of European or 
African origin” (Klosterhalfen, et al., 2005) (p.1051). Highlighting also how genetics too 
have a significant role to play in motion sickness susceptibility (Stern, et al., 1996). 
Further to gender and ethnicity, age also known to have an effect on motion sickness 
susceptibility, the direction of which is relatively well understood for children. It is 
known that infants and very young children are immune to motion sickness (Golding J. 
F., 2006) where susceptibility begins around the age of 6 or 7 (Reason & Brand, 1975), 
peaking towards the ages of 9 to 10 (Turner & Griffin, 1999) before a subsequent 
decline during teenage years. For adults however, there is greater confusion, with 
some claiming motion sickness increases with age (Golding J. F., 2006) (p.71), and 
others claiming motion sickness decreases with age (Turner M. , 1999). In this earlier 
paper (Turner M. , 1999) it is explained how familiarity and experience with travel 
modalities affects motion sickness independently of age. This study (with 3256 
participants) provides a stronger argument for the potential age effect in adulthood 
where the other studies had not considered travel experience as a factor. A greater 
exploration of age has been given in the literature review (submission 2) where it was 
concluded that it is not possible to draw robust conclusions about the effect of age (for 
adults) on motion sickness without an understanding of past travel experience. The 
exploration of age effects is still of interest and worth exploring in dedicated, 
fundamental studies, however it will not be the focus of this more applied EngD 
research. In consideration of the project sponsors motivations, the involvement of 
children was omitted from this EngD research and there was no motivation to add to 
the literature discussing the fundamental age effects.  
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No correlation between the ‘Big Five’ personality traits (extraversion/introversion, 
agreeableness/antagonism, conscientiousness/lack of direction, neuroticism/ 
emotional stability and openness/closeness to experience) and motion sickness 
susceptibility have been observed (Nieto & Golding, 2006). 
 
3.3 THE RELATIONSHIP BETWEEN MOTION SICKNESS AND AUTOMATED 
VEHICLES 
 
Upon the understanding of motion sickness onset and the expected use cases of 
automated vehicles, it is possible to bring the two subjects together to understand why 
this technology may increase motion sickness for many people. The main reasons have 
previously been classified into three key areas (Diels C. , 2014) (p. 303) which has been 
built upon to help create the classification list below, presented in no particular order: 
Table 2 Reasons why Automated Vehicles May Cause More Motion Sickness 
3.3.1 CHANGE OF THE ROLE OF THE DRIVER  
The ability to understand current and upcoming motion is related to the Postural 
Instability Theory (Riccio & Stoffregen, 1991) where understanding motion is key in 
effective postural control management. Although the exact theory linking the postural 
control theory to increased motion sickness through the removal of driving as a task is 
complicated by the disputes around the validity of the postural control theory itself 
(Warwick-Evans & Beaumont, 1991) (Warwick-Evans, Symons, Fitch, & Burrows, 1998). 
However, the reasoning for the increase of motion sickness onset remains. When a 
driver is no longer required to input lateral and/or longitudinal control there is a 
reduced ability to anticipate motion and change(s) in acceleration. This phenomenon is 
known as the ‘Profound Helplessness Reaction’ or, ‘Loss of Control Theory’. This is built 
upon findings that aircraft pilots in control of the plane do not suffer motion sickness 
when the rest of the crew do (Geeze & Pierson, 1986), and vehicle drivers do not suffer 
sickness when driving, despite suffering from motion sickness when being a passenger 
(Howard & Templeton, 1966) (p. 136) amongst others. A useful text exploring this 
relationship between control and motion sickness is provided by (Lublow & Rolnick, 
1991) who show that through control over a motion task, there is a decreased 
likelihood of motion sickness onset.  
 Classification Associated SAE Levels  
1 Change of role from active driver to passive occupant Levels 2, 3, 4 and 5 
2 Propensity to engage in non-driving related tasks Levels 3, 4 and 5 
3 Automated vehicle design changes Level 3, 4 and  particularly 5 
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Using the above findings in an automotive context provides an explanation as to why 
relinquishing control to an automated driving system may increase the chance of 
motion sickness onset. From SAE Level 2 automation onwards there are significant 
driver inputs ‘taken over’ by the car, but it is likely that this effect will be most 
significant in Levels 3, 4 and 5 where both lateral and longitudinal control is handled by 
the vehicle simultaneously.  
3.3.2 NON-DRIVING RELATED TASKS 
It is fairly well established that automated vehicles (specifically Levels 3, 4 and 5) will 
increase the freedoms to engage in non-driving related activities. Some of which have 
been discussed in the previous sections where survey data reports people want to 
engage with their consumer electronic devices such as mobile phones, watch films, read 
books and complete work-based tasks amongst others. All of these tasks increase eyes-
off-road time and therefore the theory of sensory conflict (Reason & Brand, 1975) is of 
importance. Figure 13 below shows a ‘first person view’ of an on-road Level 3 or 4 
vehicle mock-up for an occupant both driving the vehicle, and engaging in a reading task 








Figure 13 Example of Sensory Conflict in a Conditionally Automated Vehicle 
As seen in the image to the left in Figure 13, when driving a traditional vehicle (e.g., 
SAE Level 0, 1 or 2) the majority of the visual field (highlighted in purple) is of the 
outside world. Therefore, the visual system is able to detect motion, which will match 
the somatosensory system and the vestibular system. Given this ability to sense both 
afferent and efferent motion there is a minimal chance of motion sickness onset in this 
scenario. However, with the image to the right of Figure 13, the occupant is now 
reading a book and the majority of the visual field is therefore static with only a limited 
ability to gain visual information about motion (again, highlighted in purple). In this 
second scenario (right) the occupant’s visual system, registering no motion, will be in 
conflict to their somatosensory and vestibular system(s). As a result of no afferent 
motion cues, but still detecting the efferent motion, there is a sensory conflict and 
motion sickness onset is likely. Although this example is given when reading a book, 
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the effect is transferable to any task which requires the occupant to take their eyes off 
the road. Given this, it is discussed and agreed that (considering non-driving related 
activities in an automated vehicle) “all envisaged use cases can be predicted to 
increase the risk of motion sickness” (Diels & Bos, 2015) (p. 14). 
3.3.3 AUTOMATED VEHICLE DESIGN CHALLENGES 
Some concepts for automated vehicles have previously been presented – such as those 
shown in Figure 4, Figure 11 and Figure 12. It is somewhat expected that future 
automated vehicles are likely to move away from traditional vehicle design – 
particularly at the higher SAE levels of automation where traditional driving controls 
are of less importance. There is further affordance to change vehicle design where 
there is less reliance for a ‘driver’ to be attentive to the road in the traditional forward-
facing seat in front of a large windscreen. As the vehicle takes control of more of the 
DDT (Dynamic Driving Task) there is a reduced need to stick to these traditional vehicle 
layouts, and as the desire for non-driving related tasks increases comes the pull to re-
design vehicles to allow these other activities. Even with recent ADAS technology, such 
as parking assists (rear-view cameras, 360 cameras, parking sensors and even self-
parking) there has been a slow shift towards reduced need for the driver to have views 
around the outside of the vehicle. Such technology has afforded the design of DLO’s 
(daylight openings) to change from being designed with a utilitarian approach, to more 
of a stylistic approach as is evidenced in many modern vehicles. It is not possible to 
draw a direct correlation between the increase in technology and reduction in DLO 
size, but the willingness to change vehicle design is evident.  
It is likely that without the consideration of motion sickness, future automated vehicles 
may want to reduce DLO size, place display screens in the way of DLOs, include a host 
of new HMI’s (human machine interfaces) in new locations and enable flexible seating 
(including rearward facing seats). Explanations of why motion sickness will be 
increased in such designs is evident when combining the above two sections where it 
is understandable that many of these design choices will limit the ability to predict 
upcoming motion, manage postural sway, and increase the risk of sensory conflict. It is 
well established in the motion sickness literature that rearward facing seating should 
be avoided, but for the first time in an automotive context research showed 
empirically that rearward facing seating increases the incidence and severity of motion 
sickness (Salter, Ciels, Herriotts, Kanarachos, & Thake, 2019).  
Research published alongside this EngD project (as somewhat of an output from the 
literature review in Submission 2) further argued the need for motion sickness 
considerations in the design of future automated vehicles and went on to propose 
some design recommendations (Smyth, Jennings, & Birrell, 2019). As part of this 
publication, a categorisation table was developed to break down considerations for 
motion sickness in automated vehicles – see Table 3 below.   
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Table 3 Categorising Areas of Motion Sickness Management 
Category Explanation/ Examples 
1 – Occupant  characteristics E.g., a person’s natural susceptibility to motion sickness - including 
demographic differentiation, habituation, clothing, etc. 
2 – Interior design E.g.,  the design of the cabin including seat layouts, display locations, 
user interface design, DLO’s, climate control etc. 
3 – Vehicle design E.g., size, height, vehicle dynamics, suspension etc. 
4– Activity i.e., the activity of the person inside the vehicle such as working. E.g., 
reading, texting on a mobile phone, looking out the window etc. 
5 – Driving E.g., the driving style, speed, acceleration profiles, route motion path etc.  
 
This above table is useful for considering not only physical design but also system 
design, specifically in relation to category 5 Driving. A full discussion of the impact of 
automated vehicle design is given in Appendix 1. 
 
3.3.4 WHO WILL GET MOTION SICK IN AN AUTOMATED VEHICLE 
Of course, without widespread use of automated vehicles in the present day it is not 
possible to report on exactly how many people experience (or will experience) 
automated vehicle motion sickness. However, given the knowledge of how motion 
sickness is caused and how automated vehicles are intending to be used, a few papers 
have attempted to gain an estimation on the scale of the issue. One such paper looking 
at motion sickness onset likelihood for adults riding as passengers in a fully automated 
vehicle found that 37% of Americans, 40% of Chinese, 53% of Indian people would 
“experience an increase in the frequency and severity of motion sickness” (Slivak & 
Schoettle, 2015) (p.5) referring specifically to severe motion sickness. They went on to 
add that the actual figure might be greater depending on in-vehicle activity and the 
design of the vehicle. This paper also did not consider more mild cases of motion 
sickness so again, these figures could be greater still considering all levels of motion 
sickness. 
People surveyed in studies such as in the paper by Slivak, cited above, will have varying 
levels of trust and acceptance of automated vehicles. Research looking at how trust 
and situational awareness affects secondary task performance indicated that as trust 
increases, situational awareness for non-driving-related task completion does too 
(Peterson, Robert, Yang, & Tilbury, 2019). This indicates that as trust and familiarity 
within automated vehicles increases, so might peoples engagement with non-driving 
related tasks. Considering this, it is likely that predictions on how many people will get 
sensory conflict – induced motion sickness may increase as trust with automated 
vehicles increases. The increased likelihood of occupants completing non-driving 
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related activities is one significant reason why motion sickness onset may be more 
frequent in automated vehicles.  
There is no reason to believe that the demographics of motion sickness sufferers will 
change much, where those who are more pre-disposed to motion sickness currently 
will likely also be those who are susceptible to motion sickness in an automated 
vehicle. One thing that is known however, is the strong effect of habituation on motion 
sickness. Therefore, people who ride often as passengers in traditional vehicles and 
those who regularly engage in reading, text messaging, work related, or other eyes-off 
road tasks whilst in a vehicle would, in theory, be more ‘prepared’ (considering 
habituation) for the automated vehicle experience. Further, as experience with 
automated vehicles grows and people use them more frequently, it is perceivable that 
people may habituate themselves to the experience, gradually increasing their ability 
to complete eyes-off-road tasks as their experience and habituation increases. 
However, habituation is somewhat less understood in environments with intermittent 
exposure (e.g., road vehicles) compared to that of boats or planes, so it is not possible 
to conclude on the precise effect this may have at present. 
 
3.4 SUMMARY OF THE LITERATURE - PROBLEM IDENTIFICATION  
 
In summary of the previous three sections introducing motion sickness, automated 
vehicles, and the relationship between the two, the issue of motion sickness and 
automated vehicles is contextualised. It is understood that motion sickness is likely to 
be a factor for many users of automated vehicles, especially so if completing non-
driving related tasks as many claim they want to do. Even for those who do not claim 
to want to complete productivity based tasks in a vehicle, with such significant 
estimates for productivity gains in automated vehicles it seems possible that future 
employers may expect productivity from their staff as part of a job role. 
The implications of motion sickness are relatively well understood considering 
subjective discomfort – where many people have first-hand experience with the 
uncomfortable symptoms of motion sickness. Other factors are less understood, 
where more work needs to be done to understand the impact of motion sickness in 
relation to the automotive industry considering how, for example, cognitive 
performance may be impacted. The impact of motion sickness is of consequence for 
simulator-based user trials as well as automated vehicle use so this must be explored 
within this research. Further to the impact, methods of reducing or managing motion 
sickness also needs to be addressed, where existing methods should be summarised 
and a new method(s) will be explored. If it is likely that many automated vehicle users 
will experience motion sickness further work is needed in finding mitigation strategies. 
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Finally, the measurement of motion sickness is of importance for both research and 
the day-to-day use of automated vehicles to be able to manage, and one day perhaps 
predict, motion sickness onset.  
 
The problems identified are of interest to the field in general, considering the gaps in 
the literature and the problem identified, but also align well with JLR’s objectives as 
the sponsoring company.  
 
4 OVERARCHING METHODS 
 
Before the three core projects of this EngD are presented, a few overarching notes on 
methodology are given. Some measures and methods are used in many of the user 
trials which make up this EngD, therefore an introduction and explanation of these is 
given now which applies to all incidences in which these methods are applied.  
4.1 SIMULATION SICKNESS QUESTIONNAIRE (SSQ) 
 
The Simulation Sickness Questionnaire (SSQ) (Kennedy, Norman, Berbaum, & 
Lilienthal, 1993) is perhaps the most common method of measuring motion sickness 
experienced in a simulator (i.e., simulation sickness). It is comprised of 16 items, which 
allow participants to rate their severity for each symptom on a 0-3 scale ranging from 
none (0) to severe (3). The results from this questionnaire allow for a total motion 
sickness score output and can also be broken down into three subcategories, which 
include nausea (N), oculomotor (O), disorientation (D). The formula for calculating 
these categories relies on the selection of questionnaire items associated with each 
category and multiplying these by a calculated factor weighting as laid out in the 
original paper (Kennedy, Norman, Berbaum, & Lilienthal, 1993). The total score is 
calculated using the sum of all weighted scores and multiplying by another factor 
weighting as explained by Kennedy. In Submissions 3 and 4 total SSQ score was 
calculated by summing the calculated subcategories before applying a total factor 
weighting (ts) to their sum, resulting in a score that was larger, by a factor of ~14, than 
the original method set out by (Kennedy, Norman, Berbaum, & Lilienthal, 1993). The 
conclusions derived from the statistical outputs remain unchanged. For the rest of the 
research the total score calculation followed the same protocol as the original 
publication. A screenshot of the SSQ as used throughout this EngD research is given 

















 Figure 14 Simulation Sickness Questionnaire (SSQ) 
The SSQ is very useful for the measurement of motion sickness in a simulator, and as 
seen, includes a consideration for the measurement of oculomotor discomforts as well 
as a dedicated oculomotor subscale. This is important for simulator use where the 
inclusion of large display screens and dependence on efferent motion cues often 
induce oculomotor discomfort. To derive the total score as well as the subcategory 
scores the original author provides weightings to be applied. These weightings are 
included to provide ease of comparability when plotting results on a graph.  
4.2 MOTION SICKNESS ASSESSMENT QUESTIONNAIRE (MSAQ) 
 
Looking for motion sickness assessment measures for more ‘real-world’ motion 
sickness the Motion Sickness Assessment Questionnaire (MSAQ) was used (Gianaros, 
Muth, Mordkoff, Levine, & Stern, 2001). This questionnaire comprises of 16 items 
whereby participants rate their subjective severity of each symptom on a scale of 1 
(not at all) to 9 (severe). The results of this questionnaire allow for the calculation of a 
total score alongside four subscales including Gastrointestinal (G), Central (C), 
Peripheral (P) and Sopite-related (SR). Total score is calculated as a percentage of total 
points scored, similarly the subscales are calculated as a percentage taking into 
account the number of items associated with each subscale. The screenshot below 
shows the original design of the questionnaire, however the questionnaire used in this 
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EngD used a modified layout whereby the scale from 0-9 was presented alongside each 













Figure 15 Motion Sickness Questionnaire (MSAQ) 
There is a slight error made in the formulas given in the original MSAQ (Gianaros, 
Muth, Mordkoff, Levine, & Stern, 2001) which appears to be a typing error. The 
calculation for ‘central’ should also include the questionnaire’s item 9 ‘I felt 
disoriented’ which has mistakenly been given the subscale reference as ‘Q’.  
 
4.3  FAST MOTION SICKNESS SCALE (FMS) 
 
Both of the above methods of motion sickness assessment are implemented directly 
after an exposure to a motion sickness related task and capture the subjective scores 
at the time directly after exposure. A method of measuring subjective motion sickness 
in ‘real-time’ is also of use where motion sickness can be tracked and measured 
throughout a motion sickness exposure. A method for measuring this is given by 
(Keshavarz & Hecht , 2011) who present a ‘Fast Motion Sickness Scale’ (FMS). This 
scale requires participants to report their motion sickness on a scale of 0 (none at all) 
to 20 (frank sickness). An explanation is given to participants whereby their 
consideration to motion sickness symptoms should “focus on nausea, general 
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discomfort, and stomach problems” (Keshavarz & Hecht , 2011) (p.418). There are a 
few ways in which the FMS score can be calculated for overall discussion, including 
taking the mean score of all scores given, the peak score given or the final score given. 
The authors recommend the FMS peak score as the most useful metric of overall 
motion sickness severity for a scenario. This scale was used for two reasons. Firstly, 
there was already familiarity with this tool within the sponsoring company, therefore 
results could be disseminated effectively and it provided the option to compare results 
if required. Secondly, where it was understood that comparisons of ‘real-time’ motion 
sickness to physiological measures would be of interest, the scale from 0-20 allowed a 
precise rating. Other scales such as the ‘misery scale’ (MISC) (Bos, MacKinnon, & 
Patterson, Motion Sickness Symptoms in a Ship Motion Simulator: Effects of Inside, 
Outside, and No View., 2005) has also proven to be of great utility in recent literature, 
although the MISC but utilises less precise rating scale of 1-7, making it less precise, 
albeit perhaps more simple for participants. 
 
4.4 EMPATICA E4 PHYSIOLOGY WRISTBAND 
 
In addition to measuring subjective motion sickness in many of the user trials 
completed as part of this research, physiological measures were also recorded. The 
utility of physiological measures are often disputed considering motion sickness, and 
this argument will be explored within the research summarised in Project C of this 
Innovation Report. However, as the physiology equipment was used in multiple studies 
a brief explanation is given. The Empatica E4 wristband (Empatica Inc. , 2016) is a non-
invasive wrist mounted device used to collect physiological data including heart rate 
(and derivations thereof), skin temperature, electrodermal activity (EDA) and motion. 
It requires no electrolyte gel and mounts on the wrist with no significant expectation 
of discomfort. . Evidence of its utility has been shown in recent publications such as 
(Betancourt, Dethorne, Karahalios, & Kim, 2017) and (Melnicuk, Birrell, Crundall, & 







Figure 16 Empatica E4 Wristband 
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4.5  THE 3XD SIMULATOR 
 
The ‘3xD Simulator’ is a drive-in, driver-in-the-loop driving simulator located at WMG 
at the University of Warwick, UK (The University of Warwick, WMG, 2016). This was 
used for all of the simulator studies conducted for this EngD. An image of the simulator 
is presented below: 
 
Figure 17 3xD Simulator 
This simulator features a 360-degree screen providing a seamless projection of the 
created world from all viewing angles when inside the vehicle. The BUC (built up 
chassis) used within all experimentation was a Range Rover Evoque as photographed 
above. For all research, all driving related controls are linked to the simulation so the 
driver has complete control over the steering, braking and acceleration of the vehicle. 
Temperature can be controlled within the vehicle and a camera is used inside to 
monitor participants. There is a 2-way radio system allowing communication between 
the participant and the researcher in the control room. 
 
5 MOTION SICKNESS AND HUMAN PERFORMANCE (PROJECT A) 
 
This project stemmed from the literature review discussed in Submission 2 where 
much of the background literature is presented and discussed. The two user trials 
which make up this project were written up as separate submissions and presented as 
Submission 3 and Submission 4 for ease of documentation (see the portfolio plan in 
Figure 6 for further details). The results from Submission 3 and as presented in this 
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section have been used for two publications. The first explored the binary effect of 
motion sickness on human performance (Smyth, Birrell, Mouzakitis, & Jennings, 2018) 
and the second looked for a scale to the observed effect (Smyth, Jennigs, Mouzakitis, & 
Birrell, 2018). The results from Submission 4 were used internally within JLR for 







Driving simulators are very useful tools for developing and testing new technology and 
have many benefits. The immediate benefit is that of safety – particularly when the 
technology involves interaction of the driver where, without understanding the 
potential risks of the technology such as distraction, invasiveness or influence on 
driving behaviour on-road trials should be avoided. A driving simulator provides a safe 
environment in which to test prototype technology where, in the worst instance the 
driver cannot come to physical harm if they make a driving error. Further benefits that 
are particularly useful for scientific research are the controllability and repeatability 
that driving simulators offer. In a simulated environment, the researcher can have 
complete control over all conditions including (but not limited to), road layouts, events 
and traffic. This allows for greater validity when testing technology in specific use cases 
and allows for the creation of many varied scenarios to test the new technology. With 
this controllability comes another benefit – which is repeatability. In many instances, 
particularly when looking for variations between or within a demographic set it is 
imperative that everyone receives the same ‘stimulus’ (dependent variable) on which 
their response (the independent variable) can be measured. In a driving simulator 
example, it is possible to test technology in exactly the same environment and scenario 
multiple times. This is not possible in the ‘real-world’ where it would be near 
impossible to orchestrate the same events to happen in the same way multiple times 
and factors such as changing traffic conditions, weather and external events etc. will all 
limit the repeatability of the study. This ability to create repeatability between trials 
also highlights the benefit of testing time that simulators can bring. With the ability to 
run scenarios one after the other a driving simulator offers a great time saving benefit 
where on-road studies may take much longer to set up and run.  
The list of benefits discussed above is not exhaustive and there are many more 
benefits to driving simulators.  However, there are of course some drawbacks of this 
technology. The most frequently discussed challenge is that of transferability of data 
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collected in a simulator to ‘real-world’ applications. There are many aspects to this 
challenge of transferability – many of which are dependent on specific trials. For 
example, a study measuring headway as the independent variable (i.e., distance 
maintained between the driver’s car and the car in front) may want to consider 
distance perception disparity between the simulator and the real-world. A study 
measuring eyes-off-road time might consider risk perception where participants may 
be more likely to have extended eyes-off-road time if they do not perceive physical 
danger of a driving error. One particular challenge however, which spans across almost 
all simulator studies, is the propensity to experience motion sickness in a driving 
simulator. It is known that motion sickness onset is an unpleasant physical experience 
and often manifests in nausea, sweating, dizziness, fatigue and sometimes even 
vomiting (amongst other symptoms). However, aside from these subjective 
discomforts, there is also the possibility that motion sickness may influence human 
performance and thus affect the validity of user trial results. Further to this, the 
consequence of motion sickness on performance may have further implications for the 
automotive industry as a whole where motion sickness is often experienced in car 
travel (car sickness) and is likely to be experienced also in future automated vehicles. 
5.2 INTRODUCTION 
 
As previously discussed, it is possible that motion sickness can be experienced in a 
simulator where the visual system can gain information on efferent motion, but 
without any afferent motion to match, sensory conflict is likely. This is true in both 
fixed and moving-base simulators where even those which have motion may not be 
able to replicate the expected physical motion as the occupant might expect so the 
disparity between the visual, vestibular and somatosensory system still remains. Below 










Figure 18 Motion Sickness in a Driving Simulator 
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Looking at Figure 18 above it is clear to see why sensory conflict may be likely in this 
scenario. The majority of the visual field is sensing motion (highlighted in purple) whilst 
the vestibular and somatosensory systems are detecting no motion, hence a conflict is 
likely. In fact, it is not uncommon in driving simulator trials to see around 25% of 
participants end the study early due to severe motion sickness as a ‘rule of thumb’. 
Looking at actual data, one study showed it is possible to have 50.3% of participants 
drop out of a user trial (Reed, Diels, & Parkes, 2007). Another study reported 52 out of 
88 participants dropped out of a simulator study due to motion sickness (59%) (Matas, 
Nettelbeck, & Burns, 2015). A meta-study of such MS looking at multiple user trials 
(Balk, Bertola, & Inman, 2013), reported the highest dropout rate in one trial was 71% 
(pp. 259), where the mean drop-out percentage was 14% between the 9 user trials this 
paper reviewed. The results from all these studies only speak to drop-outs - it is 
expected that many more people will experience at least some degree of simulation 
sickness in a driving simulator even though it is not severe enough to make them drop 
out.  
Considering the likelihood of motion sickness onset in a driving simulator, there is 
good reason to further investigate the effect of such sickness on human performance. 
There is limited literature directly discussing the effect of motion sickness on driving 
simulator user trial data, so the literature was explored with a wider scope looking for 
any motion sickness state and its relationship to human performance. Firstly, a tank 
simulator study from 1995 reported that “simulator sickness does degrade training 
effectiveness for some trainees” (p.36) (Lampton, Kraemer, Kolasinski, & Knerr, 1995) 
where the training effectiveness is not a transferable measure. Lampton and Kraemer 
go on to advise that simulator users should not drive a physical vehicle directly after 
the simulator exposure due to their understanding the performance would be 
degraded. This recommendation is commonly found in the literature, for example, one 
driving simulator research paper recommended that motion sickness “can affect 
performance after the simulator experience” (p.795) (Brooks, et al., 2010). Where they 
reference “problems with hand–eye coordination or postural instability that could 
interfere with the real-world task of driving home” (p.795) see also (Jones, Kennedy, & 
Stanney, 2004) and urged participants not to drive immediately after the study. This 
recommendation was based on the findings that use of virtual environments “could 
directly affect visuo-motor coordination” (p.29), where virtual environments can 
induce similar motion sickness effects to other motion sickness prone activities 
(Stanney, Kennedy, Drexler, & Harm, 1999). 
One study looked at a job-related cognitive task (exact task is unspecified) and found 
that when motion sick (seasickness) the inability to complete the task increased from 
5% to 60% (Bos J. E., 2004). This decrease in cognitive function was supported by 
another paper (Colwell, et al., Human Performance Sea Trial QUEST Q-303), which was 
part of a larger seasickness project showing how cognitive task performance decreased 
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with increased motion sickness symptoms. This project (Quest 303 trial) is perhaps one 
of the most useful series of experiments in this area where a three-phase seasickness 
experiment saw participants assessed in pre-exposure over four days whilst the boat 
was docked at harbour. This was followed by an exposure phase of eight days at sea 
with varying sea conditions (and therefore varying motion sickness states) and finished 
with a one-day post-exposure phase with the ship anchored in sheltered waters. The 
project was written up in more depth in an internal report (Bos, et al., 2008) which 
explains how researchers assessed cognitive performance using the Vigilance and 
Tracking Test (VigTrack) (Valk, Simons, Struyvenberg, Kruit, & van Berge Henegouwen, 
1997) alongside the Multi-Attribute Task Battery (MAT) (Comstock & Arnegard, 1992). 
The first assessment tool (VigTrack) was originally designed for aeroplane pilots, where 
the test was designed to relate to specific tasks pilots were expected to be able to 
perform. Therefore the use of this measurement in a seasickness trial may not be 
useful for specific job-based task completion, however it should still give a useful 
report on human performance when studying pre-exposure and exposure scores. The 
task, despite being validated by its authors in other studies, doesn’t appear to be a 
purely cognitive task as there is a heavy reliance on visual tracking of an object on a 
computer screen. Thus, it is likely visual performance also will impact test results. No 
attempt to address visual implications or counter them was discussed. 
Looking then for any relationship between visual performance and motion sickness 
one study looked at visual acuity (i.e., the ability to perceive detail) where a Dynamic 
Visual Acuity test was used as previously developed (Toet & Bos, 2002). In this study 
they found “consistent behaviour: in all tests sick subjects showed worse acuities” 
(p.22) (Bos, et al., 2008). This was written up in a separate report which concludes “a 
highly significant effect of seasickness on acuities” (Bos, Hogervorst, Munnock, & 
Perrault , 2008) (p.1). Further research by NASA looked to improve task performance 
ability by reducing motion sickness. Although they did not report specific measures 
used to record task performance (as it was related to job task) they did find it was 
possible to increase task completion ability significantly by reducing motion sickness 
(Stroud, Harm, & Klaus , 2005) with a speed increase of 12% and decrease in errors 
over two conditions of 39% and 34%.  
In summary of the literature, it is shown that motion sickness affects human 
performance in a number of ways – specifically when looking at job completion. There 
is a need therefore to understand to what extent various fundamental areas of 
performance are affected by motion sickness (where many of the cited texts are 
related to specific work-task related activities). Being able to understand the effect of 
motion sickness on performance will provide a better insight to the transferability of 
simulator data to real-world where it is known that people are likely to feel at least 
some level of motion sickness in a simulator. The research question is therefore set: 
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 Does simulation sickness affect human performance? 
The benefit of such a study is of further interest to the automotive industry however, 
where this Innovation Report has already detailed reasons why future automated 
vehicles may induce motion sickness for a considerable percentage of the population. 
There is added interest to begin to consider if someone is motion sick in an SAE Level 
2, 3 or 4 vehicle is it likely that their performance will be degraded and therefore will 
this have an impact on their ability to monitor or regain control of the vehicle. This is of 
interest as it is understood that non-driving related tasks (such as reading, or watching 
films) may be desirable in automated vehicles and these tasks are likely to induce 
motion sickness in vehicle occupants. Although motion sickness may be avoided 
through the choice not to engage in these tasks, it has already been discussed in this 
Innovation Report that future employment may require work-based tasks where 
motion sickness may be unavoidable.  Although for this study, the research question 
does not extend to automated vehicle applications, the concept remains for discussion 
and adds further justification for the importance of understanding this link between 
motion sickness and performance. 
The hypothesis of this study is that human performance is reduced when experiencing 




To answer the research question a two-part user trial was devised. Phase 1 will take 
part in the 3xD simulator at the University of Warwick, and Phase 2, will take part in 
the RDM SAE Level 4 pods as part of the UK AutoDrive project in Coventry, UK (UK 
Autodrive, 2019). 
 
5.3.1 HUMAN PERFORMANCE ASSESSMENT  
In order to answer the research question concerned with the relationship between 
motion sickness and human performance it must first be established what ‘human 
performance’ is for the purpose of this study. There are hundreds of specific driving 
tasks that could be measured and with future automated vehicles, there are many 
more undefined actions that may be expected of a driver/occupant. It would not be 
practical to measure all driving related performance measures. The limitation of some 
of the previously cited works was in regards to their transferability where many 
performance metrics were specific to a unique work-based task and therefore do not 
necessarily inform on any potential relationship with another task. It was decided that 
fundamental human performance should be measured which includes visual ability, 
cognitive ability and physical ability – where auditory ability was omitted as it is not 
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necessary for driving. The Venn diagram in Figure 19 below maps out the areas of 







Figure 19 Human Performance Diagram 
Using the above diagram to measure the six areas of human performance it is possible 
to apply the findings to any task which falls into one or more of the categories above. 
For example, although this trial will not directly measure the affect of motion sickness 
on comprehension of road signs, the results from the visual-cognitive section may lend 
themselves to this application. It is hoped that many driving tasks can be mapped to 
this diagram, therefore allowing for an understanding of motion sickness for many 
tasks, rather than looking at single specific driving tasks themselves. Table 4 below 
gives some examples of what type of task could be ‘mapped’ to the fundamental 
abilities to be explored: 
Table 4 Examples of Driving-Related Tasks  
Performance area Example of driving-related task 
Visual  Identifying road signs 
 Reading in-vehicle notifications 
 Identifying obstacles  
Physical  Dexterous interaction with out-of-sight HMI or HMI when not looking 
directly at it 
 Physical manipulation of vehicle controls 
Cognitive  Situational awareness of environment 
 Route planning 
 Appraisal of danger 
Physical-Visual  Interaction with HMI (Human Machine Interface) or in-vehicle 
controls (hand/eye coordination) 
Physical-Cognitive  Interaction with variable controls (such as rate of braking or 
acceleration) 
 Emergency driving manoeuvres (reaction time in emergency braking) 
Visual-Cognitive  Identifying upcoming dangers 
 Predicting traffic flow (for example, when approaching a junction) 
 Estimating distances for braking consideration 
 
 To assess the areas of human performance set out in Figure 19 six individual tests 
were needed. There were a few criteria, which the tests should meet: 
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 These tests should be pre-designed, pre-validated and used in other published 
research to ensure transferability, validity and reliability 
 Each test should take no longer than 60-seconds to complete (<six minutes for 
the entire set) so they can be completed before motion sickness recovery, 
where subjective sickness can decline rapidly within the first 5-10 minutes 
(Goulding & Stott, 1997). 
 They should have no ‘learning effect’, so that after the initial practice with the 
task, performance should not get better with repeat exposure 
 They should represent the category which they are assigned (as per Figure 19), 
isolating the specific ability without requiring abilities from other areas of 
performance 
 
Through an extensive review of the literature six tests were found, one for each of the 
areas of performance presented in Figure 19 which are presented below: 
Test 1 - Visual performance: A visual acuity (VA) ETDRS LogMar test chart was used 
whereby participants would use only their dominant eye, standing at a set distance 
and read out the letters presented on the chart. They were scored on the total number 
of letters read. Visual Acuity (VA) is the ability to perceive detail and is quick and easy 
to administer. There are many other visual abilities that could be measured such as 
depth perception, flicker fusion, stereopsis etc. however, all these take longer than 60-
seconds to administer and require specialist equipment. It must be noted that when 
referring to ‘visual ability’ this project is just referring to visual acuity. A screenshot of 












Figure 20 Visual Acuity Test 
Test 2 - Physical performance: A card turning test was extracted from the ‘Jebson 
Taylor Hand Function Test’  (Raad, 2012). This test is used to measure physical skill and 
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dexterity in its original design. The cards used were 3” by 5” index cards as required by 
the standardized test. The cards were white and set on a dark grey table. Although 
there is visual ability required to identify the cards it is considered the visual 
requirements are extremely low where the cards are clearly identifiable, of sufficient 
contrast and size and would be used by people who are able to drive so it is assumed 
eyesight in normal conditions will not be a problem. As explained in the Jebson Taylor 
Hand Function Test, participants were scored on the time taken to turn over all cards 
for both their dominant and non-dominant hand independently. An image of someone 








Figure 21 Card Turning Test (UAB OTCLASS, 2014) 
Test 3 - Cognitive performance: A ‘Paced Visual Serial Addition Test’ (PVSAT) was used, 
which is a visual version of an n-back test (for n-back see (Kane, Conway, Miura, & 
Coleflesh, 2007)). A visual version was preferable where ordinarily this test is given 
audibly, however, without the knowledge of audible skills, ability to distinguish accents 
for participants and hearing variability between participants a visual test was 
preferred. Numbers (from 1-10) were presented on a screen and participants had to 
add the current number to the previously shown number (i.e., 1-back) and give the 
answer verbally before the next number appeared. A 200pt font size with black text on 
a white background was used and the numbers were presented on a Microsoft Surface 
Pro 4 with a display screen of 31cm. It is believed the clear representation of the 
numbers is sufficient to isolate cognitive performance by reducing any effect of visual 
performance.  Participants were scored on the number of correct answers. An example 
of the test is given below: 
-if the first number is 3 the participant doesn’t answer. 
-if the second number is 5 the participant answers 8 (3+5) 
-if the third number is 9 the participant answers 14 (5+9) etc. 










Figure 22 N-Back Test 
Test 4 – Visual-cognitive performance: A modified mental rotation test (MRT) was used 
(Peters M. , et al., 1995) whereby a ‘target’ 3D shape was presented on paper to the 
participant with four other shapes, their task was to identify which two of the shapes 
matched the target shape, despite being rotated into a different orientation. The test 
usually takes upwards of three minutes to complete however, to reduce the time 
requirements just four questions were extracted from the full test and participants had 
to complete the four questions as fast as possible. This deviation from the standard 
test reduces the transferability of the results to other studies using an MRT test, but 
due to time restrictions is was a necessary compromise. Participants were scored on 
completion time and the number of correct answers (i.e., if they gave the two correct 
shapes per question). Two example questions are given below where the target shape 
is highlighted by a thick border and the two correct answers for each question (i.e., 








Figure 23 Mental Rotation Test (MRT) 
Test 5 - Physical-visual performance: The Perdue Pegboard (Radd, 2014) was used to 
measure physical-visual performance. This test requires the physical dexterity and 
visual skill of locating pins in small holes. There are a few ways in which this test can be 
administered including constructing pins with washers and spaces. However, the basic 
version of just placing the pins in the holes was chosen as it was quicker to administer. 
Participants were tested with their dominant and non-dominant hand independently 
and were scored on the number of pins they put in the holes in the time given of 60-










Figure 24 Perdue Pegboard (OPC Health, 2018) 
Test 6 – Physical-cognitive performance: A reaction time test was used whereby a large 
traffic light was displayed on the Microsoft Surface Pro 4 screen, When the bottom 
green light illuminated (within a random length of time between 1 and 6 seconds) the 
participants had to press a physical button on a wired computer mouse. The amber 
light does not illuminate in this test. This test depended on cognitive processing speed 
and the physical response to press the button. Again, there was a visual aspect to this 
test, however, the traffic light was very large so easy to identify and given the spatial 
layout of a traffic light (familiar for all participants who all had a driving license) they 
will be able to identify the change with minimal visual skill. Participants were timed for 
five consecutive repetitions and their score was derived from the average of the five 









Figure 25 Reaction Time Test (Allen, n.d.) 
A summary of the six tests chosen to assess the human performance areas (as 






Table 5 Tests of Human Performance 
Test 
number 
Test area Test name 
Test 1 Visual ETDRS LogMar Visual Acuity 
Test 2 Physical Jebson Taylor Hand Function – Card Turning 
Test 3 Cognitive Paced Visual Serial Addition Test - PVSAT 
Test 4 Visual-Cognitive Mental rotation test 
Test 5 Physical-Visual Perdue Pegboard test 
Test 6 Physical-Cognitive Reaction time 
 
For Phase 1 of this study, the battery of six tests will be given to participants a total of 
three times each. For that reason, Tests 1, 3 and 4 (as per Table 5) were created three 
times each, each including a different set of questions so the participant did not see 
the same questions more than once. Each time the battery of tests were given, the 
order in which they were received was randomised. The first exposure to the tests is to 
teach the participants how to complete the test. The researcher will explain all 
instructions and give the participant a chance to try the tests– repeating the same test 
if required until familiar with the process. The second time they complete the tests will 
be to measure baseline performance in a non-motion sick state. The third time they 
complete the tests will be after a motion sickness exposure where their motion 
sickness will also be measured and the difference between their baseline scores and 
‘motion sick’ scores will be studied. 
For Phase 2 of this study only the cognitive and cognitive-physical tasks were used 
(Tests 3 and 6 as per Table 5). There was a significant time restriction as this trial was 
running alongside the JLR UK AutoDrive user trials so only a total of seven minutes 
available for data collection (including questionnaires etc.). These two tests were 
chosen after Phase 1 was complete as they were identified as being particularly 
interesting considering motion sickness.  
5.3.2 PROCEDURE FOR PHASE 1 – A SIMULATOR STUDY 
For Phase 1 of this two-part study design the participants will use the 3xD driving 
simulator where motion sickness (specifically, simulation sickness) will be measured. 
51 participants were recruited for this user trial using a convenience sampling 
technique. There was limited opportunity to collect pre-trial information for screening 
participants. Use of the motion sickness susceptibility questionnaire (MSSQ) (Golding J. 
F., 1988) in the trial itself was considered but omitted to ensure participant 
engagement time was kept under 60 minutes as requested within the guidelines from 
the BSREC committee. Participants were required to be aged between 18 and 65 and 
have normal or corrected to normal eyesight to take part. Upon arriving at the 
simulator at their agreed timeslot the trial was explained to them, they read through 
the participant information leaflet, signed the consent form and completed a 
demographics questionnaire. They were then trained on how to complete each of the 
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six human performance tests before their baseline scores were recorded. Participants 
were given a Simulation Sickness Questionnaire (SSQ) to complete to identify any 
baseline symptoms (such as if participant had a pre-existing headache or fatigue) so 
this could be filtered out from post-exposure scores. Participants were also asked to 
wear the Empatica E4 wristband and their physiology was tracked throughout the 
study.  
Participants were introduced to the 3xD simulator and given full instructions on how to 
operate the vehicle. The vehicle cabin was maintained at a stable 21 degrees Celsius 
throughout the study. The route was designed specifically for this user trial and began 
with an 8-minute familiarisation run, which consisted of a straight road at a constant 
speed (30mph). The concept of a familiarisation run is supported by (Reed, Diels, & 
Parkes, 2007) and this is considered an ethically appropriate way to begin a simulator-
based study to reduce the chance of immediate severe motion sickness. The main test 
route followed directly on from the familiarisation route where gradual bends and 
changes in speed were slowly introduced. The route consisted of a mixture of country, 
rural and motorway roads and takes approximately 30-minutes to complete. The final 
10-minutes of the route were particularly challenging with increasingly complex bends 
and junctions which were designed to challenge participants who have a particularly 
low susceptibility to motion sickness. Throughout the route, automated ‘sat-nav’ style 
instructions were played through the in-car speakers to the participant so everyone 
took an identical route. Multiple speed signs ensured participants completed the drive 
at a similar pace and road blocks ensured that only one route was possible to follow – 
although the researcher monitored driving progress throughout. 
Whilst driving the simulator, participants were able to speak to the researcher through 
the 2-way radio system whilst the researcher sat in the control room. Participants 
were asked once every minute to rate their motion sickness as per the FMS design 
(Keshavarz & Hecht , 2011). Participants were reminded at the beginning of the driving 
scenario that if any time they felt too unwell and wanted to end the study they should 
say so right away and the driving task can be stopped. If the researcher noted a 
particularly severe increase in FMS scores or a participant appeared to be getting more 
uncomfortable the researcher prompted the participant to consider if they were fit to 
continue. There was no specific criteria used to classify a ‘severe increase’ in FMS 
score. It was expected that scores would gradually increase, but if this increase 
became uncharacteristically high for that given individual, the researcher would ask 
the participant if they were fit to continue.  
At the end of the drive, participants came back to the control room (connected to the 
main simulator) and immediately completed the battery of six tests again, in a 
randomised order. All tests were completed within 6-minutes of the scenario ending. 
After this, another SSQ was given where participants were asked to rank their motion 
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sickness between ending the driving scenario and until this point. Even if participants 
asked to end the driving early, they were still eligible to complete the six tests and SSQ 
as long as they were happy to do so, as the length of driving was not a variable of 
interest, rather their motion sickness state was of interest. All participants were 
reminded that if they feel unwell, to stay and recover as long as necessary and to not 
drive a car for at least 1 hour after the simulator exposure, and until they feel well 
enough to do so. This user trial was approved by the University of Warwick Biomedical 
& Scientific Research Ethics Committee (BSREC) with the reference: (REGO-2017-2090). 
A photo of a participant taking part in the study is shown below in Figure 26 (with 








Figure 26 Human Performance Simulator Study (Phase 1) From the Control Room 
An example of what the participant might have seen whilst in the vehicle is also shown 










Figure 27 Human Performance Simulator Study (Phase 1) Inside the Simulator 
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5.3.3 PROCEDURE FOR PHASE 2 – A ‘REAL-WORLD’ STUDY 
Phase 2 used the UK AutoDrive trials (AK Autodrive, 2018) on which to collect 
additional data using 17 participants - none of whom had completed the simulator 
study in Phase 1. For this trial, the overall trial design was already set out by the JLR 
research team. Given this, there was no chance to contribute to the trial design and 
the study had to be written around the existing research plan. 7-minutes were given 
for data collection for this motion sickness study. When participants arrived at the 
facility they were given the SSQ to complete to capture any baseline conditions. 
Although the MSAQ would have been more appropriate for this ‘real-world’ study, it 
was important that results would be transferable to the simulator study in Phase 1 so 
the SSQ was a necessary comprise. The SSQ has been used in on-road studies 
successfully previously (Salter, Ciels, Herriotts, Kanarachos, & Thake, 2019) so it was 
still deemed an appropriate tool. After completing the baseline SSQ, participants were 
then introduced to the cognitive and cognitive-physical tests as previously explained 
and as presented in Table 5 Tests of Human Performance. They had a chance to learn 
how to complete the tests and then baseline scores were measured where the tests 
were given in a random order.  
The self-driving pod exposures formed the core of the user trial for the organisers, this 
process saw participants sitting in the self-driving pod for 8-minutes whilst the pod 
drove around a test facility. Participants were not allowed to complete any task inside 
the pod (use their phone, read a book etc.) so were asked to just sit and observe the 
‘scenery’. After the 8-minutes, participants exited the pod and completed a 
questionnaire about trust, sitting in a waiting room whilst another participant was in 
the pod. This cycle of 8 minutes in the pod, 8 minutes out was repeated four times. 
The total number of exposures to the pod was four, with a total time in the self-driving 
pod being 32-minutes. The test track was based within an approximately 24m by 34m 
warehouse and the pod followed a pre-programmed route through the track turning, 
braking and accelerating autonomously. The pod travelled at 2.5m/s (approx. 5.6mph) 
on the straights and slowed to 2m/s (approx. 4.5mph) for the corners. An image of a 






Figure 28 RDM UK AutoDrive Pod 
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Figure 29 Layout of Test Facility  
No photos of the pods or test facility were allowed at the time of testing and no 
dimensions or measures of test circuit or vehicle dynamics could be collected.  
After the final pod exposure participants came to the control room and immediately 
completed the two performance tests (cognitive and cognitive-physical) in a random 
order and completed another SSQ to give comparative results. Although participants 
completed the performance assessments only at the end of all four exposures (with 
gaps in-between each exposure), it is understood that total motion sickness recovery is 
greater than 8 minutes and certainly not less than 10 minutes (Goulding & Stott, 1997), 
so residual effects in-between exposures would be expected to ‘carry over’. This, 
although not an ideal experimental procedure was the best achievable methodology 
considering the practical limitations of this collaborative research. 
The hypothesis of this experiment was that if motion sickness was induced, this would 
be responsible for a reduction in human performance 
5.3.4 DATA ANALYSIS 
The statistics package SPSS (version 26) was used for analysis of results where people 
who dropout of the driving scenario due to motion sickness as a group were compared 
to those who completed the entire drive. This grouping method is an effective way of 
categorising motion sickness objectively whilst ensuring the outcomes of analysis will 
be practical to inform the overall research question. Mixed ANOVA’s were the primary 
method of analysis, but were supported by further t-tests, one-way ANOVAs, Welsh 
ANOVAs, Sign tests and Wilcoxon Signed-Rank tests, where appropriate. In all cases 
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5.4.1 PHASE 1 – A SIMULATOR STUDY 
51 participants took part in Phase 1 of this user trial, including 27 males and 24 
females. The minimum participant age (measured using age ‘brackets’) was 22 ± 4 
years, with a maximum age of 49 ± 4 years, a mean age of 31 and a standard deviation 
of 10.13. Exact reporting on ages is not possible where age groups were used. In total, 
45% of participants ended the study early due to MS (N=23), including 26% of males 
(N=7) and 67% of females (N=16). These participants are referred to as ‘dropouts’ and 
make up ‘Group 2’. Group 1 participants include all the participants who completed 
the full driving scenario and were not severely motion sick. All dropouts still completed 
the post-driving the SSQ and six performance tests. SSQ scores were collected and 
calculated to give a ‘total’ score and a score for the three subcategories (‘nausea’, 
‘oculomotor’ and ‘disorientation’). An exploratory analysis was conducted where 
scores were reported for ‘pre-driving (i.e., scores reported before the driving task) and 
‘post-driving’ (i.e., the scores reported directly after the driving task) including mean 
and standard deviation (SD) and this is presented below in Table 6.  
Table 6 Exploratory Analysis of the Subscales of the SSQ 
 
As seen, motion sickness was increased across the group where, on average, simulator 
use caused a total motion sickness score of 31.499. Table 7, below now looks at delta 
scores (i.e., change in sickness) for Group 1 (those who completed the driving) and 
Group 2 (those who dropped out due to sickness). All delta (Δ) scores for statistical 
analysis were calculated on an individual basis (post score minus baseline score) before 




Mean Pre-Driving SD 
Post-Driving 
Mean Post-Driving SD 
Nausea 3.18 7.05 44.71 32.74 
Oculomotor 6.66 11.39 33.44 21.66 
Disorientation 2.95 7.38 52.68 42.8 
Total 3.667 4.701 35.166 23.287 
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Looking at the SSQ scores comparatively between those who completed the driving 
(Group 1) vs those who dropped out (Group 2) a one-way ANOVA reveals significance 
for three of the four SSQ categories. Where dropouts had a significantly higher Δ Total 
SSQ score (F=10.009, p=0.003), Δ Nausea score (F=16.453, p<0.001), and Δ Oculomotor 
score (F=12.305, p<0.001). However there was no significant difference between those 
who completed the driving scenario and dropouts for the Disorientation subscale 
(F=0.361, p=0.551). Average motion sickness scores for each group has been shown 
below in Figure 30. The notation * denotes a 95% confidence significant difference, 
and ** a 99% confidence and the error bars indicate the standard deviation. 
 
Figure 30 Motion Sickness Scores for Group 1 and Group 2 
An exploratory analysis of the six human performance tests was conducted - each 
denoted by a number from 1 to 6 – as per Table 5. Tests 2 and 5 scores were recorded 



















Motion Sickness Scores (SSQ)
Group 1 Δ mean Group 2 Δ mean
SSQ Category 
Group 1 Δ 
Mean Group 1 SD Group 2 Δ Mean   Group 2 SD 
Nausea 22.279 30.221 62.856 30.376 
Oculomotor 33.308 35.809 71.416 42.658 
Disorientation 25.989 21.581 29.661 21.910 






required to report on their dominant hand). The results are presented in Table 8 
below: 











1 (Visual) Score 1.055 0.093 1.056 0.09 
2 (Physical) Dominant 3.813 0.617 4.025 0.737 
Non-Dominant 4.015 0.835 4.289 0.81 
3 (Cognitive)  Score 18.196 1.184 17.569 1.769 
4 (Visual-Cognitive Score 3.157 1.027 3.235 0.971 
Time 79.821 43.789 74.878 43.738 
5( Physical-Visual Dominant 16.039 1.673 15.529 1.641 
Non-Dominant 14.765 1.531 14.471 1.419 
6 (Physical-
Cognitive) 
Average Time 0.3 0.038 0.324 0.056 
It was shown previously that participants who dropped out (Group 2) reported 
significantly higher total motion sickness scores compared to those who completed the 
study (Group 1). To explore the scores visually, seven graphs are presented to show 
the scores before (pre) and after (post) simulator exposure for both the non-motion 
sick group (Group 1) and the motion sick group (Group 2). A note has been added 
below each graph to explain the implication of an increased score, where the 
implication of a decrease score is opposite. The notation * denotes a 95% confidence 
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 Figure 34 Visual-Cognitive Performance Score (Test 4) note: an increase in score indicates an 
improved performance 
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Figure 37 Physical-Cognitive Performance (Test 6) note: an increase in time indicates a reduced 
performance 
 
Looking at the above figures, visually, there appeared to be some differences in 
abilities between Group 1 and Group 2’s pre-exposure (i.e., baseline) performance 
scores. To understand if there was a difference, a mixed ANOVA was conducted. The 
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Table 9 – Group 1 vs Group 2 Pre-Exposure Performance Scores 
 
Groups Mean Std. Deviation N 
1 Visual  Group 2 1.0478 .06681 23 
Group 1 1.0607 .11055 28 
Total 1.0549 .09277 51 
2 Physical (dominant) Group 2 3.8261 .66436 23 
Group 1 3.8021 .58695 28 
Total 3.8129 .61675 51 
2 Physical (non-
dominant) 
Group 2 4.1426 .97678 23 
Group 1 3.9104 .69869 28 
Total 4.0151 .83489 51 
3 Cognitive Group 2 17.9565 1.49174 23 
Group 1 18.3929 .83174 28 
Total 18.1961 1.18355 51 
4 Visual Cognitive (Score) Group 2 3.0870 1.04067 23 
Group 1 3.2143 1.03126 28 
Total 3.1569 1.02708 51 
4 Visual Cognitive (Time) Group 2 80.2596 21.77686 23 
Group 1 79.4611 56.25164 28 
Total 79.8212 43.78945 51 
5 Visual Physical (non-
dominant) 
Group 2 14.7391 1.38883 23 
Group 1 14.7143 1.60686 28 
Total 14.7255 1.49771 51 
5 Visual Physical 
(dominant) 
Group 2 16.3043 1.29456 23 
Group 1 15.8214 1.92553 28 
Total 16.0392 1.67285 51 
6 Physical Cognitive Group 2 .3105 .04089 23 
Group 1 .2913 .03286 28 
Total .2999 .03757 51 
Box’s test for equality of covariance matrices (‘M test’), showed that with an M value 
of 74.440 and a p value of 0.073 we can reject the null hypothesis (with a 0.05 
significance threshold) and assure reliability in a mixed ANOVA analysis where the data 
meets the assumption of a multivariate normal distribution. 
Assuring Mauchly's Test of Sphericity indicated that the assumption of sphericity had 
been violated a mixed ANOVA with repeated measures with a Greenhouse-Geisser 
correction was used to understand if there was a difference between mean 
performance baseline scores between the groups (Group 1 and Group 2). There was no 
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main effect for group observed between baseline test scores (F(1, 49)= 0.006, 
p=0.936). 
Following this precursory analysis, the data was then explored to see if there was a 
difference between the change of performance scores of Group 1 and Group 2 
participants where motion sickness is the differentiator between the groups. This will 
give an indication as to the effect of motion sickness on human performance, where 
dropping-out of a user trial is a good indicator that someone is motion sick. A mixed 
ANOVA was conducted for each performance test. Although there were only six 
performance areas, test 2 and test 5 tested both dominant and non-dominant hands 
independently and thus 9 analyses were completed.  
Test 1 visual performance. There was no significant main effect for pre vs post test 
score F(1, 49) =0.290, p=0.866 for the entire group of participants. Further, there was 
no significant main effect between the groups F(1, 49) =0.145, p=0.705. There was no 
interaction between pre and post test scores and group F(1, 49) =0.198, p=0.658. 
These results show that performance remained unaffected after simulator use, and 
this was true for both the motion sick group (group 2) and the non-motion sick group 
(group 1). 
Test 2 physical performance (dominant hand). There was as a significant main effect 
observed for pre vs post test score F(1, 49) =15.308, p<0.001. There was no main effect 
between the groups F(1, 49) =2.288, p=1.137. Following the significant main effect of 
pre vs post, there was also a significant interaction between pre/post and group F(1, 
49) =16.251, p<0.001. The estimated marginal means showed how Group 2 (motion 
sick) took significantly longer to complete the card turning task (pre vs post exposure) 
indicating a decreased physical performance for the motion sick group (group 2). The 
estimated marginal means have been plotted below to show the direction, where an 













Figure 38 Test 2 Physical Performance (dominant hand) Error bars: 95% CI  
(Group 1 Non-Motion Sick, Group 2: Motion Sick) 
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Test 2 physical performance (non-dominant hand). There was as a significant main 
effect observed for pre vs post test score F(1, 49) =11.282, p=0.002. There was no main 
effect between the groups F(1, 49) =2.800, p=0.101. There was no significant 
interaction between pre/post and group F(1, 49) =2.032, p=0.160. The estimated 
marginal means plot below shows that although time taken to complete the task 
increased after exposure for the entire sample, the difference in scale between the 
motion sick and non-motion sick group was not significantly different showing that the 
classification for motion sickness (dropout vs non-dropouts) did not impact the scale of 
performance change. The estimated marginal means have been plotted below to show 
the direction, where an increase in score shows an increased time to complete the 












Figure 39 Physical Performance (non-dominant hand) Error bars: 95% CI 
(Group 1 non-motion sick, Group 2: Motion Sick) 
Test 3 Cognitive performance 
There was a significant main effect between exposures F(1, 49) =11.155, p=0.001. 
There was also a significant main effect of group F(1, 49) =5.114, p=0.028. The 
interaction effect was not significant at a confidence threshold of 0.05, where F(1, 49) 
=3.918, p=0.053. This result shows that performance was degraded for both groups 
and they were affected to different extents. However, the lack of an interaction shows 
again the scale of performance degradation was not well characterised by the motion 
sickness classification. The estimated marginal means have been plotted below to 



















Figure 40 Cognitive Performance Error bars: 95% CI  
(Group 1 Non-Motion Sick, Group 2: Motion Sick) 
 
Test 4 visual cognitive performance (score) 
There was no main effect observed for pre vs post exposure, F(1, 49) =0.409, p=0.525 
nor was there a difference observed between the sickness groups. F(1, 49) =0.260, 
p=0.873. Further, there was no interaction observed F(1, 49) =1.258, p=0.267, all of 
this indicates that performance was not affected through simulator use or motion 
sickness. 
 
Test 4 visual cognitive performance (time to complete) 
Similar to the visual-cognitive score analysis there was no main effect for pre vs post, 
F(1, 49) =2.920, p=0.094, between the groups F(1, 49) =0.017, p=0.898, or interaction 
F(1, 49) =0.073, p=0.789. This shows how performance (i.e., the time to complete the 
task was not affected through simulator use or motion sickness. 
 
Test 5 Visual Physical performance (non-dominant) 
There was no main effect observed between assessments F(1, 49) =2.562, p=0.116 or 
between groups F(1, 49) =0.073, p=0.789. Further, there was no interaction observed 
F(1, 49) =0.074, p=0.787 indicating that simulator use and motion sickness did not 
impact performance for the non-dominant hand. 
 
Test 5 Visual Physical performance (dominant) 
Looking at the dominant hand scores, there was a main effect observed between tests 
(pre vs post) F(1, 49) =9.910, p=0.003. However there was no significant group main 
effect F(1, 49) =0.010, p=0.920, or interaction F(1, 49) =3.670, p=0.061. The estimated 
marginal means have been plotted below to show the direction, where an decrease in 





















Figure 41 Visual Physical Performance (dominant hand) Error bars: 95% CI  
(Group 1 Non-Motion Sick, Group 2: Motion Sick) 
 
Test 6 physical cognitive performance 
For the physical cognitive performance a strong main effect between the pre and post 
test was observed F(1, 49) =33.727, p<0.001. There was also a main effect of group 
observed F(1, 49) =5.006, p=0.030. However, there was no interaction F(1, 49) =3.494, 
p=0.068. This shows that simulator use negatively affected both groups, and with a 
difference between the groups, motion sickness was a compounding negative factor 
for group 2. However, the lack of interaction again hints that the grading criteria of 
motion sick vs not motion sick was not entirely effective for predicting the scale of 
performance change. The estimated marginal means have been plotted below to show 
the direction, where an increase in score indicates a longer reaction time and thus a 










Figure 42 Physical Cognitive Performance Error bars: 95% CI  
(Group 1 Non-Motion Sick, Group 2: Motion Sick) 
The mixed ANOVA is a very thorough analysis, allowing the variance across the groups 
to be taken into account for each analysis. However, for consistency between 
submissions within this EngD research, further analysis was also done through splitting 
the groups and analysing them in comparison to one another. These outputs are useful 
to consider as a post-hoc analysis for where there was a significant main effect of pre 
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vs post exposure in the previous mixed ANOVA. The paired (pre and post) data sets 
were not normally distributed and symmetry was not observed in the data from Test 3, 
Test 4 (time and score), Test 5 dominant and Test 6. Therefore, data was analysed 
using the Sign Test for the non-symmetrical results and the Wilcoxon Signed-Rank Test 
for the symmetrical results. The output is presented below in Table 10 where all 
significant findings are highlighted in yellow and directional arrows (↑,↓) have been 
included next to significant results to show if this difference was an improvement (↑) 
or reduction (↓) in objective performance. 
Table 10 Analysis of Dropouts and Complete Scores (where ** indicates 99% confidence) 
Test Number Score Group 1 Pre vs. Post Group 2 Pre vs. Post 
1 (Visual) Score Z=-0.428 Z=-0.404 
2 (Physical) 
 




3 (Cognitive)  Score p=0.804 p=0.004 ↓ 
4 (Visual-Cognitive) 
 
Score p=0.791 p=0.118 
Time p=0.265 p=0.523 
5 (Physical-Visual) 
 




6 (Physical-Cognitive) Average Time p=0.003 ↓ P<0.001 ↓ 
 
As shown above in Table 10 there is a significant difference in many performance 
scores for Group 2 participants (i.e., those who dropped out due to motion sickness) 
where performance was statistically decreased for Physical ability (Test 2), Cognitive 
ability (Test 3), dominant hand Physical Visual ability (Test 5) and Physical-Cognitive 
ability (Test 6). For the ‘complete’ participants (i.e., those who didn’t drop out due to 
severe motion sickness there was no change in their abilities in any test other than the 
Test 6 which showed a significantly reduced Physical-cognitive ability, which used a 
reaction time test.  
The previous analysis methods have looked at motion sickness as a binary state – by 
comparing those who had to drop out of the study (Group 2) vs. those who were able 
to complete the full driving scenario (Group 1). Within the mixed ANOVA method it 
was shown that, through a lack of interaction in some tests, the grouping classification 
was not always an appropriate indicator for the difference in scale of performance 
change between groups. It was interesting therefore to see if there is a scale to the 
effect where it’s possible that motion sickness severity as ascertained from the SSQ 
may correlate to performance degradation. Participants were split into three equal 
groups of 17 participants, based on individual MS (motion sickness) severity where 
group 1 contained participants with the lowest Δ(delta) SSQ scores, group 2 consisted 
of the next 17 participants and group 3 consisted of the final 17 participants with the 
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greatest Δ SSQ scores. An ANOVA showed a significant difference between the three 
groups’ SSQ scores (F=36.882, p<0.001). An exploratory analysis of the groups 
(considering motion sickness) is given below in Table 11 
Table 11 Descriptive Statistics of MS Severity Groups 
 
Now, Table 12 below presents the mean performance delta scores for the three 
groups, where delta scores were calculated for each individual, before an average of 
each group was taken. 
Table 12 Descriptive Statistics of Performance for MS Severity Groups 
Performance area Group Mean Std. Error Standard Deviation 
Test 1 Visual 
1 0.0056 0.01312 0.05565  
2 0.0119 0.01376 0.05504  
3 -0.0141 0.01303 0.05374  
Test 2 Physical (dominant) 
1 0.0556 0.05774 0.24498  
2 0.2288 0.15137 0.60547  
3 0.3606 0.12984 0.53533  
Test 2 Physical (non-dominant) 
1 0.0922 0.10543 0.44729  
2 0.2969 0.15609 0.62435  
3 0.4435 0.17436 0.71891  
Test 3 Cognitive 
1 -0.1111 0.29024 1.23140  
2 -0.8750 0.40697 1.62788  
3 -0.9412 0.30281 1.24853  
Test 4 Visual Cognitive (Score) 
1 0.2778 0.23990 1.01782  
2 0.1250 0.20156 0.80623  
3 -0.1765 0.31196 1.28624  
Test 4 Visual Cognitive (Time) 
1 -5.8050 3.66316 15.54146  
2 -0.5550 4.35667 17.42669  
3 -8.1612 6.34660 26.16772  
Test 5 Visual Physical (non-
dominant) 
1 0.2222 0.36654 1.55509  
2 -0.2500 0.26615 1.06458  
3 -0.8824 0.34173 1.40900  
Test 5 Visual Physical (dominant) 
1 0.1667 0.27116 1.15045  
2 -0.6875 0.39496 1.57982  
3 -1.0588 0.42418 1.74895  
Test 6 Physical Cognitive 
1 0.0141 0.00372 0.01576  
2 0.0398 0.00981 0.03923  
3 0.0198 0.00744 0.03067  
Group Mean Delta SSQ Total Standard Deviation 
1 (n=17) 9.460 6.219 
2 (n=17) 27.500 6.194 
3 (n=17) 57.539 15.199 
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The above raw mean data indicates there may be a difference between the groups 
across a few of the performance scores. Box Plots of the performance change between 
the groups have been included in Appendix  4 to explore any visual relationship. 
Using a Levene Test for Homogeneity of Variance it was found that data within Test 2 
(Physical) and 6 (Physical-Visual) exhibited significance where F(2,48)=4.667, p=0.014 
and F(92,48)=4.255, p=0.02 respectively. The Welch ANOVA will be used for analysing 
Test 2 and 6. The data within tests 1, 3, 4 and 5 met all assumptions so a one-way 
ANOVA was used. The result of the ANOVA found no statistical significance between 
the three groups in Tests 1, 3, 4 or 5 where p>0.05 in all cases. Using the Welch ANOVA 
no statistical significance was found for Test 2 where p>0.05. However, for Test 6 
(physical-visual) statistical significance was found F(2,27.168)=3.468, p=0.046. For Test 
6 the Scheffe post-hoc analysis showed a statistically significant difference between 
group 1 and 2 (p=0.035) and group 2 and 3 (p=0.026), however there was no difference 
between groups 1 and 3 (p>0.05), indicating a lack of linear relationship between the 
groups.  
Another approach used to better understand if there was a relationship between 
severity of motion sickness and scale of performance change was to analyse the data 
at a group level using a liner regression. Initially, the multiple correlation coefficient R 
value at 0.588 does not indicate great quality of the prediction of test score change as 
the dependent variable. Further, the coefficient of dertmination (R2) value of 0.345 
indicates that the independent variable of motion severity change explains just 34.5% 
of the variability of the performance change. The overall ANOVA within this test shows 
that the change in test score was significantly related to motion sickness state 
F(,9,41)=2.402, p=0.027. However, all but one of the individual tests proved to be 
insignificant in themselves where p>0.05. For the cognitive test (N-Back, Test 3) 
significance was observed where p=0.027. Overall this output of the linear regression 
further examples the overall negative effect of motion sickness on human 
performance, but does not provide evidence for the subjective motion sickness scores 
as a useful predictor for the scale of performance change (R2=0.345) across tests. 
5.4.2 PHASE 2 - A ‘REAL-WORLD’ STUDY  
A further 17 participants took part in the RDM pod user trial which was used for Phase 
2, none of these participants had completed the simulator study in Phase 1 of this 
project. All participants completed the driving scenario with no dropouts. Motion 
sickness scores for ‘PRE’ SSQ (baseline) and ‘POST’ SSQ (after use of the pods) along 
with ‘PRE’ (baseline) and ‘POST’ N-Back (cognitive) and reaction time (cognitive-





Table 13 Exploratory Analysis of SSQ and Human Performance (Pre and Post) 
 
To see how motion sickness scores changed after exposure to the pods, the delta (i.e., 
change in) scores were assessed. The SSQ scores has been presented as delta total, as 
well as for its three sub-categories of nausea (‘N’), oculomotor (‘O’), and 
disorientation (‘D’). The descriptive statistics are presented below in Table 14: 
 
 
As seen in Table 14, every measure was slightly decreased after exposure to the pods 
except in the nausea scale. It appears that the pods did not induce any motion 
sickness. To assess if the use of the pod affects motion sickness it was first necessary 
to check for normality in the data so the appropriate statistical test could be executed. 
The Shapiro-Wilk test was used where the null hypothesis is that the data is normally 
distributed. In all cases p<0.05, so the null hypothesis of the Shapiro-Wilk must 
rejected and it can be concluded that the data is non-normally distributed. Given the 
lack of normality in the data, a non-parametric test was required. The data was then 
assessed for symmetry, whereby the Sign Test could be used for the for the non-
symmetrical results and the Wilcoxon Signed-Rank Test for the symmetrical results (as 
all other assumptions of each test were met). To check for symmetry, the delta scores 
(i.e., the difference between the paired data pre vs. post) was used and box plots 
created. Conclusively, none of the data was observed to be symmetrical so the Sign 
Test was used. A statistical analysis using the Sign test shows that there was no 
significant change in motion sickness total score (p=0.727), nausea (p=0.625), 
oculomotor (p=0.774), or disorientation (p=0.727) 
Looking now at the performance scores, there was no statistically significant change 
between the pre and post N-Back scores assessing cognitive ability (Z=-1.270, p=0.204) 
 N Minimum Maximum Mean Std. Deviation 
PRE_SSQ_TOTAL 17 0.000 18.7 3.3 4.746 
POST_SSQ_TOTAL 17 0.000 11.2 2.9 3.379 
PRE_REACTION 17 0.226 0.352 0.299 0.0341 
POST_REACTION 17 0.267 0.394 0.317 0.0381 
PRE_NBACK 17 14.000 19.000 17.823 1.333 
POST_NBACK 17 15.000 19.000 17.117 1.495 
Table 14 Exploratory Analysis of The SSQ Subcategories 
 N Minimum Maximum Mean Std. Deviation 
DELTA_N 17 -9.50 9.50 1.117 4.608 
DELTA_O 17 -22.70 22.70 -0.447 9.833 
DELTA_D 17 -27.80 13.90 -0.817 7.724 
DELTA_TOTAL 17 -11.2 11.2 -0.440 5.101 
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where p>0.05. However a t-test revealed there was a significant increase in cognitive-
physical ability between pre-exposure (m=0.299, SD=0.034) and post exposure 
(m=0.317, SD=0.038) t(16)=-2.251, p=0.039. 
It is now possible to explore if the statistically significant change in reaction time score 
was related to any fluctuation in motion sickness using an ANOVA. Despite the lack of 
significant change between pre and post motion sickness scores and N-Back scores, it 
is still worth presenting the data to aid discussion and give comparison to the results 
presented in the first simulation-based user trial in Phase 1. There was no statistical 
significance between delta SSQ total (i.e., the change in total SSQ score) and delta 
cognitive-physical score as determined by the one-way ANOVA (F=0.967, p=0.493). 
Likewise, there was no significance shown between delta total SSQ and delta cognitive 
score (F=1.1998, p=0.159) where p>0.05 in both instances. Looking also for any 
significance between the delta SSQ subscale scores and the two performance 
measures there too was no significance shown where delta nausea vs. delta reaction 
showed (F=0.205, p>0.05) and delta N-back showed (F=0.701, p>0.05). Delta 
oculomotor vs. delta reaction showed (F=1.200, p>0.05) and delta N-Back showed 
(F=1.218, p>0.05). Finally, delta disorientation vs. delta reaction showed (F=2.564, 




Firstly, looking at Phase 1 of this project, dropout rates in the simulator were higher 
than a usual 3xD simulator study, with 45% (n=23) participants asking to end the study 
early. It is thought that the driving route design had the biggest impact on participant 
dropouts and the track was designed to be challenging considering motions. It is 
noteworthy that every participant reported at least some motion sickness as measured 
by the SSQ proving that no one was immune to motion sickness. 
Previous literature discussed the effect of different demographics on motion sickness, 
such as gender (Jokerst, et al., 1999), age (Golding J. F., 2006) and driving experience 
(Turner M. , 1999) amongst others. These relationships did not form part of the 
research question so analysis is retained within Submission 3. 
Looking to the key findings, it was shown that motion sickness affects various areas of 
human performance. Motion sickness in this instance was considered as a binary state. 
For those who did complete the drive (Group 1) they were classified ‘not motion sick’, 
whereas those who asked to end the drive early due to sickness (Group 2) were 
classified as ‘motion sick’ and referred to as ‘dropouts’. This method has previously 
successfully been used in the published literature where dropping out is an accepted 
classifier for motion sickness state (Bertin, Collet, Espie, & Graf, 2005). There is 
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currently no validated method for categorising motion sickness states other than 
strictly by the SSQ scale, where there are no thresholds on which to infer states of 
‘motion sick’ or ‘not motion sick’. To assess human performance across the entire 
range of scores many participants would be needed each at similar motion sickness 
states. Therefore, with the modest sample size, and no real thresholds, the propensity 
to drop out of the drive was used as the defining characteristic to classify motion 
sickness. Four of the six areas of human performance (as per the Venn diagram in 
Figure 19) were shown to be negatively affected by motion sickness. Looking at the 
human performance diagram it can be amended to identify the areas shown to be 
negatively affected by motion sickness and is presented below where the red area 









Figure 43 Modified Human Performance Diagram 
Considering Visual Acuity (VA) previous literature suggests motion sickness 
(seasickness in their case) had a negative effect on VA (Bos, et al., 2008). However, the 
results found in this simulator trial should be considered as non-conclusive. It was 
noticed early on in the user trial that there may be some darkness adaptation 
benefiting participants. The control room where the VA test took place is much 
brighter than the simulator and there was no ability to change the lighting in either the 
simulator or the control room. It is likely that participants, after spending time in the 
dark simulator were dark adapted, then, when coming back to the control room for 
the post-exposure tests they benefited from being dark adapted and being tested in a 
better lit environment. This justification is supported by the literature where it has 
been shown multiple times how dark/light adaption has a significant affect on VA that 
dark/light adaption has a significant affect on acuities (Hecht, Haig, & Chase, 1937) 
(Graham & Cook, 1937) (Campbell, Harrison, & Vertigen, 1950). Unfortunately because 
of this inability to control lighting conditions, it is not possible to make any conclusions 
on the relationship observed between VA and motion sickness in this user trial.  
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Secondly, looking at the visual-cognitive assessment which consisted of a modified 
Mental Rotation Test (MRT), no significant change was observed. Contrary to the 
hypothesis, the group average score increased (insignificantly) from (m=3.157, 
SD=1.027) to (m=3.235, 0.971). The time taken to complete the test (measured in 
seconds) showed no significant change either, although the raw data showed a slight 
decrease from (m=79.82, SD=43.78) to (m=74.87, SD=43.73), albeit statistically 
insignificant. Curiously, as shown in  Figure 34 it seems that scores increased more for 
dropouts (i.e., those who were motion sick) than for those who completed the drive 
(i.e., those who were not motion sick) – this was opposite to the expected effect. Upon 
some brief further reading it was found that the ‘skill’ of spatiality, assessed using the 
MRT, has an interesting relationship with motion sickness. For example, one study 
showed that those who scored lower at spatial ability tasks reported greater numbers 
of historic bouts of motion sickness (Levine & Stern, 2002) This relationship is 
continued to be discussed and explored within Project B of this Innovation Report.  
Looking at all of the other areas of human performance it was shown that Group 2 had 
significantly reduced cognitive ability, physical ability, physical-cognitive ability and 
physical-visual ability. These findings are difficult to compare to the literature, as many 
previous projects used specific work-related tasks on which to assess performance, 
thus it is unknown what specific areas of human performance were affected in other 
experiments. One aforementioned project did find a negative relationship between 
cognitive skills and motion sickness (Bos, et al., 2008) when using the Vigilance and 
Tracking Test (VigTrack) (Valk, Simons, Struyvenberg, Kruit, & van Berge Henegouwen, 
1997) alongside the Multi-Attribute Task Battery (MAT) (Comstock & Arnegard, 1992). 
However, these tests both rely on other abilities, such as visual ability. Therefore the 
data presented in this simulator study, is in agreement with the conclusion set out by 
(Bos, et al., 2008) but adds to our understanding of this relationship, where cognitive 
ability was more isolated in this project.  
Looking to the results found in Phase 2 of this study, using the RDM pods there was no 
motion sickness being induced for participants. However, despite there being an 
observed decrease in physical-cognitive scores, there is no evidence that this 
relationship was linked to motion sickness (where there was none). As one possible 
explanation for the reduced physical-cognitive scores observed after the exposure to 
the pods, it is thought that the temperature was of influence. The outside temperature 
on the three days of the user trial was conducted had lows of 5 degrees, 1 degrees and 
-1 Degrees Celsius and the trials took place in a non-heated warehouse. Participants all 
wore insulated jackets to counter the cold, but their hands were exposed. It is 
expected that when arriving at the facility and completing the first round of 
assessments they were in a normal state considering temperature. However, after 40-
minutes in this cold warehouse it was possible that their motor skills were slowed due 
to the cold. There is much research correlating cold temperatures to decreased hand 
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performance (such as (Clark, 1961)), although no skin temperature readings were 
taken to validate the temperature as a reason for the decreased physical-cognitive 
performance so this explanation remains speculative. Another possible explanation is 
that the onset of Sopite Syndrome could affect reaction time as previously observed 
(Lawson & Mead, 1998), however there was no measure taken to measure sopite 
syndrome, so again, it is not possible to draw a reliable conclusion. Overall, with 
motion sickness not being a significant factor for these pod trials in Phase 2, and no 
relationship observed between motion sickness and human performance, this trial did 
help validate the validity of simulator study where no change in motion sickness 
showed no significance to any change in performance. Taking the findings that motion 
sickness does affect human performance as measured in the simulator study it is of 
benefit to the UK AutoDrive trials that no significant motion sickness was observed as 
this helps to validate the findings they will take away from the project. 
The implications of motion sickness affecting human performance is very interesting 
for further automotive technologies. Firstly, it highlights the importance of data 
handling for simulator-based user trials where it is not advisable to use user trial data 
for participants who have to drop out of a study due to motion sickness as it is proven 
that this level of motion sickness significantly affects their performance and therefore 
their data is not-representative of their usual abilities. At this stage it can be concluded 
that if participants are not asking to end the study early (therefore ‘not motion sick’ by 
this binary classification system) their results (for the most part) are representative of 
their usual abilities, and therefore this adds to the validity of simulator-based user 
trials. It was shown however that even for those who completed the driving task, their 
physical-cognitive ability did significantly decrease where their reaction time 
(measured in seconds) increased from (m=0.3, SD=0.038) to (m=0.324, SD=0.056). A 
few papers look at reaction time in simulator environments such as (Guzek, Jurecki, 
Lozia, & Stanczyk, 2006) and (Guzek, et al., 2012) and both confirm that reaction time 
is affected negatively through simulator use. The exact reason why is described in 
these reports in relation to specific driving tasks, rather than a change in fundamental 
ability. It is possible that Sopite Syndrome (Graybiel & Knepton, 1976) could be a factor 
which is a complex condition related to drowsiness and fatigue related to motion 
exposure. This usually is of consequence when experiencing physical motions but it is 
possible that the perceived sensation of self-motion experienced in the simulator 
through vection could induce similar sensations which may induce sopite syndrome. 
Previous research has explored the onset of Sopite Syndrome in simulators and details 
how this fatigue and drowsiness related syndrome is indeed a factor for vehicle 
simulators where there is no physical motion (Lawson & Mead, 1998). No data 
collected to assess participants for sopite syndrome symptoms (as this research was 
solely interested in motion sickness). However it is conceivable that it may have had a 
role to play in the observed reduction in physical-cognitive ability in the pod trials – but 
this can not be proven. 
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Within this project (specifically Phase 1 where more data was collected), it was also 
considered if there was a scale to the effect of motion sickness and human 
performance. This, although not the primary research question, was of interest 
considering the impact of performance degradation. It has already been discussed that 
when looking at motion sickness as a binary measure (sick or not sick) a difference has 
been observed between the two group’s performance scores. However, it is 
interesting to explore how one might go about understanding if there is a scale 
between motion sickness severity and performance change. As a brief insight, Table 11 
presents an exploratory method for splitting participants into lowest, highest  and 
those in the middle of severity scores – dividing the group equally into three as more 
of an ‘exploratory’ approach. It was shown how the grouping of participants using SSQ 
data, assigning participants based on their subjective motion sickness severity into 
three groups (low, medium, high) showed no changes. The implication of this 
highlights the utility of the binary method used for grouping sick / not sick participants 
in this study (using dropouts as the grouping variable). A linear regression was also 
conducted to further explore this relationship, but again did not support any linear 
relationship between the scale of motion sickness and the scale of performance 
degradation.  
In order to provide a more reliable analysis of a linear relationship it would be 
necessary to first collect a much larger range of motion sickness data. The largest score 
measured by the SSQ in this user trial was 71.1, whereas the largest total motion 
sickness score achievable would be 224.4 indicating this experiment observed only up 
to 31% of the range of possible SSQ data. An experiment to better understand if there 
is a linear relationship might involve identifying motion sickness severity score targets 
as ‘groups’, and subjecting participants to a motion sickness stimulus until they reach a 
common group threshold. A comparison between groups of participants each at a 
discrete level of subjective motion sickness would then show, more robustly, if there is 
a linear relationship between the scale of motion sickness severity and the scale of 
performance degradation.  
This consideration highlights two limitations on the ability to conclude on any linear 
relationship – firstly, there is no validated method of splitting SSQ severity into groups 
there may be a better way to interpret this subjective data. Secondly, all participants 
were constantly reminded they can end the study if they feel too sick. It is likely this 
data set has not captured the full extent of motion sickness severity, where if 
participants were required to endure the motion sickness inducing task for longer a 
greater state of motion sickness would be measured and a greater range of data may 
reveal a significance between subjective score and performance. However, due to 
ethical considerations and concern for participant wellbeing no one was subjected to 
any more motion sickness than they opted to tolerate. Use of the motion sickness 
susceptibility questionnaire (MSSQ) (Golding J. F., 1988) may have provided a useful 
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method of categorising participants and collecting data from a broad demographic 
considering susceptibility and it is unfortunate this data was not collected. 
Overall, and besides the simulator transferability questions, considering the impact of 
motion sickness on performance (simulation sickness in this instance) these findings, 
and that which was explored in the literature, may have significant implications for 
future automated vehicles. The propensity for automated vehicles to induce motion 
sickness is quite well established in the literature and summarised in this Innovation 
Report. It is now seen (both in this experiment and the background literature) that 
motion sickness can reduce human performance in a number of ways. If, for example 
in a SAE Level 3 vehicle, the user is experiencing motion sickness, and thus their 
performance is degraded, it is possible that their ability to regain control of the vehicle 
may be deteriorated. There is no agreement yet about the time between a Level 3 
vehicle asking the user to regain control, and the time in which the user is required to 
take control. However, in one well cited report a 10-second handover request is 
recommended (Melcher, Rauh, Diederichs, Widlroither, & Bauer, 2015). Considering 
subjective motion sickness recovery, for the most part, takes 15-30 minutes there is 
perhaps an implication for the timeline of vehicle handover. If automated vehicle 
induced motion sickness is affecting performance, it may not be advisable to hand over 
control of a vehicle within this 10-second time frame. Further, in a Level 4 vehicle, if 
the occupant is experiencing motion sickness they may decide to regain control of the 
vehicle as a method of self-help, where ‘controllability’ and driving a vehicle is a known 
way to minimise motion sickness onset (Howard & Templeton, 1966). However, if the 
user is motion sick to the degree of no longer being able to tolerate the environment 
(similar to ‘dropouts’ in this project’s experimentation) it is possible that the users’ 
cognitive, physical and other performance areas will also be reduced – the extent to 
which this has a safety implication is not known, but worthy of consideration. These 
concerns have not been directly addressed in an automated vehicle instance, so no 
precise conclusions can be drawn, but the consideration of this has been highlighted 
for the first time, and the need for further research has been identified and justified.  
Considering also the previously discussed use cases of automated vehicles, it is 
apparent that productivity is a significant influencer on the appeal of these vehicles. 
Morgan Stanley have estimated that the ability to work within an automated vehicle 
could bring US$508 billion per year to the US economy (Morgan Stanley, 2013) (p.50) – 
clearly identifying the possibility of productivity in an automated vehicle. It was also 
discussed that many of these work-related tasks would induce the likelihood of motion 
sickness meaning people may not want to be productive. Further to this, it is now 
proven that motion sickness can negatively influence various areas of performance – 
this may further limit the productivity benefits expected. Going back to the literature it 
was shown in a seasickness trial how work task-related performance suffered 
significantly when motion sick (Bos J. E., 2004), and the experiment presented here 
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confirms these findings. This starts to bring into question the true ability to be 
productive in an automated vehicle. This, as a potential issue is worsened still when 
considering how different demographics are more affected than others considering 
motion sickness – so it is likely this productivity concept may be rather limited 
considering inclusivity. This inclusivity consideration was further discussed in a recent 




Motion sickness has been shown to be a significant negative influencer on four of the 
six human performance categories highlighted for this study: including, cognitive 
ability, physical ability, physical-cognitive ability and physical-visual ability. The test 
results from the visual ability and visual-cognitive ability remain inconclusive from this 
trial due to uncontrollable light conditions concerning visual skills, and external 
variables of spatial awareness ‘training’ and simulator exposure for the visual-cognitive 
skill. It was also shown that physical-cognitive skill (reaction time in this case) was 
negatively affected not only by motion sickness, but by simulator use in general as well 
as pod use. This is expected to be related to sopite syndrome, although this was not 
measured so cannot be reliably concluded upon. It does highlight however cause for 
concern of the transferability of reaction-time measures from simulator data to ‘real-
world’ applications. If future reaction-time based research is completed in a simulator 
(3xD or otherwise) it is recommended that Sopite Syndrome is measured and perhaps 
a baseline reaction time assessment is given alongside the primary task to compare 
reaction time differences between simulated and real-world. All other areas of 
performance are considered to be transferable from simulator to-real-world if 
participants are not experiencing motion sickness which makes them drop out. It is 
advised that if participants do drop out of a study all of their data should be omitted 
from the study where the validity of their performance is not assured.  
The RDM pods were shown in this specific user trial to not be an influencer on motion 
sickness and more explanations as to why this is the case is given in Submission 4, 
where vehicle speed, and inability to complete secondary tasks were thought to be of 
most significance.  
This project, using original data and supported by the background literature has 
identified the need for future research around the safety of vehicle handover scenarios 
for future automated vehicles – specifically SAE Level 3 and 4 vehicles. Motion sickness 
induced performance degradation may impact the safe ability for someone to regain 
control of a vehicle. Further to this safety concern, bringing into consideration the idea 
of productivity in automated vehicles, this research highlights a possible limitation to 
productivity goals - such as predicted by (Morgan Stanley, 2013). 
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This project has also allowed for an opportunity to provide useful impact to the 
sponsoring company- JLR. Through the literature review presented in Submission 2, 
and the simulator-based user trial as discussed (and presented in Submission 3) a ‘best 
practice’ guide was created for JLR research staff who will run future user trials. This 
document is summarised into a one page handout and was designed to be easy to 
follow to ensure maximum validity of future JLR studies as well as minimise participant 
dropouts and ensure participants are taken care of appropriately considering motion 
sickness. The latest copy of this is presented in Appendix  2. Further, as a summary of 
the project on the UK AutoDrive project a 1-page summary was also completed for the 
JLR staff (See  
Appendix  3). This was used to show that motion sickness was not a significant factor 
for their user trials, adding validity to their research findings and providing useful 
information about the usability of these pods considering motion sickness. The findings 
around performance degradation provided a useful insight into the issue of motion 
sickness for automated vehicles and helped scope future research plans for JLR as a 
result. 
5.6.1 FUTURE RESEARCH 
Although this research project has made many contributions, some further questions 
and areas of interest for future research have been raised. As a brief summary these 
have been noted below: 
- The extent to which motion sickness affects specific driving tasks in a 
simulator should be addressed (such as lane keeping, apprehension of 
danger, headway etc.) to ensure transferability of trials containing those 
variables.  
- Impact of motion sickness compared (using identical performance 
measures) to other common driver states such as fatigue 
- Areas of visual performance should be addressed in a more controlled 
environment. 
- A method for categorising or grouping motion sickness severity states using 
the SSQ should be examined. 
- Consideration of vehicle handover implications with regards to motion 
sickness should be further explored  
- The effect of motion sickness and/or simulator use and the mental rotation 
test should be further explored 
- The impact of Sopite Syndrome on automotive technology (simulators and 






This project was effective in addressing the primary research question, but had a few 
limitations that are important to note. As an overall point it is first worth mentioning 
that although the term ‘motion sickness’ is used, the specific form of this sickness was 
‘simulation sickness’.  
Firstly, the categorisation method of human performance only allowed for one test per 
performance area, where in fact there are many. For example, visual skills can relate to 
visual acuity, depth perception or night vision etc. Cognitive skills could include 
processing, working memory or long term memory etc. For this experiment, only one 
test was allocated to test each area of performance. This was done to ensure the tests 
could be completed before motion sickness subsided, but due to this, some wider 
information on each area of performance is missing.  
The grouping method of motion sickness severity was based on a binary classification 
related to the objective measure of dropping out or completing the trial. This was 
effective for addressing the research question, but leaves further questions about the 
linear relationship of motion sickness and performance which this data is not entirely 
suitable to address. Subjecting participants to a motion sickness stimulus to the point 
that they reach a specific level of sickness would allow for better grouping of 
participants for analysis. Further, as a limitation to the data set, only relatively 
moderate sickness was captured, where participants were advised to end the study if 
they became to unwell. This limits the breath of data available and the maximum 
motion sickness score collected was 71.1, out of a total possible score of 224.4. This 
does not limit the applications of the primary research question, but hinders 
understanding about the linear relationship. 
Considering the follow up trial in the ‘RDM pods’, motion sickness was expected to be 
very low given the experimental design, and this was bared out in the data. This limits 
the utility of the data collected to directly show ‘real-world’ comparability. The 
extraneous conditions, and the lack of control over experimental design and 











6 VISUOSPATIAL TRAINING AND MOTION SICKNESS (PROJECT B)  
 
This project was conceived through the exploration of the results from Project A and a 
deep review of the literature. Some of this background literature was added to the 
Literature Review presented in Submission 2. This project was a two-part study, 
beginning with simulator trials followed by on-road trials. These two phases are 
written up as Submissions 5 (simulator study) and 6 (on-road study) as shown in Figure 
6. This project identified a new way of reducing motion sickness susceptibility through 
training visuospatial skills. JLR (the sponsoring company) placed an embargo on this 
project to restrict a journal publication where they want to protect the intellectual 
property associated with the findings. Therefore, no publications have been made as 





This Innovation Report has established the issue of motion sickness onset for future 
automated vehicles and vehicle simulators for developing new technology. Of course, 
the reduction of motion sickness considering onset frequency and overall severity is 
something that would be of great benefit to the automotive industry as a whole. There 
are a few methods through which motion sickness can be managed. These have been 
categorised as part of this EngD (see Table 3) and the publication (Smyth, Jennings, & 
Birrell, 2019) which has been included in Appendix 1. As part of this categorisation for 
motion sickness countermeasures, some previous design-based methods were 
considered and this has been discussed in the literature review as seen in Submission 
2. Many design recommendations for automated vehicles have been summarised in 
(Diels & Bos, 2015) which include methods for reducing the onset of sensory conflict 
through ensuring outside views in the direction of travel. Later research looked at the 
location of display screens finding that indeed, those which allow maximum peripheral 
vision to the motion can reduce sickness (Diels C. , Bos, Hottelart, & Reilhac, 2016). A 
sea-sickness study concerned with HMI (Human-Machine Interface) design looked at 
the utility of presenting artificial horizons on display screens with some success (Bos, 
Houben, & Lindenberg, 2012).  
Other methods of reducing motion sickness in automated vehicles which are recently 
being explored include the use of Bone Conducting Vibration (BCV) headsets which use 
vibrations to disturb the signals between the vestibular system and the brain, 
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essentially ‘masking’ the afferent motion. The effectiveness of these methods is hard 
to establish in the current literature and is a relatively new development. It is expected 
that, if effective, it is only a short-term solution however. Something that one might 
want to use for a short drive where motion sickness is likely, but not for extended 
periods. Other methods of reducing motion sickness in an automated vehicle include 
the use of Virtual Reality (VR) headsets (e.g., (California, United States of America 
Patent No. US 2018/0089901 A1, 2018)) which look to provide the afferent motion 
cues to match the efferent motion being experienced. Again, there is no literature 
discussing the effectiveness of this method, but one questions is raised – the 
acceptability of wearing a VR headset throughout a journey. It thought to be unlikely 
people will want to wear a VR headset throughout a car journey. A slightly less 
intrusive method presents designs for glasses which project light in the periphery 
vision to help infer motion cues see (University of Michigan Regents, 2018) although 
again, no data has been published to attest to the success of this method. 
Drugs such as scopolamine have been shown many times to be effective in reducing 
motion sickness (Sherman, 2002), (Wood, Manno, Wood, Manno , & Redetzki, 1966) 
and (Schmäl , 2016). However, not only do these drugs limit habituation (Wood C. D., 
et al., 1994) (p.632), the also bring many side effects such as drowsiness and fatigue 
which last for many hours and affect day-to-day tasks which limit the application of 
medication. Medication is thought to be a very useful method of elevating motion 
sickness for ‘one-off’ applications (such as when on a cruise ship for recreation), 
however long term use is not advisable.  
Despite there being various methods discussed, all are limited by specific use cases. 
For example, for HMI based solutions, one has to be actively engaging with the HMI. If 
someone wants to work on a personal electronic device such as a phone, tablet or 
laptop (as is common for work-related tasks) they will not benefit from the in-car 
design implementations. Considering wearables, the user has to be actively wearing 
them every time they travel, this is unlikely to be desirable. For medication it is unlikely 
someone can use prescription motion sickness medication for a commute to work and 
then have a productive day on account of the fatigue-inducing side-effects.  All of 
these solutions are limited further when considering future Mobility as a Service 
(MaaS) concepts which see ride sharing and multi-vehicle mobility solutions where 
specific mitigation strategies may not be possible in a ride-sharing scenario and design 
may differ from vehicle to vehicle. Consideration needs to be given to methods of 
reducing personal susceptibility to motion sickness, in a non-invasive, non-drug related 
and non-vehicle-design dependent way which will reduce motion sickness across any 
use case.  
In Project A (presented also as Submissions 3 and 4) an interesting effect was observed 
between simulator use and the mental rotation test (MRT). It was found here that 
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participants average MRT score and completion time after simulator exposure was 
statistically unchanged (see  Figure 34 and Figure 35). This was despite the fact that 
many participants were suffering from motion sickness and other areas of 
performance were decreased – including cognitive ability. Initial exploration of these 
results and some literature started to reveal a possible relationship between mental 
rotation ability and natural motion sickness susceptibility. Further research into the 




Mental rotation is an aspect of visuospatial ability – a relatively well-studied subject in 
itself. Looking to the literature for more information about visuospatial skills, the most 
prominent, and widely discussed area is surrounding gender variability in visuospatial 
ability. Many studies highlight how, on average, males have an improved ability in 
visuospatial tests over females. For example, one study measuring the difference 
between males and females highlighted gender differences among a variety of 
visuospatial tasks –identifying particularly large sex differences specifically in the MRT 
(mental rotation test) (Linn & Petersen, 1986). Other research has confirmed these 
findings also finding males outperforming females in the MRT abilities (Peters, 
Chrisolm, & Laeng, 1995) and other visuospatial tasks including water level tests and 
rod and frame tests (Robert & Ohlmann, 1994) and (Scholl, 1989). Using the water 
level test combined with a card rotation test, this gender difference and direction is 
again confirmed by (Sigorella, Jamison, & Krupa, 1989) where they went on to highlight 
how “sex, self-concept, and spatial activities made significant direct contributions to 
the prediction of spatial performance” (p. 1). Across a variety of tests, and research 
projects the same gender effect is revealed multiple times and it can be concluded that 
gender has a significant role to play in natural visuospatial performance. 
 
This gender difference is immediately of interest where this EngD research has 
identified in a previous simulator trial (presented as Project A and in Submission 3) 
how a far greater number of females dropped out of the simulator study due to 
motion sickness than males. So it also becomes apparent that there is a gender 
difference in motion sickness susceptibility. This is not a new finding, in fact the 
literature is very clear on this gender effect considering motion sickness  - for example 
(Jokerst, et al., 1999), (Flanagan, May, & Dobie, 2005), (Dobie, McBride, May, & Dobie, 
2001) and (Matchock, Levine, Gianaros, & Stern, 2008). This relationship is well 
established where not only is this gender effect observed when specifically looking for 
it, as in the above studies, but has been observed in a variety of motion sickness 
studies including studies assessing airsickness (Lindseth & Lindseth , 1995), 




It is shown that females score lower at visuospatial performance tests, and experience 
more motion sickness. Conversely, males score higher at visuospatial tests and 
experience less motion sickness. One factor linking these two relationships can be 
found in research discussing the effect of sex hormones on both visuospatial skills and 
motion sickness. It has been previously shown how oestrogen (female sex hormone) 
fluctuations throughout the menstrual cycle influence spatial ability, where females 
perform worse at spatial tasks when menstruating (Silverman & Phillips, 1993). It has 
also been shown how fluctuations in female sex hormones throughout the menstrual 
cycle affects motion sickness susceptibility (Hausmann, Slabberkoorn, Van Goozen, 
Cohen-Kettenis, & Gunturkun, 2000).  
 
Given the nature of these findings it starts to become possible to consider that there is 
an underlying relationship between visuospatial ability and motion sickness 
susceptibility. Further to the findings presented in Project A and Submission 3, it is 
interesting therefore to consider if through improving visuospatial ability it is possible 
to reduce motion sickness susceptibility. Some research discusses the effect of 
hormone manipulation on visuospatial ability (Van Goozen S. , 1995). However, 
hormone manipulation is to be avoided for this application, and two research 
questions (RQ’s) are highlighted: 
 
RQ1 - Is it possible to improve visuospatial ability through non-invasive training tasks?  




To address the two research questions it was decided that a two-part user trial would 
take place. The first trial will be a simulator-based study, which is useful for a low-cost, 
quick, controlled and safe way to assess RQ2. Further, it is possible that the interesting 
effect between simulator use and visuospatial performance (as measured by the MRT) 
was linked to the visually intensive simulator environment. Following the success of 
the simulator trial as Phase 1, an on-road study will take place to further answer RQ2 
by providing information on the applicability of findings to ‘real-world’ motion sickness 
– this on-road part will be presented as Phase 2.  
6.3.1 DEVELOPING THE VISUOSPATIAL TRAINING PACK 
In order to answer RQ1 it is necessary to develop a method of training visuospatial 
ability. There were no useful academic publications advising on the training of 
visuospatial skills in a non-invasive manner, therefore a slightly more experimental 
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approach was needed, guided by common practice rather than scientific literature. 
There were found to be many sources online providing training platforms for training 
visuospatial ability for people who want to prepare for recruitment aptitude tests – 
where some tests similar to the MRT are commonly present. Many sources online 
advocate (through their conception and design) that repeat exposure to, and practice 
with these tasks can improve  ability. Therefore, a training pack was to be developed 
which included many visuospatial tests and through repeat exposure and practice with 
these tests it was conceivable that participants could improve their visuospatial ability. 
It was not practical to create entirely new visuospatial tests and training tasks, 
therefore online resources were used to create a novel assemblage of pre-existing 
visuospatial tests which would be used as the training pack. A few considerations were 
needed before deciding on the format for a training regime. Firstly, it was decided that 
the training tasks needed to be printable pen and paper tasks so that participants 
could be given a hard copy – thus controlling the variable of screen size and effects of 
VDU (Visual Display Units) if this was an online training task.  
 
Next, it was considered that for both phases (simulator and real-world) participants 
would provide a baseline motion sickness susceptibility score, complete the training 
pack, and then give a comparative motion sickness score. Therefore, the training pack 
should be long enough to ensure that habituation to the baseline motion sickness 
exposure was not an issue between the two exposures, but short enough to ensure 
participants do not withdraw from the study due to frustration of a long training 
period. Consulting a motion sickness expert (Diels C. , 2018) it was thought that 14-
days would be long enough to ensure habituation to the motion sickness task (used for 
a baseline measure) would not be a factor for the second exposure. Although the 
literature is sparse, 14-days does seem appropriate, where one study recommends 
that when looking to habituate someone to a motion sickness task, repeat exposure 
should take place within one week (Kennedy, Jones, Lilientha, & Harm,, 1993). Further 
supportive evidence to attest to one week as suitable time for habituation to the task 
to subside is found in (Dunlap, 2000). The effect of time taken to train on the 
effectiveness of the visuospatial training was unknown, but it was hoped that 14-days 
should provide enough time to see some training effect if indeed possible. 
 
To assemble the training pack, 14-days’ worth of training tasks were needed. For 
practicality sake, it was decided that training should last around 15-minutes per day 
where it was unlikely that participants would want to take part if the training tasks 
took up too much time. Three main sources for training tasks were found which 
included website dedicated to testing and training spatial abilities (amongst other 
traits for aptitude test preparation) (IndiaBix, 2009), a book published about 
mechanical and spatial aptitude (Learning Express, 2001) and an US army flight 
aptitude test document (Wiener, 2005). Training tasks were selected within these 
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sources, primarily based on the supportive information given by (Voyer, Voyer, & 
Bryden, 1995) around visuospatial training. Table 15 below gives an outline of each 
test chosen to be included in the training pack as well as the source. 
 
Table 15 Tests Used for Visuospatial Training Pack. 
Day Test name Description of training task  Source 
1 Image analysis  A selection of shapes is given along with four 
assembled shapes. Participants imagine constructing 
the pieces and choose which answer resembles the 




2 Paper folding 
task 1 
A target shape is presented on imaginary transparent 
paper. Four possible answers are given with the paper 
folded in half, participants have to fold the shape In 
their head to work out which folded shape matches 




3 Perdue Spatial 
test 
A shape is presented in two orientations. The 
participant has to work out how the shape has been 
rotated. They are then presented with another shape 
which they have to mentally rotate in a similar way to 
the first shape and work out which answer has the 
same orientation 
(Bodner & Guay, 
1997) 
4 Block counting A complex 3D shape is shown, made up of many 
uniform blocks. The participant has to work out the 
number of blocks present, imagining the side of the 
shape that isn’t visible. 
(Learning 
Express, 2001) 
5 Unfolded cube 
test 
An unfolded cube is presented with images on each 
face of the cube. Four assembled cubes are then 
presented with images on each side. The participant 
has to imagine assembling the cube to decide which 
one of the four options is not possible. 
(123Test, 2018) 
6 Paper folding 
task 2 
The same test as ‘paper folding task 1’, but with a 






A 2D pattern (with fold lines) is presented along with a 
series of four 3D shapes. Participants have to imagine 
the pattern being folded and decide which shape it will 
make when 3D. 
(Learning 
Express , 2001) 
8 Spatial analysis 
task 
Participants are given an engineering drawing of a 
shape with views from the top, side and front. They 
have to imagine these 2D shapes as a 3D object and 





A line diagram is shown along with four much more 
complex line diagrams. The participant needs to find 
the original diagram within one of the four complex 




10 Rotated blocks Participants have one ‘target shape’ and five other 
shapes. The participant needs to report which one of 
the five shapes is the same as the target shape (but 
rotated in a different orientation) 
(Wiener, Part 14 
ROTATED 
BLOCKS, 2005) 
11 Mixture of tests Tests comprise of a mixture of block rotations, paper 
folding, shape rotations, pattern identification, shape 







The same test as ‘Embedded images 2’, but with a 




13 Matching pieces 
and parts 
A shape is presented along with five smaller shapes. 
Participants have to decide which two of the five 




14 Rotated shapes Participants have one ‘target shape’ and four other 
shapes. The participant needs to report which one of 
the four shapes is the same as the target shape (but 





To give an example of the type of questions within the training tasks highlighted in 
Table 15, an example of one question from each day’s training is presented below in 
Table 16: 
Table 16 Examples of Training Tasks 





















































Participants would be given the training pack as a hard copy, where instructions were 
given to complete one training task per day, and at the beginning of each day there 
was a short explanation on how to complete the task. Participants were told to spend 
at least 15-minutes on the training task each day, so everyone had the same training 
exposure. For example, if the days training only took 10 minutes to complete 
participants would spend the remaining 5-minutes re-reading and checking their 
answers – ensuring they were practicing visuospatial tasks for at least 15-minutes per 
day. If the task took longer than 15-minutes participants were asked to continue until 
the task allocated for that day was complete. For this trial, there was no benefit in 
randomising the task order between participants, as this study was not interested in 
how visuospatial skills can be trained or what tests are most appropriate, but instead 
more fundamentally, if they can be trained. There was no practical way to ensure 
adherence to the training regime, and participant training material was not marked. 
6.3.2 COMMON METHODOLOGY 
To assess the effectiveness of this training pack on visuospatial abilities (RQ1) and the 
subsequent effect this has on motion sickness (RQ2) two separate studies were used 
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(Phase 1 and Phase 2), although the methodologies followed the same basic format. 
Initially participants would be assessed to measure their baseline visuospatial 
performance. Alongside this, participants would also take part in a driving exposure to 
measure their baseline motion sickness susceptibility. In Phase 1, this would be a  
simulator study where participants will be driving the 3xD simulator as the motion 
sickness task. In Phase 2, this will be an on-road study where participants will be sitting 
as passengers in a vehicle (one at a time) which is being driven round Warwickshire 
roads as the motion sickness task. Once baseline visuospatial performance and 
associated motion sickness susceptibility is captured, participants will then enter the 
‘training phase’ where, over the next 14-days, participants will train their visuospatial 
skills using the training pack developed. After the 14-day training period, participants 
will return and researchers will assess their visuospatial performance once again to see 
if training has had an effect. Immediately after this assessment, participants will take 
part in an identical driving task and their motion sickness state will be measured and 
compared to their baseline scores (before training). At no time were participants told 
that this training would reduce their motion sickness, the information sheets were 
kept vague so as to not influence any placebo affect. During both drives, participants 
wore the Empatica E4 wristband to collect physiological data for a later study. Figure 







Figure 44 User Trial Diagram 
6.3.3 PROCEDURE FOR PHASE 1- A SIMULATOR STUDY 
To assess the effectiveness of visuospatial training on reducing motion sickness in a 
simulator (therefore simulation sickness) the participants who took part in the 
previous user trial assessing human performance were re-recruited (as per Project A 
and Submission 3). Those who reported the highest motion sickness scores were 
contacted to take part in this next user trial, where there was no benefit in reducing 
motion sickness for those who did not get motion sick. Participants were ranked in 
accordance to their SSQ score and 20 of those with the highest scores were contacted. 
Using the same participants was beneficial as baseline data on their motion sickness 
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need for two exposures. It was also considered an ethical way of running this trial as 
participants will already be aware of the risks of taking part, so can make an informed 
choice if they want to take part in this follow up study. The second user trial would 
take place approximately 6-months after the human performance trial, therefore 
habituation to the simulator was not a factor. 
Participants were recruited to this user trial via email and the participants received an 
information leaflet about the study proposal. If participants agreed to take part, they 
were met at the University of Warwick (UoW) and were asked to complete a mental 
rotation test (MRT) to capture their baseline visuospatial performance. The MRT was 
originally developed by (Vandenberg & Kuse, 1978) but the recreated version by 
(Peters M. , et al., 1995) was used in this study, which included CAD (Computer Aided 
Design) images and were much easier to read than the original. Two tests were 
assembled: one to be given before the visuospatial training pack and one to be given 
after to capture the effect of the training. Upon meeting at the agreed timeslot, 
participants were asked to complete one MRT test, where they were given three 
minutes to complete the test in silence. As before, a score of ‘1’ was given only if they 
selected both answers correctly per question. Where two MRT tests are used, the 
order in which they are received (before or after training) was randomised. As baseline 
motion sickness (from the previous human performance trial) was already recorded for 
participants there was no need for a motion sickness exposure before training and 
data from the previous study was carried over.  
The participants were then given the visuospatial training folder and an explanation as 
to how to complete the folder was given. Participants went away and completed the 
training pack for 14-days where they received a few follow up emails during the 
training period to remind participants what day they should be on. After this 14-day 
training period, participants returned to the 3xD simulator and completed another 
MRT, which was in the same style as their pre-training MRT, but a different set of 
questions to remove any memory or learning effect. Participants then completed the 
same driving task as described in Project A (and Submission 3), following identical 
instructions introducing them to the vehicle, an identical route and in identical 
conditions (climate, traffic, route speed, lighting etc.). Participants were recruited to 
return as close as possible to the same time of day as when they completed the first 
simulator study. As before, this driving task took up to 30-minutes to complete. 
Motion sickness was measured by completing an SSQ (Kennedy, Norman, Berbaum, & 
Lilienthal, 1993) before and after the simulator exposure and through administering 
the once-per minute FMS (Keshavarz & Hecht , 2011) measure to track motion sickness 
throughout the exposure. As before, participants were made aware of all the risks of 
taking  part and were reminded they can end the driving at any time if they feel too 
motion sick. The researcher again would monitor participant wellbeing throughout the 
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study and if someone was getting notably more motion sick, they were asked to 
consider if they felt fit to continue or not. All participants were reminded that if they 
feel unwell, to stay and recover for as long as necessary and not to drive a car for at 
least 1 hour after the simulator exposure, and until they feel well enough to do so. 
From this experimental design, the data set collected included baseline motion 
sickness susceptibility (from the first study human performance study in Project A), 
baseline visuospatial ability (as assessed using the MRT), post-training visuospatial 
ability (as assessed using a second MRT) and post-training motion sickness (as 
measured in the second simulator exposure. To take part in this study, participants 
were given £40 in Amazon vouchers as a gesture of thanks for giving up their time to 
complete the 14-day training pack. Payment was given to participants mid-way 
through training so that there was no sense of payment being related to driving 
simulator performance. This study was given ethical approval by the Warwick BSREC 
with reference (REGO-2017-2090 AM01). 
6.3.4 PROCEDURE FOR PHASE 2- A ‘REAL-WORLD’ STUDY 
For Phase 2 of this study, the methodological approach was kept as similar as possible 
to that of the simulator-based study; however the main difference was the motion 
sickness exposure was an on-road scenario. For this study, participants would be 
driven around in a vehicle to measure the susceptibility to motion sickness in a car (car 
sickness) and it was further explored if increasing visuospatial skills (RQ1) could 
decrease motion sickness in the ‘real-world’ (RQ2). 
To complete this study, a new set of participants were used, who had not taken part in 
any previous trials as part of this EngD. JLR, as the sponsoring company of this project 
and as a stakeholder for the IP (intellectual property) which is created from this study, 
insisted that the study must be kept confidential and therefore only JLR staff can be 
used, who all have agreed to a JLR non-disclosure agreement. Considering this, 
practicality of this user trial was of importance, where participants needed to be 
accessible from a common location during office hours. Participants from the JLR 
Whitley site (Coventry, UK) were recruited for this user trial where recruitment emails 
indicated that we were particularly interested in gaining participants who suffer from 
motion sickness. It was decided that all trials would be completed in the mornings, so 
that if motion sickness was a factor, symptoms should subside before participants have 
to drive home in the evening. JLR Whitley site was chosen as this site consists of mostly 
business-related staff, therefore reducing the chance that visuospatial skills would be 
skewed by job (e.g., JLR for design engineers who might use CAD frequently). 
Participants were recruited via email using an internal JLR email list where those who 
were most susceptible to motion sickness were of most interest. For this trial, there 
were 20 testing days available (five working days per week, and a four week study) and 
with three timeslots for testing (9am-10am, 10am-11am, 11am-12noon), a total of 30 
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slots for user trials. It was decided that this trial would aim for 20 experimental 
participants who would receive training, and 10 participants to act as control group – 
who would not receive the training pack. JLR were in charge of recruitment, where 
access to internal email databases was restricted. The method of assigning participants 
to the control and experimental group was limited whereby the first 20 participants to 
take part formed the experimental group, and the final 10, the control group. This was 
decided purely for a practical reason where the sponsor wanted to ensure firstly there 
were enough experimental participants to collect data on. 
Participants will be assigned two 1-hour user trial timeslots spaced exactly 14 days 
apart, where the timeslot will be at the same time of day to ensure consistency for 
personal factors and road conditions (as much as possible). When participants were 
met for the first time they completed a demographics questionnaire and an MRT test. 
This MRT test is the same as used in Phase 1, where two tests were created and given 
to participants in a random order (one before training, one after). Once baseline 
visuospatial performance was measured participants were taken to the vehicle and 
taken on a ~30-minute drive around Coventry roads. Participants were to sit in the 
near-side rear seat of the 2018 Land Rover Range Rover Sport L494 fleet vehicle 
supplied by JLR. The same vehicle was used for all participants and temperature was 
maintained at a steady 21 degrees Celsius for all participants. The lead researcher sat 
in the front nearside seat and a trained JLR driver was driving the vehicle. No 
conversation unrelated to data collection was allowed between the researcher and 
participant. A mock-up photo of the user trial lay-out is shown below in  










  Figure 45 On-Road Visuospatial User Trial 
The route taken was designed to take approximately 30-minutes and included a 
mixture of road types and speeds. Including country roads, rural and town roads as 
well as a short section on a dual carriageway. Participants were reminded they can end 
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the drive at any time if they feel motion sick, where multiple safe pull-over spots were 










Figure 46 Route for On-Road Visuospatial Trial 
The JLR driver was trained on the route, and practiced it multiple times before the 
trials, to ensure driving style was as consistent as possible between drives. It was 
considered that between the first and second drives (spaced 14 days apart) that 
participants may act differently. Specifically, if motion sickness was experienced in the 
first drive participants may spend more time in the second drive looking out of the 
window in front and doing other self-preservation activities. Therefore, it was 
important that participant activity was controlled as much as practical so that the two 
driving exposures were as comparable as possible (mostly considering sensory 
conflict). A reading task was designed whereby, throughout the drive, text would 
appear on the head-rest-mounted screen in front of the participants for 30-seconds at 
a time. Participants would read through the text and then it would disappear for 30-
seconds before new text re-appeared and the cycle would continue throughout the 
drive. The reading tasks were taken from an adult learning website ( British Council, 
2019) and were written in basic English so comprehension for someone who has a full-
time job at JLR was not considered to be an issue. The blocks of text were randomised 
so no specific story was followed which may have resulted in an emotional response. 
Two reading tasks were created, one for the first drive, and one for the second. The 
order in which they were received was randomised between participants. The use of 
this reading task was not likely to affect subjective or physiological responses as is 
validated in a recent text by (Horrey, Lesch, Garabet, Simmonds, & Maikala, 2017). An 

















Figure 47 View of the Reading Task 
Throughout the drive, the researcher measured motion sickness once per minute using 
the FMS method. Motion sickness was also assessed using the SSQ before and after 
the trial. This questionnaire was useful for making comparisons between the 
simulator-based trial and this on road trial. However, due to its simulator-focused 
design, the MSAQ was also used which is considered more appropriate for ‘real-world’ 
motion sickness. As there was a basic reading task being completed it was interesting 
also to collect some secondary data on the perceived workload of this task so the 
NASA TLX (Task Load Index) (NASA, 1986 ) was used after the drive to address the 
workload of reading whilst being driven around. The MSSQ (Golding J. F., 1988) was 
considered for participant recruitment, but there were limitations on what data could 
be collected before meeting the participant as recruitment was handled by JLR staff, so 
this was not used. 
After the first drive, the experimental participants were given the training folder (the 
contents of which have been previously explained) and the training was explained fully 
to each participant. The control group did not receive a training folder. After 14-days 
and when the training had been completed, participants returned for the second 
(post-training) exposure at the same time of day as their first trial. Comparative 
visuospatial skills were measured again using another MRT (for both control and 
experimental participants). After this, participants were taken on another drive, 
following an identical route to the first drive and maintaining the same driving style 
from the trained JLR driver. Participants completed another reading task throughout 
the drive although the text was different. Motion sickness was assessed using the FMS 
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throughout the drive and the SSQ, MSAQ and TLX were given at the end of the drive. 
No payment was given to participants for this user trial and the user trial was approved 




6.4.1 PHASE 1 – A SIMULATOR STUDY 
All participants (n=20) completed the training tasks in their entirety and attended the 
simulator driving part of the trial. In total, there were 10 males and 10 females; ages 
were reported in discrete categories so no descriptives of age is possible. A total of 
seven participants ended the driving early on account of motion sickness (35%). All 
participants were able to complete the SSQ after the drive so data from all participants 
(n=20) was retained for analysis. People who dropped out of the driving task due to 
sickness are referred to as ‘dropouts’. 
Addressing RQ1 it was explored to see if the visuospatial training pack was successful 
in increasing visuospatial ability (as measured with the MRT). Some descriptive 
statistics of the Mental Rotation Test (MRT) scores before the training period (pre-
training MRT) and after the training period (post-training MRT) is presented below in 
Table 17: 
Table 17 Exploratory Analysis of MRT Scores 
 
The mean MRT score has increased (pre to post training) from 5.10 to 7.05, showing a 
mean average increase of 38.24%. A t-test revealed this increase in visuospatial ability 
before and after training to be statistically significant t(19)=-4.278, p<0.0001 thus 
answering RQ1.  
Previous literature identified an interesting gender effect with regards to visuospatial 
ability. The data collected here showed males performed significantly higher than 
females for their MRT baseline with an average male MRT score of 6.2 (SD=1.39) 
compared to females with an average score of 4.0 (SD=2.53). A one-way ANOVA  
identified this difference as significant where p<0.05 (F=5.76, p=0.027). After training 
 N Minimum Maximum Mean Std. Deviation 
Pre-Training MRT 
score 
20 1.00 9.00 5.1000 2.29186 
Post-Training MRT 
score 
20 1.00 12.00 7.0500 3.39466 
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males had an average score of 8.8 (SD=2.34) and females 5.3 (SD=3.47). This also proved 
to be statistically significant where p<0.05 (F=6.991, p=0.016).  
Looking then to motion sickness, first an exploratory analysis of SSQ data is presented 
below in Table 18, which includes the total SSQ score as well as the three SSQ 
subcategories where the change in mean score is presented as delta (Δ): 
 Table 18 Exploratory Analysis of SSQ Scores 
 
The data presented in Table 18,shows how total SSQ score for the group decreased 
from an average of 66.299 to 32.164, showing a 51.48% decrease across the group 
after the training period. A similar direction is seen for the subcategories where 
Nausea decreased by 40.36%, Oculomotor by 46.94% and Disorientation by 53.11%. 
These changes in motion sickness scores have been presented graphically below in 
Figure 48. For all results presented The notation * denotes a 95% confidence 
significant difference, and ** a 99% confidence and the error bars indicate the 




















SD Δ Mean 
Nausea 68.95 34.89 45.79 39.58 -23.16 
Oculomotor 45.87 17.99 28.43 18.54 -17.44 
Disorientation 77.96 25.30 45.24 31.57 -32.72 




















Simulator Sickness Questionnaire Scores






To analyse if these changes in SSQ scores before and after training were statistically 
significant, paired T-tests were first performed (where the data met all the 
assumptions of the test) and the results are presented in Table 19 below: 
Table 19 Statistical Analysis of SSQ Scores 
 
As shown above, all reductions in motion sickness measured across four SSQ outputs 
were shown to be statistically significant where p<0.05 in all cases.  
Looking at participants individually, it is seen that three participants did not improve 
their visuospatial ability through training, whereas the rest of the group (n=17) did. 
Removing these three participants from the group, it is then shown that motion 
sickness, for those who improved their visuospatial ability, was reduced on average by 
58.02% in total SSQ score, 47.77% for Nausea, 46.16% for Oculomotor, and 46.94% for 
Disorientation. As before, all of these decreases were shown to be statistically 
significant when assessed using a paired T-Test where p<0.05 in all instances. Despite 
the small sample size (n=3), it was further shown that for these three participants who 
did not improve their visuospatial abilities, also showed no significant change in their 
SSQ scores after training (t(2)=-1.947, p=1.91) where p>0.05. 
To understand if there was a gender effect in motion sickness reduction the change in 
motion sickness scores between genders was examined. The Shapiro-Wilk Test resulted 
in a p value greater than 0.05 for both groups, and a homogeneity in variance test 
(Levine) resulted in an output of (F(1,18)=0.014, p=0.906) - showing the data was both 
normally distributed had homogeneous variances. Therefore, an ANOVA was used to 
explore if there was a gender effect in the extent to which total motion sickness was 
reduced after training. The ANOVA provided a results of (F=4.211, p=0.055) indicating 
that there was no gender effect where p>0.05. This showed both genders benefited to 
a comparable scale from the training. 
Further to the subjective motion sickness questionnaires, it was also interesting to 
explore participant dropouts – looking at motion sickness in a binary manner. Rate of 
participant dropouts before and after training is presented below in Figure 49. The 
notation * denotes a 95% confidence significant difference and the error bars indicate 
the standard deviation. 
 
SSQ Category (pre training vs. post 
training) df t Sig. (2-tailed) 
Nausea 19 2.175 0.043 
Oculomotor 19 2.597 0.018 
Disorientation 19 3.236 0.004 











 Figure 49 Dropouts Due to Motion Sickness 
Total dropouts across the group decreased from 13 to 7 (a 46.2% decrease) after the 
training period. A paired T-test was used to examine the significance in observed 
reduction in propensity to drop out after training compared to before. This test 
showed this decrease to be significant where t(19)=-2.854, p=0.010. However, as this 
study (specifically RQ2) is interested in the effect of increased visuospatial skills on 
motion sickness, the three participants who did not increase their visuospatial scores 
can be removed from the group and it is then shown improving visuospatial ability was 
responsible for reducing dropouts by 60%, although given the small sample size 
statistical analysis is not reported on. 
 
6.4.2 PHASE 2 – A ‘REAL-WORLD STUDY 
Despite filling 29 (out of a possible 30) timeslots with 19 experimental participants and 
10 control participants, there were seven people who withdrew from the study due to 
work commitments. The total experimental group therefore consisted of 15 
participants, and a further 7 participants made up the control group. The experimental 
group consisted of 6 males (40%) and 9 females (60%) and the control group had 3 
males (~40%) and 4 females (~60%). The mean age for the experimental group was 
33.6 (SD=12.8) with the youngest participant being 20 and the oldest being 59. The 
mean age for the control group was 32.4 (SD=8.24) with the youngest participant being 
24 and the oldest being 45. One participant (in the experimental group) asked to end 
the driving task during their baseline exposure due to motion sickness. No participants 
asked to end the driving in the post-training exposure. Data was reserved for this one 
‘dropout’ for analysis.  









































The mean MRT score for the experimental group increased (pre vs. post training) from 
5.26 to 7.67, showing a mean average increase of 45.81% for the experimental group. 
For the control group (i.e., those who received no visuospatial training), average MRT 
score increased from 4.42 to 5.71, showing a mean average increase of 16.96%  To see 
if MRT score was significantly changed for the control and experimental groups a 
mixed ANOVA was performed. Box’s test for equality of covariance matrices (‘M test’), 
showed that with an M value of 4.163 and a p value of 0.321 we can reject the null 
hypothesis (with a 0.05 significance threshold) and assure reliability in a mixed ANOVA 
analysis where the data meets the assumption of a multivariate normal distribution. 
Using a mixed ANOVA with a Greenhouse-Geisser correction it was shown that there 
was a mean change in MRT scores before and after the intervention (F(1,19) = 11.203, 
p=0.003). Further, there was a significant difference between the groups (Experimental 
group vs control) after the intervention (F(1,19) = 19.628, p<0.001).  
A paired T-test confirms the experimental group significantly improved their scores, 
t(14)=-5.150, p<0.001, whereas the control group did not t(6)=-1.89, p=0.108. 
Considering any gender effect it was shown for the total sample (e.g, experimental and 
control participants) that males had a significantly higher MRT ability before training 
with a mean score of 6.38 (SD= 2.669) compared to females with a mean score of 4 
(SD=2.082) (F=5.210, p=0.034) where p<0.05. Experimental participants (i.e., those 
who underwent the training period were analysed again for a gender effect. Here, it 
was shown that with a mean male score of 10.50 (SD= 2.88) and mean female score of 
5.77 (SD= 2.22) there was a statistically significant difference between the genders  
(F=12.875, p=0.003) where the p value was <0.05 showing males improved their scores 
to a greater degree than females. 
As two MRT tests were used, one pre-training and one post-training (given randomly 
between participants) it was explored to see if the tests were of the same difficulty. A 
paired t-test revealed no significant difference between scores for the two tests (MRT1 
vs MRT2) where t(16)=0.566, p=0.579 
 Group Mean Std. Deviation N 
Pre training MRT score Experimental  5.27 2.789 15 
control  4.00 1.673 6 
Total 4.90 2.548 21 
Post training MRT score Experimental  7.6667 3.39467 15 
control  5.5000 1.51658 6 
Total 7.0476 3.10606 21 
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Looking at the motion sickness data for the experimental group, Table 21 below 
provides an exploratory analysis for both the SSQ and MSAQ data including all 
subcategories.   
Table 21 Exploratory Analysis of Motion Sickness for the Experimental Group 
 
Table 21 shows an average decrease in total MSAQ scores from 36.85 to 17.73, 
showing a 51.89% decrease. A similar direction is seen within the MSAQ subcategories 
with gastrointestinal decreasing by 54.71%, central decreasing by 49.47%, peripheral 
decreasing by 42.66% and sopite-related decreasing by 43.37%.  For the SSQ, total 
scores were decreased from 46.87 to 19.45, showing a 58.50% decrease. For the 
subcategories of the SSQ, Nausea decreased by 68.08%, oculomotor decreased by 
41.97% and disorientation decreased by 56.89%. 
Presenting this graphically,  
 
Figure 50 below shows the decrease in motion sickness scores for the experimental 















Post-Training      
SD Δ Mean 
MSAQ 
Gastrointestinal  
49.07 28.28 22.22 7.57 
-26.85 
MSAQ Central 35.55 27.15 17.96 9.67 -17.59 
MSAQ Peripheral 34.81 25.76 13.33 3.37 -21.48 
MSAQ  Sopite-
Related 
36.66 18.46 20.74 9.08 
-15.93 
MSAQ Total 36.85 21.10 17.73 6.08 -19.12 
SSQ Nausea 59.78 29.39 19.08 14.86 -40.70 
SSQ Oculomotor 40.93 23.41 23.75 16.91 -17.18 
SSQ Disorientation 68.67 66.85 29.60 24.60 -38.98 
















Figure 50 Motion Sickness Scores Before and After Training (Experimental Group) 
 
A paired T-test was performed for both SSQ and MSAQ  scores for the experimental 
group, including total scores and all subcategories, the results of which are presented 
below in Table 22: 
Table 22 Statistical Results of Pre and Post Training for Experimental Group 
 
As seen in Table 22, all decreases in MSAQ and SSQ scores were statistically significant 
where p<0.05 in all cases.  
Motion Sickness (experimental group) df t Sig. (2-tailed) 
MSAQ Gastrointestinal 14 4.370 0.001 
MSAQ Central 14 2.841 0.013 
MSAQ Peripheral 14 3.622 0.003 
MSAQ  Sopite-Related 14 4.181 0.001 
MSAQ Total 14 4.342 0.001 
SSQ Nausea 14 5.924 0.000 
SSQ Oculomotor 14 3.956 0.001 
SSQ Disorientation 14 2.866 0.012 


















Again, to see if there was a gender effect in motion sickness reduction, the change in 
motion sickness scores between genders was examined for the experimental group. The 
Shapiro-Wilk Test resulted in a p value greater than 0.05 for both groups (p=0.714 for 
females and p=0.238 for males), and a homogeneity in variance test (Levine) resulted in 
an output of (F(1,13)=0.066, p=0.802) - showing the data was both normally distributed 
had homogeneous variances. Therefore, an ANOVA was used to explore if there was a 
gender effect in the extent to which total SSQ motion sickness was reduced after 
training. The ANOVA provided a results of (F=12.875, p=0.003) indicating that there was 
a gender effect where p<0.05. This showed females had a statically greater reduction in 
motion sickness compared to males where average reduction in scores for females was 
-21.57 (SD=21.32) and for males, -13.29 (SD=21.97). 
Looking now to the control group (n=7) for any changes in motion sickness, an 
exploratory analysis of their data is presented below in Table 23: 
Table 23 Exploratory Analysis of Motion Sickness for the Control Group 
For the control group, mean total MSAQ score increased by 11.98% where 
gastrointestinal increased by 44.11%, central decreased by 7.69%, peripheral 
decreased by 18.18% and sopite-related increased by 10.25%. For the SSQ, total score 
also increased, this time by 3.70%, where the subcategories of nausea decreased by -
6.66%, oculomotor increased by 4.44% and disorientation increased by 29.16%. 
Presenting this data graphically, Figure 51 shows the scores for all categories of the 
SSQ and MSAQ for the control group.  For all results presented the error bars indicate 

















40.476 17.336 58.333 48.723 17.857 
MSAQ Central 30.952 15.991 28.571 15.274 -2.381 
MSAQ Peripheral 29.100 22.673 23.809 14.480 -5.291 
MSAQ  Sopite-
Related 
30.952 16.544 34.127 20.012 3.174 
MSAQ Total 31.051 13.553 34.722 20.230 3.670 
SSQ Nausea 61.328 29.070 57.240 25.240 -4.088 
SSQ Oculomotor 48.728 37.354 50.894 30.544 2.165 
SSQ Disorientation 47.725 33.961 61.645 46.763 13.920 

















Figure 51 Motion Sickness Scores Before and After Training (Control Group) 
Looking for any significance between the changes seen above in  
Figure 51, paired T-tests were performed for each category, the results are presented 
below: 
Table 24 Statistical Results of Motion Sickness Change for Experimental Group 
 
Table 24 shows that there was no significant change for any motion sickness score for 
the control group – in either the SSQ or MSAQ where p>0.05 in all cases. 
Motion Sickness (Control group) df t Sig. (2-tailed) 
MSAQ Gastrointestinal  6 -1.158 0.291 
MSAQ Central 6 0.679 0.522 
MSAQ Peripheral 6 0.909 0.398 
MSAQ  Sopite-Related 6 -1.220 0.268 
MSAQ Total 6 -0.997 0.357 
SSQ Nausea 6 0.750 0.482 
SSQ Oculomotor 6 -0.603 0.569 
SSQ Disorientation 6 -1.871 0.111 













Motion Sickness Scores (Control Group)
Baseline Mean Comparitive Mean
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Group data has been individually analysed (e.g., control and experimental groups are 
analysed separately). A mixed ANOVA has also been conducted with group 
(control/experimental) as the between groups variable and motion sickness (pre and 
post) as the within groups variables. The SSQ and MSAQ (totals) did violate the 
assumptions of this test where the null hypothesis of Box’s test for equality of 
covariance matrices was accepted at a 95% confidence level where (M=11.107, 
p=0.023) for the SSQ and (M=27.442, p<0.001) for MSAQ. However, given the uneven 
groups it is understood that the M Test is not necessarily robust, so this is ignored. It 
was shown that SSQ total was significantly reduced between exposures (F(1,20) = 
11.23, p=0.003) where p<0.05. Further, there was a significant difference between the 
control and experimental group for SSQ (pre vs post exposure) (F1,20) = 14.203, 
p=0.001. There was a strong and significant interaction observed (F(1,20) = 14.203, 
p=0.001)  Observing the estimated marginal means output presented in Figure 52 
below, it is clear that the experimental group significantly reduced their scores where 













Figure 52 Estimated Marginal Means for Pre and Post SSQ Score Control Vs Experimental  
Error Bars: 95% CI 
Looking also at the MSAQ total, there was a significant change observed within the 
main effect of  MSAQ scores between exposures (F(1,20) = 4.908, p=0.039) where 
p<0.05. Further, there was a significant difference between the control and 
experimental group for MSAQ (pre vs post exposure) (F1,20) = 10.679, p=0.004. There 
was also a strong and significant interaction effect observed (F(1,20) = 10.679, 
p=0.004) Observing the estimated marginal means output presented in  
Figure 53 below, it is clear that the experimental group significantly reduced their 
















Figure 53 Estimated Marginal Means for Pre and Post MSAQ Score Control Vs Experimental  
Error Bars: 95% CI 
Finally, it is also possible to explore the secondary data looking at workload of the 
reading task using the TLX (non-pairwise) – commonly referred to as Raw TLX or ‘RTLX’. 
For the experimental group RTLX score decreased from 33.80 to 24.40 showing a 
decrease of 27.8%. This decrease was proven to be statistically significant where 
t(14)2.847, p<0.05. For the control group, RTLX increased from 37.26 to 40.00, a 
difference of 7.35%. This increase was not significant however where t(6)-0.961, 
p=0.374. These scores are shown below in Figure 54 for both the control and 









Figure 54 RTLX Scores for the Control and Experimental Groups 
Rejecting the null hypothesis of Box’s test for equality of covariance matrices where 
(M=5.034, p>0.05) it was possible to conduct a mixed ANOVA comparing change in 
RTLX (pre vs post) between the two groups. This test revealed at a group level there 
























contrasting the changes experienced within each group (control vs experimental) a 
difference was observed (F(1,19) = 5.616, p=0.029) where p<0.05. There was also a 
significant interaction effect observed (F(1,19) = 19.000, p=0.029)  The estimated 
marginal means graph below indicates how the aforementioned reduction in RTLX for 












Figure 55 Estimated Marginal Means for Pre and Post RTLX Score Control Vs Experimental 
As there were two reading tasks used, and given randomly between drive 1 and drive 2 
between participants, a test to see if reading task influenced the RTLX score was 
carried out, to make sure there was no bias in the reading tasks. A paired T-Test 
showed there was no significant difference between RLTX scores for the two reading 




This project looked to address two research questions: 
RQ1 - Is it possible to improve visuospatial ability through non-invasive training tasks?  
RQ2 - Does increasing visuospatial ability decrease motion sickness susceptibility? 
To address these two research questions a two-part user trial was devised including 
both simulator-based, and on-road experimentation. The motion sickness being 
measured in the simulator is often referred to as ‘simulation sickness’ whereas for the 
on-road study it is commonly referred to as ‘car sickness’ for the on-road trial. 
However, as the term ‘motion sickness’ is an umbrella term capturing all forms of 
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motion sicknesses it can be summarised as such. Each research question can be 
discussed before conclusions bring the project together. 
6.5.1 RQ1 - IS IT POSSIBLE TO IMPROVE VISUOSPATIAL ABILITY THROUGH 
NON-INVASIVE TRAINING TASKS? 
Discussing first RQ1, which looked to validate a method for training visuospatial skills 
using a pen and paper training folder, it was shown in both user trials that this pack 
was successful across the groups. There was no literature or previously proven method 
for training visuospatial skills, therefore this pack was devised to facilitate practice with 
various visuospatial tests in hope that this would train participant skill. In Phase 1, it 
was shown how average visuospatial ability significantly increased by 38.24% across 
the group. In the on-road study it was shown that the training pack significantly 
increased visuospatial skill by 45.81%. As these two groups used the same training 
pack, it is possible to combine these two groups (giving a sample size of 35) to provide 
an overall average visuospatial score increase of 42.03% after training.   
As a validation to this training pack being the only independent variable, a control 
group was used in the on-road study who did not complete the training pack over the 
14 days. Strictly speaking, this control group was not a true control, where they did not 
complete any ‘training task’ and thus had a different experience to the experimental 
group. This group may be better considered as an ‘untrained group’. However, the 
term ‘control group’ is used as an easily understood phrase. It was shown that for this 
control group, there was no significant change in their MRT scores, thus it is believed 
that this training pack is a successful way of training visuospatial ability. It is not known 
if this is the most effective method of training, and it is not known what specific tests 
contributed the most, and/or what training time, exposure frequency is optimal. This 
project did not set out to create the best training pack, but rather see if it was possible 
to train these skills so that later research can refine the training.  
In the simulator, three people did not improve their score and in the on-road trial, one 
person in the experimental group did not improve their visuospatial score. As there 
was no way to accurately control how people were training, there are three initially 
considered reasons why no change in visuospatial score was noticed. Firstly, it is 
possible that there was just no effect where these people did train as recommended, 
but this style of training was not successful for these people. Second, participants may 
not have trained as recommended and perhaps rushed the training without engaging 
with it properly. A third, perhaps more speculative reason, where all four participants 
who did not increase their scores were female it is possible that hormonal fluctuations 
had an effect on their ability, where it is known that natural hormonal changes 
throughout the menstrual cycle does have a significant effect on MRT score (Silverman 
& Phillips, 1993). Menstruation was not a variable that could be controlled, and this is 
highlighted as a possible drawback of this experiment. 
101 
 
6.5.2 RQ2 - DOES INCREASING VISUOSPATIAL ABILITY DECREASE MOTION 
SICKNESS SUSCEPTIBILITY? 
With good evidence that the training pack increased visuospatial performance, RQ2 
could then be addressed and the data was examined to see if this visuospatial 
performance was effective in reducing motion sickness susceptibility. For the simulator 
study, there are three methods of measuring the impact. It was shown that, for those 
who improved their visuospatial ability, participant dropouts due to motion sickness 
reduced by 60%, average, SSQ total reduced by 58.02% and drive time for those who 
did still drop out (n=4) increased by 104.87%. All of these changes were statistically 
significant. There was no control group for this study as simulator time was strictly 
limited and there was only time for 20 participants, it was decided to retain the entire 
sample as experimental where removing enough for a meaningful control may have 
impacted the validity of this first study due to limited sample sizes. However, three 
participants did not improve visuospatial skills. Despite this being a very low sample 
(n=3) it is interesting, on an anecdotal level to see that there was no significant change 
in their collective SSQ scores before and after the training period. Their drive time did 
not change significantly and there was also no change in their propensity to drop out 
(where all three dropped out both before and after the training period). No meaningful 
conclusions can be drawn from this due to its limited sample size, but does bode well 
for the validity of the relationship between increased visuospatial skills and reduced 
motion sickness where this is further evidenced. 
Looking to the on-road study, it is positive to see a similar direction and scale of results 
for on-road motion sickness, or car sickness. It was shown that for the experimental 
group, average total SSQ decreased by 58.50% and average MSAQ decreased by 
51.89%. Again, these reductions were proven to be statistically significant. Both of 
these scores are a very sizable reduction in motion sickness scores. Anecdotally, one 
participant dropped out of the first driving scenario (pre training) 13 minutes into the 
drive giving an FMS score of 17 out of 20. This same participant, after training, gave a 
score of 5 out of 20 at the same minute 13, and went on to complete the entire drive 
with a maximum FMS score of only 7 out of 20 for the entire post-training drive. 
As this on-road study benefitted from having a control group it was positive to see that 
both MSAQ and SSQ did not significantly change between the two exposures for those 
with no visuospatial training. This, matched with the finding that their visuospatial 
skills remained the same helps validate that this visuospatial training was indeed the 
only factor which influenced the reduction in motion sickness for the experimental 
participants.   
As well as motion sickness, this on road trial was able to collect data on the workload 
for completing the reading task. Using the RTLX it was shown that workload 
significantly decreased by 27.8% for the experimental group, but had no significant 
change for the control group. This was a very basic reading task – designed for adults 
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learning to read, and, as there was no goal for the readers it was not expected to see 
such a large decrease in perceived workload. However, this change was seen, and adds 
to the literature previously discussed where reducing motion sickness was shown to 
increase job performance (Stroud, Harm, & Klaus , 2005). There were no measures of 
how successful participants were at completing the reading task, as this was not the 
primary aim of the study, rather, workload was an easy secondary data set to capture 
with minimal interruption to the primary research questions. Support for the RTLX is 
given by (Byers, Bittner, & Hill, 1989), who show that the pairwise comparison (as is 
needed for the standard TLX calculation) is not needed and further validates the 
methodology of this analysis.  
The results showing decreased motion sickness leads to decreased workload further 
builds on the findings within Project A, to show how motion sickness does have an 
impact on human performance. Linking this very basic finding back to automated 
vehicle productivity, where reading is a known desired use case for automated vehicles 
(State Farm, 2016), this work evidences the importance for motion sickness 
management, where motion sickness will likely impact productivity.  
Considering the effect of gender again, it was shown in the simulator experiment that 
males and females benefited equally from statistically comparable reductions 
(considering scale) in motion sickness reduction. However, the on-road experiment 
identified that males reduced their sickness more so than their female counterparts, 
on average. This mixed result makes it difficult to conclude on the exact gender effect 
of this motion sickness management method and more data would be required to 
answer this question with controlling for the menstrual cycle advised for further study.  
6.5.3 OVERALL DISCUSSION 
Firstly, to discuss the validity of the findings, the first concern with this study was in 
ensuring that the habituation to the task from the first exposure would not impact the 
second exposure. The literature discussed indicated that anything over one week 
should be sufficient to reduce the chance of repeat exposures (Dunlap, 2000). Further 
a leading academic in the field of motion sickness was also consulted who agreed that 
14-days was sufficient to ensure that repeat exposures should not have any effect 
(Diels C. , 2018). In the simulator study, actual time between the first exposure (as 
discussed in Project A) and the second exposure to the driving task was 6 months, so 
this certainly would not be an issue. For the on-road study, the lack of change in the 
sickness scores for the control group confirmed that there was no habituation to the 
first exposure. Controlling the two exposures to ensure they were as similar as possible 
was straightforward in the simulator, where all factors (including, but not limited to, 
climate, traffic, route, vehicle etc.) were controllable and maintained the same 
between exposures. Driving style including speed could be a factor for motion sickness 
also, where self-regulation of driving could have been a factor. In the simulator study, 
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the six month gap between exposures is likely to be of benefit where participants were 
not freshly practiced in operating the simulator so they could not easily employ self-
help measures which may have skewed results for the second exposure. Secondly, 
speed limit signs were placed very frequently and participants were under strict 
instruction to adhere to these speeds as close as possible throughout both exposures, 
so it is thought that driving style was as similar as reasonably possible to control 
between the two exposures. Also, the times of the two exposures were kept as close 
to the same time of day as possible.  
For the on-road trial, the 14-day gap in between the two exposures was seen to be 
effective in removing any habituation where the control group showed no significant 
change in motion sickness scores. The driver was a JLR trained driver and was 
conscious to drive in a comparable manner throughout all drives, they were not aware 
of who was a control participant or an experimental participant. The lead researcher 
who was in the vehicle throughout all drives was also conscious of the driving style and 
despite (subjectively) monitoring for consistency did not need to advise the driver at 
any time as the driving style was considered to be very consistent throughout all 
drives. Traffic conditions were harder to control, however the route was checked with 
the Highways Department to ensure no road works were planned at any time during 
the study (which they were not). The time of day that participants completed the study 
was also kept the same between exposures, ensuring that routine traffic at specific 
times was going to be the same. These external variables are a limitation of any on-
road study, but in this trial, there were no significant timing deviances between drives.  
The only other significant factor which was uncontrolled was female menstruation. It is 
known that hormone fluctuations throughout the menstrual cycle affect both 
visuospatial skills (Silverman & Phillips, 1993) and motion sickness (Hausmann, 
Slabberkoorn, Van Goozen, Cohen-Kettenis, & Gunturkun, 2000). Unfortunately this 
was not possible to control or measure for this user trial. Succeeding in reducing 
motion sickness despite this, provides a more realistic use-case for the concept of 
visuospatial training. 
Overall, the methodology of this two part study was thought to be very effective in 
isolating visuospatial training as the only variable which had changed between the two 
exposures. The scale of the impact of this study was not of great consequence as a first 
of its kind study to explore the relationship between visuospatial skills and motion 
sickness. However, it was of benefit to see this effect to be very strong, and this 
certainly adds to the justification for further experimentation. Specifically, this training 
method has a lot of scope for further development. Further research should look at 
the most effective training tasks, the optimal training time and frequency and, other 
methods (other than pen and paper) through which training can be possible. Further, 




The exact psychophysiological mechanism through which motion sickness is affected 
through this visuospatial training is as yet unknown. This research represents the first 
time that this link has been identified and explored with data. Upon initial 
consideration, it is perceivable that the cognitive ability to understand/ comprehend/ 
process motion aids in the ability to sub-consciously process the moving environment 
– overcoming sensory conflict, the sense of ‘lack of control’. This concept of pre-
conditioning is supported in the literature discussing the working memory model the 
‘visuospatial sketchpad’. This model is concerned with the retention of object and 
spatial information (Buchsbaum & D'Esposito, 2008), and it is considered that the 
training regime improved skills within this ‘visuospatial sketchpad’ as a collective of 
working memory skills. This improvement in working memory skills within this model 
linked strongly with orientation and movement may logically be of benefit when trying 
to comprehend and subconsciously resolve motions (actual and perceived). 
Increased visual dependence is observed in individuals who have less ‘confidence’ in 
vestibular or somatosensory functions (i.e., a decreased dependence) and rely more on 
visual cues for information – see (Agarwal, et al., 2011). Research linking visual 
dependency to motion sickness is sparse. Looking at one paper however, researchers 
observed that participants who were more susceptible to motion sickness also were 
more affected by a visual motion stimuli (Yokota, Aoki, Mizuta, Ito, & Isu, 2005)  – i.e., 
had an increased visual dependence. It is conceivable therefore to consider that 
through reducing visual dependence (though, say, training visuospatial skill to enhance 
somatosensory dependence) you may be able to reduce susceptibility to motion 
sickness. Linking this correlation of visual dependency and motion sickness to training 
previous literature has discussed how repeat visual motion stimuli can reduce visual 
dependence and manage (somewhat) postural sway (Pavlou, et al., 2011). Although 
there is recent agreement that postural sway is not a cause of motion sickness, the link 
between the two is certainly established and motion sickness is understood to 
commonly proceed postural sway effects (Stoffregen, Hettinger, Hass, Roe, & Smart, 
2000). 
It is possible this enhanced ability to resolve motions is linked to the habituation effect, 
whereby repeat exposures to a motion sickness-inducing, or spatiality-challenging task 
can reduce the susceptibility to motion sickness through ‘habituation’ - see (Wood C. 
D., et al., 1994). This supports the idea of the visuospatial sketchpad as a working 
memory function for the comprehension and therefore processing of motion. If this 
affect is linked to habituation and working memory, the length of effect time before 
reduced susceptibility to motion sickness is present may be linked to a similar period 
as habituation or working memory skill retention.  
The impact of this method for reducing motion sickness by training visuospatial skills is 
considered to be very impactful for JLR, the automotive industry and the field of 
motion sickness as a whole.  Considering the automotive industry, many current 
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recommendations for reducing motion sickness in future vehicles, as previously 
discussed, are limited by specific use cases. For example, many require the user to be 
looking at an HMI screen, some require the user to wear various wearables throughout 
a journey, and some require fundamental changes in a vehicles design (often referred 
to as body in white). All of the previous recommendations are useful and valid, 
however, the method presented in this project, is thought to be independent of all 
these limiting factors and is a method to reduce susceptibility to motion sickness 
across any use case, vehicle, or situation.  
There are many benefits this new finding can have for the automotive industry. With 
the assumption that this effect can be translated into a refined training tool, it may be 
useful to help reduce simulator dropouts in future research as well as ensure 
transferability of simulator data is improved where the impact of motion sickness on 
human performance can be reduced. Considering real-world applications, many people 
want to use automated vehicles to complete entertainment and productivity based 
tasks (such as reading, watching films, working etc.) which have previously been 
identified as motion sickness-inducing tasks. With a method of reducing motion 
sickness susceptibility it is possible to improve automated vehicle users ability to 
complete these tasks comfortably. The exact scale to which this method can reduce 
motion sickness is as yet unknown, thus the full potential is not possible to comment 
on. As knowledge within the field progresses it is hoped that this training tool can be 
refined to be more effective than it has already proven to be. 
There also is no reason to believe this effect would not be transferable to other motion 
sickness states where the utility of this technique has already been shown to work in a 
simulated environment (with no efferent motion) and an on-road environment (with 
limited afferent motion cues). The impact of increasing visuospatial skills could indeed 
be useful for reducing seasickness, VR sickness or airsickness. Although there is no data 
to support this claim, it is recommended that the transferability of this relationship 
should be further explored. This finding could have a great impact on other areas 
where motion sickness is an issue and this method has the potential to significantly 
benefit multiple fields. For example, studies have previously tried to improve job 
performance through reducing motion sickness susceptibility, for example, a military 
tank simulator training experiment showed how simulation sickness degraded training 
effectiveness (Lampton, Kraemer, Kolasinski, & Knerr, 1995). Various other projects, 
including Project A of this Innovation Report, have discussed the impact motion 
sickness has on human performance – for example (Bos, et al., 2008). It is possible that 
this knowledge about how to reduce motion sickness susceptibility can benefit many 
sectors where it is known that visuospatial training is useful for both simulator and 
real-world motion sickness. Such industries that could benefit include military 
simulator training, sea-sickness in navy staff, motion sickness for the tourist industry 
(e.g., seasickness on cruise ships, airsickness on aeroplanes etc.). The data presented 
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as part of this research supports the effectiveness of this training for both males and 
females. It is therefore conceivable that this method may help improve inclusivity in 
fields where motion sickness is a limiting factor for females – who, on average, are 
more susceptible to motion sickness than males.   
As a final note on this project, and re-visiting the subject of transferability between 
simulator and real-world experimentation, this user trial evidences that the effect 
observed in the simulator was similar to that which was observed in the real-world. 
Direct comparison of the two motion sickness reductions is not possible, where the 
route design and task (i.e., simulator participants ‘drove’ the vehicle, and on-road 
participants sat as occupants) are not comparable. However, now it is known that this 
effect is useful for both simulators and real-world it is possible to recommend that 
future research to refine this method can be conducted in a simulator. The simulator 
allows for greater repeatability where many conditions can be kept the same and is 
both quicker and easier to run trials without being limited by uncontrollable external 
variables such as traffic. 
Further discussions around gender differences and real-time motion sickness 
measured by the FMS for both the on-road and simulator study can be found in 




This project has validated a method, using a novel assemblage of pen and paper 
training tasks, to significantly improve visuospatial performance. It was shown that for 
the whole sample (n=35) visuospatial performance (as measured with the MRT) 
improved by 38.24%. A small control group (n=7) who received no training showed no 
significant change in their visuospatial skills, highlighting this training pack as a 
successful method of training visuospatial skills in a non-invasive manner. Further, 
through a two-phase user trial involving both simulator-based and on-road 
experimentation it has been proven that through increasing visuospatial performance 
it is possible to decrease motion sickness. Increasing visuospatial performance was 
shown to reduce motion sickness in a simulator by 58.02% with a further 60% 
reduction in simulator dropouts. This was also evidenced in an on-road trial where 
motion sickness was reduced by 57.19% after visuospatial training.  
Although the exact mechanisms for this effect are as yet unknown, the concepts of 
visual dependency and the visuospatial sketchpad have been discussed. It is 
considered that this training method may be linked to reducing ones visual 
dependency through the training of spatiality and orientation working memory skills. 
This training may mitigate sensory conflict by resolving visual conflicts (by way of 
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reducing dependency) giving way to greater comprehension of motion through the 
somatosensory system.   
The applications of this finding may be useful for reducing motion sickness for future 
simulator participants, reducing motion sickness in current vehicles, and reducing 
motion sickness in future automated vehicles. It is also shown, through some 
secondary data that this reduction in motion sickness was responsible for a significant 
reduction in workload (measured using the NASA RTLX) – adding to the strength of this 
method for enabling productivity in future automated vehicles. The applications of this 
method for reducing sickness go beyond just the automotive industry and may benefit 
various other industries and motion sickness applications, such as seasickness for navy 
staff and tourists or simulator sickness for military or professional training amongst 
others. The transferable nature of these findings evidenced through this two-part user 
trial show that simulator testing is a useful and valid way of continuing this further 
research where many more future questions have been highlighted.  
6.6.1 LIMITATIONS 
Within this research looking at visuospatial performance training, the majority of 
participants for the simulator trial were JLR staff or University staff/students and all of 
the participants for the second on-road study were JLR staff. Every effort was made to 
recruit from diverse occupations where both the university and JLR employ a wide 
range of job types. Although unmeasured, it is very likely that these groups were not 
representative of the general population where the group most likely had higher than 
average educational qualifications. This is worth considering when looking at the 
effectiveness of the training and working memory skills, where people with greater 
experience of further education may be more skilled at learning than others. It is 
conceivable that the effectiveness of the training pack may be greater for a group with 
more educational experience. This is not thought to affect the relationship observed 
between visuospatial performance and motion sickness, rather it could have skewed 
the results on the effectiveness of the training pack.  
The training packs were not marked so understanding of individual training task 
performance was not possible. Further, there was no practical method to ensure 
adherence to the training regime. Although the data provided strong evidence that 
these skills can be trained, it provides limited evidence for the scale of training 
effectiveness where there was no control over training regime effort. 
Finally, as mentioned within the body of the research, the ‘control’ group used was not 
a true control. A true control would have seen participants completing a training pack 
in the same routine of the experimental participants where this training pack would be 
for unrelated tasks -such as numeracy (for example). This would ensure that both 
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groups had a more similar experience, and ensure that there was no bias from 




With the new knowledge created within this research project there were a few routes 
available for commercialisation, each would conclude on slightly different future 
research questions. There was, of course, a desire to make this research applicable to 
the sponsoring company, so it was decided that experts within JLR would be brought in 
to inform on the future of this research – giving a business case of direct benefit to the 
sponsor. A workshop was held to explore methods of exploitation of this knowledge, 
where through the creation of some project proposals, a research plan could be taken 
to higher management to fund a larger scale research project to develop this motion 
sickness management method. The workshop took place over one afternoon and a few 
‘design thinking’ ideation exercises were used to gather information about areas of 
exploitation for this new finding in the context of JLR. Firstly, a presentation was given 
about this project (both simulator and on-road trials) to get everyone to a common 
state of knowledge about this relationship between visuospatial skills and motion 
sickness.  After the presentation, three core areas of interest for further research were 
presented: 
1 – Understanding underlying effect 
2 – How can the effect be improved and developed 
3 – How can this knowledge be applied and what ‘product(s) or service(s)’ can be 
created. 
With these three categories as headings, groups were formed and research questions 
were identified which were deemed to be of importance to answer each  area. 
Alongside this, workshop participants had to rank each research question (high, 
medium or low) for the impact to JLR, as well as for the complexity of the research 
question (using the same scale). 
After research questions were established, everyone was asked to write down a 
company they perceive to be innovative and inspiring. The task then was to imagine 
that their chosen company has this new knowledge and to think, and write down how 
this company might turn it into a product. This was a useful way of enabling creativity 
in the ideas generation phase. 
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A product ideas matrix was then put up on the wall consisting of age categories on the 
X-axis (young, middle aged, retired) and use cases on the Y-axis (personal life, in car, 
other brand related ways). The task was then to think about what exploitation 
methods could be used for each category. When ideas started to slow, participants 
were stopped and they were told to imagine the IP now belonged to a theme park and 
now continue to place ideas on the board about how this theme park could exploit this 
knowledge – again to further enable creative thinking. A photo of some of the 
workshop participants filling in the ideas matrix is shown below in Figure 56 (where 












Figure 56 Workshop Participants Completing the Ideas Matrix 
The final task was for the groups to identify what they thought to be the best product 
or exploitation ideas, taking them off of the ideas matrix and back to the research 
questions where each product idea was assigned research questions which 
participants decided needed to be answered to achieve this goal. 
This workshop was very useful for quickly generating some concepts for further 
products to help the sponsoring company benefit from this new knowledge. The 
results from the workshop were given to the management staff for JLR as a business to 
decide how a new project could be developed based on the findings from this EngD 
research. A JLR team was formed to develop a mobile application for visuospatial 
training, the utility of which will be used by JLR to further answer some research 
questions highlighted and explore the idea of a possible future product. Some 
screenshots of this mobile app, which the information from this EngD project helped to 














Figure 57 JLR Motion Sickness App 
 
6.8 FUTURE RESEARCH 
 
In summary of the findings from this project, and on reflection of the workshop which 
was run to further explore areas of exploitation of this knowledge, many areas for 
further research questions were highlighted. These areas of research were considered 
the most important questions for the automotive industry and the sponsor of the 
project (using a quantitative assessment of importance as measured in the workshop): 
1. What are the psychophysiological underpinnings to this effect, through what 
mechanisms does visuospatial training reduce motion sickness susceptibility and how 
long does this effect last?  
2. To what extent is visual dependency related to visuospatial performance and are 
those with a greater visual dependency more prone to motion sickness?  
3. What are the most effective training tasks to use to reduce motion sickness, and 
what is the most effective medium to interact with the training ? 
4. What is the optimal training regime, considering length of training sessions, 
quantity/frequency of training sessions and reinforcement? 
5. How acceptable do people find it to train their visuospatial skills and are people 
willing to do these tasks to improve their motion sickness resilience? 
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7 UNDERSTANDING THE MEASUREMENT OF MOTION SICKNESS (PROJECT 
C)  
 
This project looked to explore how motion sickness may be tracked, measured or even 
perhaps predicted for ‘real-time’ automotive applications – although the scope 
allowed this project to consider motion sickness in a cross-industry manner. The initial 
consideration for a physiological project came from the literature discussed in 
Submission 2, where there was much discussion about the utility of various 
physiological measures on which to track motion sickness. JLR, as the sponsoring 
company proposed the use of an physiological monitoring system using just two 
physiological measures (electro dermal activity and skin temperature) to measure and 
give feedback on motion sickness in real-time. This project therefore set out to explore 
the feasibility of such physiological measures to measure real-time motion sickness 
onset (presented in full in Submission 7). It used the machine learning model 
developed in Submission 1 to propose useful data sources which may be used to 
accurately measure, and perhaps predict motion sickness onset in the future. The 
human factors approach to machine learning model has been published (Smyth, et al., 
2018) and the analysis of physiological data as an indicator for motion sickness has 






Currently, the most accurate and useful methods for measuring real-time motion 
sickness onset is through the application of subjective questionnaires FMS (Keshavarz 
& Hecht , 2011) or MISC (Bos, MacKinnon, & Patterson, Motion Sickness Symptoms in 
a Ship Motion Simulator: Effects of Inside, Outside, and No View., 2005) – both of 
which require the subject to report their own subjective symptoms. These methods 
are useful for ‘lab-based’ research purposes where participants have the time and 
proclivity to respond to questioning. However, for commercial applications where it 
may, for example, be useful to measure motion sickness of a vehicle occupant, it 
would be advantageous to track motion sickness without requiring regular and in-
depth questionnaires. Being able to track motion sickness state may be beneficial for 
many reasons. For example, there are a few known ways to help mitigate motion 
sickness and if a vehicle can notice an occupant is getting motion sick, these mitigation 
strategies can be implemented. Example mitigation strategies have been previously 
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discussed in this Innovation Report and might include, changing the route to a less 
sickness-inducing route, providing airflow to the occupant, and encouraging eyes-on-
road to minimise sensory conflict amongst others. Having an objective measure of real-
time motion sickness would also be useful for the purposes of future motion sickness 
research.  
When this project began, JLR as the sponsor and case study of this EngD, were 
discussing the utility of physiological data for measuring motion sickness in user trials. 
Specifically they were keen to use the measures of skin temperature and electro 
dermal activity (EDA) to infer real-time motion sickness state for vehicle occupants and 
user trial participants. This was known as a challenging subject, with many discussions 
in the literature. This project therefore looked to see if these physiological measures 
alone were useful for measuring or even predicting real-time motion sickness state, 
and looked to advise on what data would be most useful for a future motion sickness 




The evolutionary theory of motion sickness (Treisman, 1977) argues that when a 
sensory conflict is taking place the body assumes a poison has been ingested and is 
responsible for the conflict in senses. This somewhat explains some of the common 
symptomology of motion sickness where people sweat (a response used to push toxins 
out through the skin) and core body temperature drops to preserve vital organs. It is 
therefore perhaps reasonable to presume that physiological measures may be a good 
indication of motion sickness onset.  
Looking at functions such as heart rate (and derivations) it has been concluded 
previously that there are no consistent agreement between heart rate measures and 
motion sickness state (Hu, Grant, Stern, & Koch, 1991). As an example, research has 
previously claimed to observe a correlation between heart rate and motion sickness 
(Cowings, Sutter, Toscano, Kamiya, & Naifeh, 1986), whereas others disagree, finding 
no correlation (Graybiel & Lackner, 1980). The lack of agreement has been 
documented well in a report by (Hu, Grant, Stern, & Koch, 1991). Although there is a 
great deal of contradictory literature, overall researchers tend to agree that heart rate 
(and derivations thereof) are not a useful indicator of motion sickness.  
 
Other research looking to measure motion sickness using physiological measures looks 
to skin sweat response – also referred to as Galvanic Skin Response (GSR) or Electro 
Dermal Activity (EDA). This, given the known response to motion sickness explained by 
the evolutionary hypothesis (Treisman, 1977), makes logical sense as an area to 
explore. Research in this field has previously found a link between those with a 
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naturally high sweat rate (volar sweating) and increased propensity to become motion 
sick (Parker, 1971). This effect was further discussed in an aviation study which 
correlated increased skin sweat response to higher motion sickness questionnaire 
scores, after a motion sickness exposure (Warwick-Evans, et al., 1987). However,  it 
was further explained how external variables are likely interfering with the data, where 
they found little support for the link between skin sweat response and single incidents 
of motion sickness. Another study claimed that phasic skin conductance was a useful 
indicator of motion sickness when all participants in the study had reached a similar 
level of subjective sickness (Golding J. , 1992). All these previous studies do show 
support for the relationship between motion sickness and skin sweat response.  
The second measure of interest in the literature is that of skin temperature. This 
measure is a logical area for exploration where the thermoregulatory response to 
motion sickness is relatively well understood and documented (Nobel, Tribukait, 
Mekjavic, & Eiken, 2012). There are fewer research projects looking at skin 
temperature as a measure of motion sickness, although one key text does summarise 
this measure as worthwhile pursuit (Nalivaiko, Rudd, & So, 2014). 
To date there has only been one published text looking at the ‘real-time’ measurement 
of subjective motion sickness analysis of associated skin response (Bertin, Collet, Espie, 
& Graf, 2005). The conclusion of this work agreed that motion sickness is related to 
skin conductance and skin temperature but concluded that the only ‘useful’ analysis of 
this data relies on post-hoc analysis (p287). This research required manipulation of the 
data based on the entire journey - involving minimum and maximum scores of the 
individuals as well as the group to normalise the data before processing. Further, there 
is discussion about the temporal nature of motion sickness onset where 
symptomology proceeds subjective discomfort, and the state of relaxation was 
concluded to be an effector, rather than motion sickness itself. 
Given this background literature the research question was therefore set: 
RQ1 - Is it possible to correlate motion sickness in real-time to electrodermal activity 
and skin temperature using non-invasive methods? 
The scope of this research question was specific to ‘non-invasive’ where the goal was 
to assess these measures for utility in a consumer application. With this in mind, the 
scope was set to exclude lab-based medical grade physiological equipment as well as 
equipment which required head-mounted equipment or electrolyte gel – which would 
be inconvenient for a consumer. Further, the importance of ‘real-time’ is emphasised 
where the motivation for measuring physiological states was to help predict and 
measure motion sickness in real-time for both user trials and vehicle features. The 




7.3 METHOD  
 
To assess the relationship between real-time motion sickness and the physiological 
measures of EDA and skin temperature some original data was needed. The user trials 
discussed in this Innovation Report including the human performance simulator trial 
(Project A and Submission 3), the visuospatial training simulator study (Project B and 
Submission 5) and the visuospatial training on-road study (Project B, Submission 6) 
provided a good opportunity to collect physiological data. Throughout these studies, 
participants wore the Empatica E4 wristband (Empatica Inc. , 2016) which measured 
physiology in real-time. This wristband is a wireless wrist-mounted device, which 
requires no gel and can be worn comfortably without irritation. The E4 records EDA in 
the unit of micro-Siemens (μS) and skin temperature in the unit of degrees Celsius (°C) 
both at 4hz which provides 240 data points per minute. Throughout the user trials, 
participants also reported subjective motion sickness at a rate of once per minute 
using the FMS (Keshavarz & Hecht , 2011). This subjective real-time information was 
used to compare to the objective physiological data collected. Due to the nature of the 
user trials, every participant had a minimum of two minutes rest time whilst wearing 
the E4 and before the trial began where baseline ‘rest’ data was collected.  
Environmental conditions were kept as similar as possible throughout the studies 
where both simulator trials and on road trials had an average temperature of 21 
degrees Celsius maintained throughout and no windows were opened during the on 
road trials so airflow was not a factor.  
7.3.1 DATA ANALYSIS 
To analyse the data collected, three groups were established into which participants 
were categorised for analysis. These groups are described below in Table 23) 
Table 25 Groups for Physiology Analysis 
 
Group 1 (as presented in Table 23) contained 14 participants made up of seven males 
and seven females with mean age of 30 (SD=10.69). Seven of these participants ended 
the simulator driving task early due to severe motion sickness (one male and six 
females) However, the physiological data of these participants was retained for 
analysis, but trimmed up until the point in which they ended the driving scenario. The 
average drive time for Group 1 was 22 minutes, with the longest drive being 33 
Group Number Description Group Size 
1 Simulator study participants N=14 
2 On-road study participants, first exposure N=26 
3 On-road study participants, second exposure N=21 
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minutes. Due to these dropouts, the shortest drive was 8 minutes. This group contains 
participants from both the human performance simulator trial and the simulator-based 
visuospatial training trial, although participants only appear once in this data set. 
Group 2 contained 26 participants made up of 12 males and 14 females and the mean 
age of the group was 33.6 (SD=12.8). There were no dropouts in this group and the 
average drive time was 28 minutes with the longest drive being 31 minutes and the 
shortest being 27 minutes. Group 2 consisted of participants from the first on-road 
study as part of Project B’s visuospatial training research. 
Group 3 contained 21 participants made up of 10 males and 11 females with a mean 
age of 31.1 (SD=11.8). Again, there were no dropouts in this group and the average 
drive time was 28 minutes with the longest drive being 30 minutes and the shortest 
being 27 minutes. This group of participants contains the same participants as in Group 
2 however; this is their second exposure to the on-road driving task explained in 
Project B. There are fewer participants in Group 3 as some in Group 2 withdrew from 
the study before their second exposure due to work commitments.  
In total 1,603 minutes of motion sickness data was collected, which equated to 
384,720 measures of EDA, 384,720 measures of skin temperature and 1,603 measures 
of subjective motion sickness. Given the amount of data collected, (with physiological 
scores being captured at a rate of 4hz), the data was first processed to calculate the 
mean score for both physiological measures (individually) for the one minute leading 
up to the associated FMS score. For example, if the FMS score was given at minute 
two, the associated physiological data was calculated from taking the average of the 
measures recorded between minute one and minute two. This process provided each 
participant with a once-per-minute score of EDA and skin temperature to correlate to 
that minute’s subjective sickness score. Using each participants baseline scores, the 
delta (Δ) scores were then calculated using the same method as set out in this paper 
(Meehan, Insko, Mhitton, & Brooks, Jr, 2002) using the below formulas: 
Δ EDA minute x = EDA minute x – EDA baseline 
Δ Skin Temperature minute x = TEMP minute x – TEMP baseline 
To analyse the data, the main motivation for this research must be considered so that 
any conclusions made are practical considering the overall goal – understanding the 
utility of physiological data for real-time measure of motion sickness. Firstly, the term 
‘real time’ is often discussed within the literature with regards to physiological 
measurement. In many cases real-time is discussed as a matter of a few hundred 
milliseconds. However, considering subjective data is to be analysed at once every 60 
seconds, this is our threshold for ‘real-time’ analysis. This means that methods 
involving post-processing of data are not suitable for the scope of this project. The 
data needs to be analysable within a rolling 60 second timeframe to be considered 
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practical. The motivation for method selection was driven solely on the goal to 
understand if these physiological outputs are useful as real-time predictors/measures 
of motion sickness. Therefore, methods involving significant post-hoc analyses 
(including normalisation of data) were disregarded. Pearson’s correlations were to be 
the primary method for analysis of this collected data where this method is a practical 
method for determining real-time correlation without post-hoc data manipulation and 




Data was collected throughout all the user trials conducted in Projects A and B, 
however due to some technical issues with the device and the data collection method, 
some data was lost. Overall, data sets from 40 participants data was retained for 
analysis, where 21 of these participants completed repeat-measure trials so in total 61 
sets of data were collected.  
For Group 1, the average EDA during the rest period was 0.782μS, SD=1.063, which 
increased during the driving scenario to an average of 1.015μS, SD=1.531. The average 
skin temperature for the rest period was 32.644°C, SD=0.935, which decreased during 
the driving scenario to an average of 32.298°C, SD=1.528. 
For Group 2, the average EDA during the rest period was 0.669μS, SD=0.635, which 
increased during the driving scenario to an average of 1.092μS, SD=1.683. The average 
skin temperature for the rest period was 32.086°C, SD=0.559, which decreased during 
the driving scenario to an average of 31.925°C, SD=0.475. 
Finally, for Group 3 the average EDA during the rest period was 0.685μS, SD=0.262, 
which increased during the driving scenario to an average of 1.225μS, SD=0.043. The 
average skin temperature for the rest period was 32.368°C, SD=1.448, which 
decreased during the driving scenario to an average of 32.061°C, SD=0.431. 
To begin to explore the relationship between these three measures (subjective score, 
skin temperature and EDA)  
Figure 58 below presents the average EDA, skin temperature and FMS score for Group 















Figure 58 Electrodermal Activity (EDA), Skin Temperature and Subjective Motion Sickness (FMS) – 
Group 1 (simulator) 
Figure 59, below, combines all the data from the on-road participants (where the 
environment is the same) to present the data from the average EDA, skin temperature 








Figure 59 Electrodermal Activity (EDA), Skin Temperature and Subjective Motion Sickness (FMS) – 
Group 2 -road) 
Looking at the graphs presented above in Figure 58 and Figure 59, there does appear 
to be some visual signs of a relationship between these variables at a group level, 
particularly when observing the timings of peaks and troughs. However, the error bars 
included (calculated from standard error) begin to highlight the degree of variance 
between each participant where there are substantial changes in the size of these 
error bars as the trials progress. The error bars appear much greater for the on-road 
trial presented in Figure 59 – perhaps due to the variance in environmental conditions 














These graphs are looking at the groups as a whole, and do not consider any 
participants scoring or physiological response individually.  
To better understand if there is an underlying practical relationship between real-time 
motion sickness severity and the physiological measures of EDA and skin temperature 
at an individual level, the correlations between these measures were considered on an 
individual basis. To begin analysis, the data within three groups was first checked for 
normality using the Shapiro Wilk test which showed the data was not normally 
distributed in any group (where p<0.05 in all cases). Therefore the non-parametric 
Spearman's rank-order correlation was used to look for  the statistical relationship 
between subjective motion sickness (as measured using the FMS) and the  
physiological measures of EDA and skin temperature. The results of this analysis are 
presented below in Table 26. 
Table 26 Correlations of EDA and Skin Temperature (TEMP) Against Subjective Motion Sickness (FMS) 
  Group  Participant rs FMS vs. EDA rs FMS vs. TEMP 
Group 1 
 175 .815** 0.166 
 180 -.865** -.814** 
 195 0.066 0.238 
 237 .847** -.941** 
 388 0.145 0.084 
 489 0.232 .894** 
 549 -.647** -.603** 
 607 0.181 -.651** 
 633 -0.365 -0.079 
 731 -0.334 -0.115 
 784 -0.228 -.825** 
 846 .627** -.684** 
 950 .982** -0.746 
 968 0.353 -0.263 
 
 519 -0.516 -.491** 
 699 0.316 0.316 
 524 -.723** -0.267 
 856 -0.145 -0.082 
 394 .422* .398* 
 473 .563** .821** 
 57 -0.243 .460* 
 781 .609** .765** 
 447 0.051 -.579** 
 217 -.890** .939** 
 150 .529** .737** 
 766 0.003 -.514** 
 110 -0.078 0.284 
 956 .378* .683** 
 283 -.373* 0.115 
 580 .779** .841** 
 20 .459* .415* 
 476 .484** .436* 
 146 0.092 -0.276 
 480 0.216 .646** 




Table 26 presents all of the individual correlations (Spearman’s rs ) between subjective 
motion sickness (FMS) and the physiological measures on a case-by-case basis. The 
notation of ** denotes significance at a 99% confidence rating and * denotes 
significance at a 95% confidence rating. The colour scheme of red, orange and green 
has been used to help identify the significant correlations, where green represents 
correlations that are significant with 99% confidence, orange with 95% confidence and 
red shows no significant correlation. Already there are many varying correlations here, 
with a mixture of significance values and lack of significance. To summarise the 
significant Spearman’s rs   correlations Table 27 has been created which presents the 
quantity of significant correlations (using both levels of significance) and totals for 
each. 
Table 27 Summary of Significant (99%), Significant (95%) and Non-Significant Correlations between 
Groups 1, 2 and 3 
 
 
 948 -.584** .768** 
 215 0.011 .667** 
 9 .831** .838** 
 810 -0.126 -0.277 
 177 .431* -.527** 
Group 3 
 519 -.775** -.796** 
 524 -0.007 -.747** 
 856 -0.144 0.176 
 394 0.187 0.302 
 473 -0.313 -0.205 
 57 -0.097 -0.179 
 781 0.857 0.000 
 217 .750** -.750** 
 766 0.132 -.499** 
 956 -0.064 0.187 
 283 .567** .645** 
 580 0.250 -0.036 
 20 0.257 .882** 
 476 0.054 .381* 
 146 .751** .633** 
 480 .810** .943** 
 322 0.133 0.285 
 948 .439* .428* 
 215 .581** -0.063 
 9 -0.383 -.762** 
 177 0.228 .526** 
 Group 1 Group 2 Group 3 Total 
  n % n % n % n % 
p>0.05 15 54% 18 35% 23 55% 56 46% 
p<0.05 (95%) 0 0% 11 21% 3 7% 14 11% 
p<0.01 (99%) 13 46% 23 44% 16 38% 52 43% 
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As shown in Table 27, over the entire sample of 122 correlations, 54% were shown to 
be significant (at either 99% or 95% confidence) where 46% were shown to not be 
significant. Looking at just the significant results, correlations ranged from +0.982 to -
0.865 for EDA and from +0.894 to -0.941 for skin temperature where positive one 
(+ve1) is a perfect negative correlation and negative one (-ve1) is a perfect negative 
correlation. There appears to be a great deal of variance between the scales and 
directions of these correlations so the histograms in Figure 60 and Figure 61 have been 
created below to give an indication of the variance of correlation values observed 


















Figure 61 Correlation Values for Skin Temperature vs FMS 
The figures presented above provide a good visualisation of the range of correlations 
observed within this data set. This gives an indication of a lack of utility of these 
measures at an individual level, where one might expect to see leptokurtic or 
platykurtic distributions trending towards either a negative or positive correlation 
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direction if these measures were directly related to motion sickness in ‘real-time’. For 
the EDA vs FMS correlation, the distribution of the Pearson’s correlations is normally 
distributed as shown with the Shapiro-wilk test where p>0.05 at p=0.215. Temperature 
vs FMS was non-normally distributed where p<0.05.  
This research (considering its application and motivation of the sponsoring company) is 
not concerned with correlation at a group level, but rather at an individual level. To 
help illustrate the range of correlations at a group level further, graphs from four 
example participants (two with no motion sickness and two with motion sickness) have 
been presented below. These participants were chosen as they (in pairs) showed 
similar styles of motion sickness onset, where the first two had a very flat FMS profile, 
and the second two had quite a varied and high motion sickness experience. These 
examples further identify the complexity in deriving commonalities between individual 


















































Figure 64 Participant 956 (varied motion sickness) 
 
Moving back towards looking at these measures as a group, and away from individual 
scores an average correlation figure needed to be calculated. A common process for 
doing this involves transforming the data into a Fisher’s z score, calculating the 
average, and then transforming the data back. Another method involves averaging 
observed sample rs correlations (Alexander, Scozzaro, & Borodkin, 1989) which is 
thought to be a superior method (Alexander R. A., 1990). The process of this 
calculation is presented below: 
𝑟 ∗̅ =
∑(𝑛𝑖 − 1)








Using knowledge presented by the original author on how this equation was derived 
author (Hotelling, 1953) it is possible to rearrange this equation slightly as in its current 
published form, it is easy to misinterpret. The revised formula used to calculate 𝑟 ∗̅ is 
presented below: 
𝑟 ∗̅ =





∑ 𝑛𝑖 − 𝑘
 
Using this re-ordered equation (adapted from (Alexander R. A., 1990)) the average 
correlation figures for each physiological measure and each group have been 
calculated and is presented below in Table 28:  
Table 28 Average Correlations for Groups 1, 2 and 3 
 
The strongest correlation given in the above table is rs-0.3 for Group 1 skin 
temperature vs FMS. This score of rs-0.3 is considered to be a very weak correlation, 
and this is perhaps no surprise when observing the range of correlation values as 
shown in the graphs for Group 1 skin temperature vs FMS. Overall, none of these 
correlations are deemed to be of any use, where these average correlations are all 
considered to be very weak.  The method used to calculate these averages is reported 
to be the most unbiased and useful method (Alexander R. A., 1990). However, the 
method using Fisher’s Z score is more commonly used where more recent research 
often uses this method (for example (Ghassan , Flordelis, & Tufvesson, 2017). Given 
this more recent support for this method, and considering the transferability of this 
project to future research, this Fisher’s Z method was also used to re-run the 
calculations of averages for each physiological score. The method through which this 









And finally, 𝑧̅  is transformed to ?̅? by: 
 
Average Correlation Coefficient ( 𝑟 ∗̅ ) 
 EDA vs. FMS Temp vs. FMS 
Group 1 -0.03 -0.30 
Group 2 0.11 0.29 
Group 3 0.20 0.07 
Combined 0.12 0.15 
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?̅?′ = tanh (𝑧̅) 
Further information and detail on this method, including explanations of the notation 
is given in (Alexander R. A., 1990). Using this method, the results are presented below 
in Table 29: 
Table 29 Average Correlations for Groups 1, 2 and 3 
 
The results presented in Table 29 are very similar to that which is shown in Table 28 
and the conclusion about the weak nature of these correlations remains the same 




Previously published research has identified the link between the physiological 
measures of EDA and skin temperature and motion sickness onset (Parker, 1971). 
These findings support our understanding about the body’s response to motion 
sickness onset (Treisman, 1977) and the concept that motion sickness evokes both 
sweat and thermoregulatory responses is not disputed. Specifically, one might expect 
to see an increased sweat rate and decreasing temperature when suffering from 
motion sickness. The relationship between EDA and skin temperature as proven in 
previous literature is not disputed and at a group level, the relationship between 
motion sickness and EDA and skin temperature is established. Indeed, this effect was 
found within some participants, for example, participant 237 of Group 1 showed a 
correlation between EDA and FMS of rs+0.847 and for skin temperature and FMS rs-
0.941 (where p<0.01 in both cases). When looking to the data as a whole (as presented 
in Table 26) many of the correlations observed are found to be significant with 
significance observed in 54% of all correlations found (n=66) which may indicate there 
is some utility in these measures.  
The analysis of this data was conducted to understand if there was feasibility in using 
these physiological measures as ‘real-time’ indicators of motion sickness state. The 
intended purpose of these measures therefore dictated the analysis methods used and 
disregarded any methods requiring post-hoc analysis (e.g., normalization of data). The 
analysis of Pearson’s correlation is rather basic considering the breath of the available 
 
Average Correlation Coefficient ( 𝑟 ∗̅ )                                                      
 EDA vs. FMS Temp vs. FMS 
Group 1 -0.04 -0.30 
Group 2 0.06 0.21 
Group 3 0.18 0.07 
Combined 0.02 0.02 
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statistical tools available for physiological analysis. However, all methods, including 
phasic responses (measuring peaks and troughs) require significant post-hoc analysis. 
That is to say, they cannot be computed in real-time, and certainly not give an 
indication of prediction, where a peak is only identifiable after a decline. Similarly, 
cross correlation analysis was considered as a method for analysing the results, where 
it was shown in the plots (Figure 58 and Figure 59) physiological data falls somewhat 
behind subjective sickness. Such a calculation would account for difference in time-
domains. However, this method was not of use considering the ‘real-time’ dependency 
for this analysis where any delay greater than one-minute (i.e., our minimum 
subjective threshold) would render these measures useless for a practical application. 
Other, traditional research looking to understand physiological measurements will first 
transform the group data to avoid skew, kurtosis, and heterogeneity of variance. 
However, the process of normalising data cannot be done in ‘real-time’ and thus those 
methods were avoided for this research. Similar motivations are seen commonly 
within the literature, for example (Khalaf, et al., 2020) who also are aware that 
individual differences (especially emotional reaction) can lead to group-level data 
being unrepresentative of data on an individual level.  
Looking into the individual correlations across the group, a wide range of correlations 
are observed ranging from rs+0.982 to rs-0.865 for EDA, and rs+0.939 rs-0.941 for skin 
temperature. This range of correlations have been plotted in the histograms presented 
in Figure 60 for EDA and motion sickness and in Figure 61 for skin temperature and 
motion sickness. It is within these figures that it becomes quickly apparent that this 
range of correlations indicates a lack of utility for these measures for a ‘basic’ real-time 
assessment at an individual level. It is thought that this range of correlations is the 
most useful indicator for a lack of overall correlation between these variables using a 
real-time method. However, to quantify this further, average correlations were 
calculated using the method set out in (Alexander R. A., 1990). It was shown here that 
the overall correlations for the physiological measures to motion sickness (FMS) were 
shown to be rs0.12 for EDA and rs0.15 for skin temperature (see Table 28). This finding 
and ultimate conclusion at this time are in agreement with previously published 
literature (Harm, 1990) which summarises that there is a lack of utility for physiological 
measures at an individual level, and the experimentation and presentation of original 
data in this Innovation Report provides data to support this claim. 
The data presented here is interesting for two other reasons, firstly in assessing the 
difference between simulator sickness and ‘real-world’ motion sickness. Secondly in 
providing data for 21 repeat measures participants, where all participants in Group 3 
also appear in Group 2.  
Looking firstly at the difference between the simulator and real-world motion sickness 
correlations where in the simulator trial there was afferent (visual) motion, but no 
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efferent (physical) motion, and in the on-road ‘real-world’ study there was efferent 
motion but limited afferent motion. It is not strictly possible to compare the scale or 
‘shape’ of the motion sickness onset between these two scenarios, where the route 
design was entirely different. However, comparing results of significance between 
Group 1 and Groups 2 and 3 combined there is little evidence of differentiation. That 
is, nothing between the two categories of groups appears to highlight a difference 
between the data sets when looking at the individual scores in Table 26, or the 
summary of the group’s correlation significance levels in Table 27. Therefore, despite 
not running user trials directly comparable to each other considering route design, at 
this time there is little evidence to say that the relationship between these 
physiological measures in the simulated and real-world differ from one-another. 
Although it is agreed that further research would be required considering 
transferability if a valid physiological method was found.  
With more room for discussion (considering the availability of data collected) is the 
‘repeat-measures’ aspect of Groups 2 and 3, where for all members of Group 3, they 
also appear in Group 2 as their first exposure. Any analysis and conclusions taken from 
this have to consider that participants were only measured during two exposures, it 
may be argued that two interactions is not enough for a true repeat-measures analysis. 
However, where it is well understood that individual characteristics such as aerobic 
fitness affect both motion sickness susceptibility (Cheung, Money, & Jacobs, 1990) and 
sweat response / thermoregulation (Green, Pritchett, Crews, McLester, & Tucker, 
2004). It is therefore conceivable that individual/personal factors could influence the 
reliability of the real-time correlations. The (somewhat limited) data presented in this 
report however does not support this, where for example, participant 146 provided 
non-significant correlations of rs0.092 for EDA and rs-0.276 for skin temperature for 
their first exposure (in Group 2), but on their second exposure (in Group 3) their 
respective correlations were rs0.751 and rs0.633 both significant with a confidence 
level of 99%. In fact, with 21 repeat exposure participants, only one participant 
showed significance in both physiological measures during both exposures. Participant 
217 showed correlations rs-0.890 for EDA and rs0.939 for their first exposure (both 
significant with a confidence of 99%). Where for their second exposure they showed 
correlations of rs0.750 for EDA and rs-0.750 for skin temperature – both again 
significant with a 99% confidence level. As seen, despite the strong significance level, 
both directions to the correlations were reversed from (+ve) to (-ve) for EDA and from 
(-ve) to (+ve) for skin temperature between the first and second exposures. The 
findings within this data set therefore provide no evidence to support the idea that 
physiological measures are reliable even within individuals.  
Looking at reasons to explain this lack of agreeable correlation between these 
physiological measures and subjective motion sickness at an individual level, it is 
immediately apparent that the measures of EDA and skin temperature (amongst many 
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other physiological measures) are affected by a great deal of other ‘real time’ 
variables. For example, states of arousal (where the term ‘arousal’ is used to cover 
many emotional states) are known to evoke significant physiological responses 
(Warwick-Evans, et al., 1987). Where it is summarised in a further report how most 
researchers agree that the physiological responses of motion share many of the 
component characteristics of stress or alarm (Harm, 1990) (p.164). In fact, specific 
research addressing the relationship between stress and EDA confirms this correlation 
(Ionescu-Tirgovişte & Pruna, 1993). Using this knowledge, an anecdotal evidence that 
sensations of motion sickness can be both stressful, and alarming it is conceivable that 
the physiological responses being measured in a motion sick state could be 
significantly affected by emotional/arousal states – and not just the state of motion 
sickness. There are a great deal of  motional states and arousal states that may alter 
physiological measures, such as excitement, anger, fatigue, stress, alarm, frustration, 
confusion, fear, discomfort etc. therefore it is likely these states of arousal that are 
responsible for a lack of correlation between physiology and motion sickness 
evidenced in this data. Previous literature also looking at simulator sickness and EDA 
concluded that sensations of relaxation were related to physiological measures (Bertin, 
Collet, Espie, & Graf, 2005) which supports this issue. 
Further to these relationships between emotional state and physiological measures 
there are also other external factors that influence physiology and associated 
measurements. Specifically considering on-road experimentation, changes in 
environment may have a significant affect on physiology. Sunlight (directional 
temperature), ambient temperature, radiant temperature, humidity and airflow 
(amongst others) will likely affect both sweat response and skin temperature through 
conduction, convection and evaporation. Considering these factors (specifically 
evaporation of sweat) it also quickly becomes apparent how these physiological 
measures are themselves strongly linked to one another both as effectors and 
affecters. The thermoregulatory response to heat is to cool the body through sweating 
(measured as EDA) and associated evaporative heat loss. For such measures to be 
useful to compare at an individual level during a user trial or commercial application, 
the effect of environmental change and difference between exposures must be 
considered. Conclusively these physiological measures (and others) are not 
independent of emotion, environment, or even themselves. 
As a final note on the applicability of these measures as a real-time measure and/or 
predictor of motion sickness, it has previously been concluded that physiology is a 
delayed response to subjective scoring (Min, Chung, Min, & Sakamoto, 2004) and this, 
also appears to be evident in this data set. When looking at the graph presented in  
Figure 58, there is a notable delay between the pick ups/decreases in subjective 
motion sickness (FMS) and the physiological measures. The challenge with addressing 
such a time delay within the scope of this work is that delays are only identified 
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retrospectively, if it was possible to predict future data based on existing data there 
would be no need to collect data at all. This is in agreement with the aforementioned 
literature (Min, Chung, Min, & Sakamoto, 2004)  who also used a graphic simulator for 
their study, and further supports the idea that these physiological measures are less of 
a direct response to motion sickness, and perhaps a response to the emotional state / 
alarm / arousal of not feeling well and this may be responsible for such a ‘delay’. 
Analysis of this delayed response were considered, but as the primary objective is to 
consider the applicability of these measures as a real-time measure (e.g., to replace a 
validated subjective scale), the conclusion of such an analysis would not address this 
objective.  
It is known that the measures of EDA and Skin temperature are related to motion 
sickness. But the relationship has only ever been observed at a group level, with 
significant post-hoc analysis e.g., (Bertin, Collet, Espie, & Graf, 2005) – limiting the 
application of such measures for a consumer application. This previous research is the 
only identified paper discussing real time measures, and they also conclude that to find 
such relationships requires significant post-hoc analysis. Although, they did not provide 
data and analysis to explore the true real-time calculation, the results presented in this 
innovation report are in agreement with the previous conclusions from the literature.  
 
7.6 CONCLUSION  
 
This project, building on the previous literature which has identified a relationship 
between EDA, skin temperature and motion sickness has looked to see if there was a 
correlation between these various measures in the hope to find a method for 
objectively measuring motion sickness in real time using practical methods. Collecting 
data alongside three user trials, a total of 40 participants provided 61 sets of data 
(where some participants took part in a repeat-measures study) and a total of 1,603 
minutes of motion sickness data was captured comprising of EDA, skin temperature 
and real-time subjective motion sickness.  
Despite 54% of the correlations showing significance, the range of these correlations 
(ranging from +0.982 to -0.865 for EDA, and +0.939 -0.941 for skin temperature) 
indicated that at a cohort level, there is little evidence that these physiological 
measures alone are reliable or useful predictors or measures of subjective motion 
sickness on an individual real-time level. The reasons for this wide range of results, and 
lack of agreement between correlation direction are as yet unquantified. However, the 
literature provides ample evidence that many other factors and states of arousal also 
affect these physiological measures, where perhaps these other variables have a 
greater impact on these measures and thus render them useless as motion sickness 
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predictors. The average correlation throughout the entire sample was rs0.12 for EDA vs 
motion sickness and rs=0.15 for EDA vs skin temperature – both are considered 
incredibly weak.  
There are currently no other published works looking to assess real-time motion 
sickness as a correlate to these physiological measures (simulator or real-world based) 
so comparisons are not possible. The only text found which looks at similar measures 
utilises a technique involving significant post-hoc analysis and thus does not address 
this research question of real time assessment (Bertin, Collet, Espie, & Graf, 2005). 
Overall, it can be concluded that these physiological measures alone show little 
suitability as motion sickness measures for real-time assessment at an individual level 
and further research needs to be conducted to understand the effect of motion 
sickness on physiological measures and methods for measuring/analysing this in real 
time. It may be possible to combine much more information and/or filter physiology 
based on the understanding of external variables. The outcome of this research does 
not dispute the previously found correlations using more advanced analysis, and the 
conclusions from this research should be considered with an understanding for the 
motivations of the analysis methods used and their strict focus on ‘real-time’ 
practicalities.  
 
7.7 FUTURE RESEARCH – A MODEL FOR COLLECTING MOTION SICKNESS-
RELATED DATA 
 
There are many factors that may influence the onset of motion sickness in a vehicle, 
from demographics, to specific driving scenarios. Some of these factors are already 
known and somewhat understood. Previous research discussed in specific relation to 
physiological measures of EDA and skin temperature have been proven to not be 
useful by themselves using real-time analysis methods. However, there may be the 
ability to predict or measure motion sickness using a collection of information and 
informative data.  
Considering motion sickness onset likelihood it is known how gender (Jokerst, et al., 
1999), ethnicity (Klosterhalfen, et al., 2005), driving experience (Turner M. , 1999) and 
perhaps age (Golding J. F., 2006) (Reason & Brand, 1975) (Turner & Griffin, 1999) are 
useful to identify motion sickness susceptibility for a group. Further, it is known how 
completing tasks which allow for sensory conflict (Reason & Brand, 1975) such as 
head-down reading, or interaction with HMI out of the line of sight of the window 
(Diels C. , Bos, Hottelart, & Reilhac, 2016) will all affect the likelihood of motion 
sickness. Considering an automated vehicle, route and driving style will have a further 
impact on motion discomfort (Mountain View , CA USA Patent No. US 10 , 107 , 635 
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B2, 2018), where exposure to specific periodic motion frequencies (vibration) is also 
known to be an affecter of motion sickness (Smart Jr & Stoffregen, 1998) (p.437). 
Considering other factors, environmental changes can also have an impact on 
subjective discomfort, where cooler temperatures are often advised to limit motion 
sickness discomfort (although ambient temperature may not necessarily be linked to 
the motion sickness onset frequency (Turner & Griffin, 1999). Fresh airflow and 
unrestrictive clothing can also aid in the ability to manage the thermoregulatory 
responses to motion sickness and associated discomforts.  
When looking into the propensity for motion sickness onset, with the overall goal of 
being able to predict motion sickness onset before it happens so that preventative 
measures can be initiated, it quickly becomes apparent that there is a plethora of 
information sources on which one can make a measurement or prediction.  Submission 
1 of this EngD looked at machine learning systems to automate in-vehicle features, 
based on user routine. The conclusion of this project presented a model for enhanced 
machine learning which can be used to identify different sources of data to collect. 
This data is thought to be useful for the machine learning algorithm to be both trained 
and used for various applications. More detail on the specifics of this model creation is 
found within Submission 1, as well as a full explanation of its expected utility within 
the realm of automotive in-vehicle features (such as climate). However, this model can 
also be used to help explore the various metrics which may be useful in measuring or 
predicting motion sickness. The human factors approach to enhanced machine 
learning model has been modified slightly to remove specific notations for the SLC 
project as well as to remove notations focused on ‘user routine’. The revised model is 






Figure 65 A Human Factors Approach To Machine Learning Model 
As a brief explanation as to the utility for the model presented above in Figure 65, it is 
considered that through using this model to identify all the streams of information 
available to a machine learning system, the ability to understand/measure/predict 
motion sickness state may be enhanced. There are three primary sources of 
information highlighted here. The human (to the left of the model), from the vehicle 
(from the left of the model) and from contextual data (from the bottom of the model). 
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The machine learning algorithm, being an entire subject in itself is not of interest to 
this human factors model, where this is just designed to inform on types of data to 
collect, rather on what to do specifically with that data. Given the range of data types 
available between different sources, and within different sources, there is likely to be 
some data which is more important than others. For example, predisposition to 
motion sickness and history of motion sickness is perhaps more important than 
clothing for predicting the onset of motion sickness. Therefore, to highlight this, the 
arrows used are of varying thicknesses, symbolising varied weights of importance 
(which may differ, person to person). Each section of this model is now briefly 
explained with some example types of data that would be useful to collect. 
7.7.1 COMMUNICATION BETWEEN USER AND VEHICLE 
This section explores the availability for the occupant to communicate with the vehicle 
and the vehicle to communicate with the occupant (represented with double headed 
arrows). The overall idea of a model such as this is to limit the requirement for the user 
to input information (such as filling out questionnaires), however there should still be 
an option to capture user input if they so desire, as their subjective motion sickness 
rating is the most important aspect. It is recommended the system includes the option 
for a user to input motion comfort feedback, where a dial, similar to a volume knob for 
a radio, may be an easy way for someone to set and adjust their subjective sickness to 
inform the car. Further to this, there must be a method through which the vehicle can 
communicate to the occupant. If, for example, motion sickness countermeasures are 
being initiated, (such as a change in route), informing the occupant of this will both 
inform them of the system status, and perhaps increase their self-efficacy in the 
knowledge that mitigation strategies are being employed. Another area of information 
about the human which is useful for the machine learning system is understanding the 
occupants’ demographics, where it is known that factors such as fitness, age, ethnicity 
and certainly gender are all related to motion sickness severity. This information could 
be input by the user in a personal vehicle, or captured as part of a personal profile in a 
shared mobility instance. Further information, such as visuospatial performance may 
be accessible if the user is willing to communicate with the system. As a final point, 
despite the current lack of understanding about its utility, physiological measures 
could be transmitted from consumer wearables to the vehicle. At present, there is 
little support for the utility of this data, however, when combined with other 
information sources and/or filtered to remove other variables it could be of use. 
7.7.2 PROCESS BASED LEARNING 
The system should be able to register various interactions with the vehicle and, from 
these interactions (or processes) gain knowledge about motion sickness state. This 
could include monitoring preferred driving style, interaction with features known to be 
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linked to motion sickness management -such as opening the windows, or using the 
HVAC (Heating, Ventilation and Air Conditioning) system or other actions an occupant 
takes. Further, in an automated vehicle processes could include understanding what 
the activity of the occupant is at that time. For example, if on-board sensory 
equipment can monitor occupant activity to detect if they are reading, working with 
their head down, watching a film, sleeping or are monitoring the road, this information 
will help determine the chance of motion sickness onset. 
7.7.3 STORED AND CONNECTED KNOWLEDGE  
This category explored the ability for knowledge to be collected, stored and shared 
between vehicles. For example, route type and design could have an impact on motion 
sickness where straight roads and constant speed are preferred over winding roads 
with varied speed limits. This information (a ‘heat map’ of motion sickness routes for 
example) can be stored within the vehicle to both inform on motion sickness likelihood 
and use in case a mitigation is needed (changing route). Connected vehicles, will have 
the ability to share data between them, so based on many interactions with the same 
route, a database of knowledge can be stored about different road sections.. 
7.7.4 CONTEXTUAL DATA 
Contextual data which may be of use to understanding motion sickness onset may 
include weather and climate, where increased heat and humidity (although may not be 
a cause of motion sickness) certainly will affect subjective discomfort through the 
inability to thermoregulate – a known factor for motion sickness onset. Other 
contextual information may include knowledge about the vehicle being used, including 
interior design layout (considering flexible seating, or size and location of DLO’s) 
through which efferent motion cues can be gained. Further, vehicle dynamics and 
suspension could be monitored, adjusted and informed upon for understanding 
motion sickness onset and for counteracting motion sickness 
7.7.5 SUMMARY 
This model is designed to capture various data types, which can be used to inform a 
machine learning algorithm. The nature of a machine learning system is that it requires 
training data on which to learn about the correct interpretations. This data could be 
labelled (supervised learning), or unlabelled (unsupervised or reinforcement learning). 
The exact implementation of a machine learning system is well beyond the scope of 
this brief note on measuring motion sickness. However, as a brief hypothetical 
example, using information already discussed within the Innovation Report, it is 
possible to better understand the utility of this model. The benefit of this model is in 
its ability to combine data sources, such as (in this hypothetical example), an Asian 
female, who has history of motion sickness, is traveling on a route known to impact 
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motion sickness and approaching traffic moving at inconsistent speeds, she started 
head down reading and a change in her physiology has been noticed. Stringing a 
hypothetical set of information together starts to show how many streams of data, 
which on their own are perhaps not useful, can be used as a collective to understand 
motion sickness likelihood. Of course, this model is untested so the effectiveness of 
this cannot be discussed, rather the contribution is in highlighting how all these data 
sources may fit together for future research on the measurement of motion sickness 
state.  
 
7.8 ADDITIONAL NOTES ON MOTION SICKNESS MEASUREMENT   
 
Throughout this project, and EngD Innovation Report, three key methods of measuring 
subjective motion sickness severity were used: the Simulator Sickness Questionnaire 
(SSQ) (Kennedy, Norman, Berbaum, & Lilienthal, 1993), the Motion Sickness 
Assessment Questionnaire (MSAQ) (Gianaros, Muth, Mordkoff, Levine, & Stern, 2001) 
and the Fast Motion Sickness Scale (FMS) (Keshavarz & Hecht , 2011). Given the 
amount of data collected and the reliance on subjective motion sickness assessment 
for many conclusions it is useful to explore the effectiveness of these measures. A 
correlation analysis has been done using the data collected in Project A and B and 
written up in Submission 6 as the on-road motion sickness trial where participants 
completed all three questionnaires simultaneously (SSQ, MSAQ and FMS). The results 













Table 30 Correlation Between Subjective Motion Sickness Scales 
  
Table 30 shows every measure of subjective motion sickness was significantly 
correlated with 99% confidence (p<0.01) as denoted by the double asterisk ‘**’. The 
correlations shown are strong, which bodes well for the validity of the results 
discussed within this EngD research. Despite the SSQ being designed specifically for 
simulators with a strong visual aspect, it is correlated to the MSAQ in this real-world 
study with a person’s score of rs0.888. This is considered a very strong correlation and 
informs on the ability to compare simulator sickness to real-world sickness using these 
same measures in both environments. FMS peak score (i.e., the maximum FMS score 
given throughout an exposure) was recommended by the original author to be of most 
utility (Keshavarz & Hecht , 2011). The data presented confirms this, where the FMS 
peak score has the strongest correlation to both MSAQ (rs 0.838) and SSQ (rs 0.742). 
These strong scores validate the FMS scale for the real-time measurement of motion 
sickness as discussed in this project, and for the use of this method going forward in 
cases where full questionnaires are not possible. 
 
 





1 .975** .933** .718** .803** 
Sig. (2-tailed) 
 
0.000 0.000 0.000 0.000 
N 51 51 51 51 51 
FMS Peak Correlation 
Coefficient 
.975** 1 .932** .742** .838** 
Sig. (2-tailed) 0.000 
 
0.000 0.000 0.000 
N 51 51 51 51 51 
FMS Final Correlation 
Coefficient 
.933** .932** 1 .700** .798** 
Sig. (2-tailed) 0.000 0.000 
 
0.000 0.000 
N 51 51 51 51 51 
SSQ Correlation 
Coefficient 
.718** .742** .700** 1 .888** 
Sig. (2-tailed) 0.000 0.000 0.000 
 
0.000 
N 51 51 51 51 51 
MSAQ Correlation 
Coefficient 
.803** .838** .798** .888** 1 
Sig. (2-tailed) 0.000 0.000 0.000 0.000 
 
N 51 51 51 51 51 
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8 A NOTE ON SIMULATOR TO ‘REAL-WORLD’ TRANSFERABILITY 
 
Although not a core aim of this EngD project, transferability of data from simulator 
trials to real-world applications has been a significant consideration in many of the 
research projects that make up this Innovation Report. It is possible to conclude on 
some of the findings and discuss some of the implications that have been highlighted 
along the way.  
Firstly, and upon reflection of Project A, it was shown how simulator sickness, as is a 
common phenomenon in simulator trials, can have a significant effect on human 
performance. It is with this understanding that future projects must consider user trial 
data collected in a simulator and the influence that motion sickness may have on this 
data. Thinking about common industry focused research methods, such as the ‘2/12 
rule’ as it is commonly referred to. This ‘rule’ is a guideline published by NHTSA 
(National Highway Traffic Safety Administration) in reference to eye-glance behaviour 
for in-vehicle HMI’s, it advises that glances away from the road (to interact with a 
piece of HMI) should consist of glances no longer than 2 seconds, and for a total eyes-
off-road time of less than 12 seconds to complete the task. It is deemed that anything 
longer (in glance duration, or total eyes-off-road time) constitutes a bad and possibly 
dangerous HMI design (Perez, Hulse, & Angell, 2013). Guidelines such as these, and 
others are commonly used in industry-based research, and some academic research 
also. It is therefore important, considering these small thresholds that performance is 
measured in a simulator. Specifically, if someone asks to end the driving task early, 
their user trial data should be omitted from the data set where it is likely their 
performance is degraded to the extent to which their interaction data is significantly 
different from their usual ability. Without a further grading criteria for motion sickness 
severity, it is not yet possible to say at what point, on a subjective scale, motion 
sickness affects results. Further to this issue of performance degradation, due to the 
known effects of Sopite Syndrome, and as the data supports in Project A it is not 
advisable to run reaction-time based user trials in a simulator due to reduced reaction 
times which may not be directly transferable to real-world abilities. If reaction time, or 
any other assessment-dependent specific performance ability is being studied, it is 
recommended that a baseline and post-simulator assessment is used (as was done in 
Project A). These additional assessments will be able to validate if the simulator has 
affected these fundamental skills, and thus conclude on the validity of the data 
collected during the trial. 
From Project B, it seems that the effect of visuospatial training on motion sickness 
susceptibility is worthwhile testing in simulator and on-road environments equally. The 
data presented in Project B does not highlight that simulator sickness and car sickness 
differ from one-another in their relation to visuospatial ability and its relationship to 
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motion sickness. It can be recommended that simulator trials are beneficial here 
where transferability does not appear to be of concern. However, simulator trials seem 
to be more of an ‘extreme’ environment for people, with drop-out rates being higher 
than on-road trials. For example, 35% (n=7) people dropped out of the simulator 
visuospatial trial, whereas only one participant (4%) dropped out of the on-road trial 
due to motion sickness. This is a factor worthy of consideration when planning a study 
where motion sickness is a factor. Dropouts should be considered in the target sample 
size and in a simulator study the researcher should account for a greater number of 
dropouts when recruiting. Anecdotally, the estimated average number of dropouts per 
3xD simulator trial is around 25%, observed through experiments at WMG. It is hard to 
compare dropout rates between simulators given how many factors, such as field of 
view (Bos, de Vries, van Emmerk, & Groen, 2010), impact motion sickness. A meta 
study on this subject, presented a mean drop-out percentage of 14% between 9 
different simulator trials (Balk, Bertola, & Inman, 2013). This figure is thought to be 
realistic for a generic trial, but perhaps more pronounced when the test route is 
designed to be particularly challenging or in a 360degree field of view, such as the 3xD 
simulator.  
No data presented in this research indicated that physiological response to motion 
sickness differs between simulated and real-world, despite the change in 
efferent/afferent motion cue significance. Simulators are far easier to control for this 
style of testing, where airflow, directional/ambient/radiating temperature can all be 
controlled or eliminated, as these are known effectors of many physiological signs. It is 
therefore predicted that there is greater utility in simulator testing for fundamental 
physiological research. However, of course the transferability of any effects found 
within a simulator may be limited in direct transferability to the real-world, where 
environmental factors an important variable. 
It has been shown in the correlation matrix in Table 30 that the MSAQ and SSQ are 
strongly correlated. Therefore, ideally when running a repeat measures study including 
simulator and real-world experimentation (such as in Project B) both questionnaires 
should be used. This ensures that later simulator-only trials can be compared to the 
SSQ, and later on-road trials can be compared to other MSAQ’s (where SSQ is 
advisable for simulator studies, and MSAQ for any real-world studies). However, if this 
is not possible, then either questionnaire may be suitable as a compromise. It is 
recommended that if only one questionnaire is to be used the MSAQ allows for a 
greater range of severity assessment, and four (rather than three) subcategories which 
improve precision and areas for exploration over the SSQ. As recommended by the 
author (Keshavarz & Hecht , 2011), the FMS peak score seems to be the most useful 
score for measuring motion sickness, and given its strength in correlations it may be 




Finally, considering the subcategories of motion sickness severity, in the simulated and 
real-world, previous literature has looked to classify the profile of the SSQ dependent 
on the environment (Kennedy, Lane, Lilienthal, Berbaum, & Hettinger, 1992). Using the 
categories of nausea (N), oculomotor (O) and disorientation (D), it was summarised 
that the motion sickness profiles in different motion sickness environments are as 
follows: 
 Virtual environments as D>N>O. 
 Space sickness as O>D>N, 
 Simulation sickness as O>N>D 
 Seasickness/airsickness as N>D>O 
With the data collected over this EngD project, it is possible to compare simulation 
sickness findings and present a profile based on car sickness. Table 31 below 
summarises all simulator trial participants and all on-road trial participants over all 
experimentation (inclusive of repeat-measures) and presents the N, O and D average 
scores. 
Table 31 Profiles of Motion Sickness (SSQ) 
 Count Nausea (N) Oculomotor (O) Disorientation (D) 
Simulator Sickness  71 46.14 30.93 48.95 
Car sickness 51 45.97 38.58 50.98 
 
Given the results from the SSQ used throughout this study it is seen that with a sample 
size of 71, the profile of motion sickness in a simulator is: D>N>O and for car sickness, 
it is also shown to be D>N>O.  
The simulation sickness profile is entirely reversed to that which is presented 
previously by (Kennedy, Lane, Lilienthal, Berbaum, & Hettinger, 1992) where it is 
considered that simulator design may have a significant role to play. It is also 
interesting to note that despite the change in afferent/efferent motion cue 
significance, on-road motion sickness measured by the SSQ follows the same profile as 











This Innovation Report has detailed the background literature and the scope of the 
research completed within this project. It has then presented three research projects 
(A, B and C) which collectively address the aims and objectives as previously set out 
and focus on understanding the impact, reduction and measurement of motion 
sickness. Although each of these projects include their own discussion in specific 
relation to their individual findings, this section will bring together all research as an 
overall project. This discussion section will pull out the key findings from the three 
projects to show the impact of this project as a whole to both academia and industry. 
To complete this discussion, the limitations of the project as well as some 
opportunities for further research are highlighted. Firstly, the objectives as set out at 
the beginning of this Innovation Report are presented once again: 
1. To critically review the body of literature covering motion sickness with an 
emphasis on impact to automotive applications 
2. To explore the impact of motion sickness on human performance to inform 
transferability of simulator data to real-world 
3. To advise on the most appropriate way to conduct user trials for future 
simulator-based experimentation (including that of motion sickness 
management) to inform ‘best practice’ of vehicle simulator trials. 
4. To consider the impact motion sickness may have on the utility of future 
automated vehicles 
5. To detail state of the art methods for managing motion sickness in vehicles 
6. Design, test and validate a method of reducing personal susceptibility to 
motion sickness 
7. Provide information on the ways through which a motion sickness 
management method could be implemented in production vehicles 
8. Explore methods for the measurement and detection of motion sickness 
9. Explore the feasibility of physiological data as objective measures of motion 
sickness and provide information about useful metrics through which motion 
sickness may be measured objectively.  







9.1 KEY FINDINGS –  CONTRIBUTIONS TO ACADEMIA  
 
The rapid and competitive development of automotive technologies sometimes means 
the technology is available before the human factors considerations have had time to 
be fully addressed. Human factors is often trying to catch up with technological 
developments, where it is often only after technology introduction that manufacturers 
consider, or have time to consider, human integration. As evidence to this, there is 
much ongoing research around existing (i.e., consumer available) technology such as 
touch screen HMI usage (Large, et al., 2019) and ADAS features (Caber, Langdon, & 
Clarkson, 2019) – many of which have been available on the consumer market for 
many years. With the next shift in the automotive industry heading towards 
automated vehicles, there are already concepts for such vehicles (for example see the 
concept vehicle in Figure 4), and a growing consumer expectation – as seen in Figure 
10. There is therefore a pressing need to address the human factors considerations for 
such technology to enable future vehicles to be developed, designed and 
manufactured in a user-focused manner. There are already hopes for automated cars 
to be on the road in just a few years (Driverless Future, 2017), so there is a great 
urgency for human factors researchers to ensure the technology is usable, safe, 
enjoyable and effective. With that in mind, this EngD project looked to address the 
relationship between motion sickness and future automotive technology – covering 
both the development (using driving simulators) as well as considering the end goal of 
automated vehicles. 
The first contributions of this EngD are found within the Literature Review presented in 
Submission 2 and as summarised in Section 3.3 in this Innovation Report. The 
relationship between motion sickness, driving simulators and automated vehicles was 
considered and contextualised. A clear argument as to why motion sickness is a factor 
for automated vehicles is presented evidencing innovation of existing knowledge. An 
update of the state of the art of motion sickness management for driving simulators 
and automated vehicles has been explored within Submission 2. Using this knowledge 
it was possible to conclude upon some areas for design recommendations within 
future vehicles (as summarised in Table 3) and form the basis for future research which 
this EngD then set out to address. Since then, the three core projects which tell the 
story of this EngD are able to break down further contributions: 
9.1.1 MOTION SICKNESS AND HUMAN PERFORMANCE (PROJECT A) 
Project A has, for the first time in an automotive context, shown how motion sickness 
significantly affects various areas of human performance (as seen in Table 10). This is 
of consequence for the transferability of simulated data to real-world applications 
where it has been recommended that simulator dropouts should be omitted from the 
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data analysis of performance related trials, where severe motion sickness resulting in 
someone ending the study early is known to significantly reduce their performance in 
many areas. This builds upon the previous literature which hints at motion sickness 
degradation in task-specific domains, such as in (Stroud, Harm, & Klaus , 2005), (Bos J. 
E., 2004) and (Lampton, Kraemer, Kolasinski, & Knerr, 1995). Through testing 
fundamental abilities rather than specific work or driving related tasks, the utility of 
the findings are not limited by or to the tests chosen unlike previous studies. Further, 
the utility of a simulator for reaction-time based experimentation has been 
questioned, where data suggests reaction times are significantly reduced when using a 
simulator, likely due to Sopite syndrome. These core findings have allowed for an 
update on the utility of driving simulators for user trials and allowed for the creation of 
a best practice guide for simulator use (see Appendix  2). With the on-road aspect to 
this trial, it was possible to explore the transferability of these simulator findings to the 
‘real-world’, and the measurement of motion sickness was able to help validate the 
data found in the UK AutoDrive project (as summarised in Submission 4). Overall, this 
project helped to validate the transferability of simulator data where non-dropout 
performance was, for the most part, no different from baseline performance – adding 
reassurance to future user trials looking to develop technology in a simulator.   
9.1.2 VISUOSPATIAL TRAINING AND MOTION SICKNESS (PROJECT B) 
This EngD research has shown, for the first time how training visuospatial ability can 
significantly reduce motion sickness susceptibility for both simulator-based (Figure 48) 
and on-road motion sickness ( 
 
Figure 50). Previous research had indicated that visuospatial performance and motion 
sickness were related (Van Goozen S. , 1995), but there has been no attempt, until 
now to try and train visuospatial skills to reduce motion sickness. This is of great 
significance for a few reasons. Firstly, for future simulator trials (where pre-training 
may reduce dropouts, and ensure transferability of performance related measures). 
Secondly, for the automotive industry in that this method may act as a mitigation 
strategy to reduce car sickness in both traditional and future automated vehicles. 
Finally, this key finding is of significance for the field of motion sickness in general, 
where this relationship has been identified and validated as a motion sickness 
management method. These findings, may be more effective than design-based 
methods for reducing motion sickness given their the to other environments. The 
ability to reduce personal susceptibility to a motion sickness-inducing task (proven for 
both simulator sickness and car sickness) may be a useful tool for the estimated 1/3 of 
the population who suffer from high motion sickness susceptibility (U.S. National 
Library of Medicine, 2019). Not only has this relationship been established, but this 
project has shown the effectiveness of pen and paper training tasks, assembled in a 
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novel form, using pre-existing tests in improving visuospatial ability – providing a 
method as well as the relationship. 
Again, although not a core aim, this method has further shown how the motion 
sickness reduction (through the training of visuospatial tasks) can reduce workload for 
a simple reading task. It is possible that this method can be used to not only reduce 
subjective sickness, but improve productivity in automated vehicles, and possibly other 
job roles where motion sickness is a factor (such as navy crew, or for military simulator 
training tasks). This effect has not been quantified, but this project certainly has 
highlighted the scope for further research in this field.  
9.1.3 UNDERSTANDING THE MEASUREMENT OF MOTION SICKNESS 
(PROJECT C) 
Although this project has not concluded on a successful method of objectively 
measuring motion sickness, it is of equal importance to highlight how real-time motion 
sickness cannot be measured using just EDA or skin temperature alone - furthering the 
pursuit to an overall objective measure. This project, for the first time has looked at 
how real time motion sickness and the physiological response of EDA and skin 
temperature are (in their unfiltered and individual analysis) are not useful predictors of 
motion sickness state using ‘real time practical methods’. Previous research has 
identified a link between EDA and motion sickness (Parker, 1971) (Warwick-Evans, et 
al., 1987)  (Golding J. , 1992), and this may have been misconceived by some to think 
EDA is a direct measure of motion sickness. However, through disbanding this as an 
objective measure for real-time severity or onset (although not disputing that the two 
are related) this project has made progress in the continuation of this pursuit to find 
an objective measure. Through the exploration of physiology and motion sickness this 
research (exampled in Figure 60 and Figure 61) has shown the importance of sample 
size in such research where given the diversity in correlation strength and diversity, 
with a small sample size the relationship could be easily misinterpreted. As a 
conclusion of this project, a new model is presented through which other data (known 
to affect motion sickness) can be collected to help identify a holistic method of 
measuring motion sickness in real-time through the use of machine learning 
(presented in Figure 65). The utility of each data stream suggested has been of proven 
utility in other research projects highlighted in Submission 2 and throughout the EngD. 
It is expected that the sum of these parts may provide the ability to infer motion 
sickness state and this contribution will stand as justification for future research.  
 
9.2 KEY FINDINGS - IMPACT ON THE SPONSORING COMPANY 
 
Throughout this research, consistent consideration has been given to the applicability 
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of key findings to JLR as the sponsoring company – ensuring this EngD remains not only 
innovative but also relevant. Although the project has shifted quite far from its initial 
conceptualisation – within the SLC team some valuable contributions were made 
during this first small project (Submission 1). The SLC team were struggling at the time 
to understand why there was such disparity between  users’ actual routine, and their 
prediction of their routine. Through the creation of a new model on which human-
focused data could be collected, this research was able to identify some errors in their 
current model, and propose considerations for the next iteration of product 
development. The impact of this project was proven through the invitation to present 
at the internal JLR technical specialist conference where the model created was 
disseminated among the research team and taken on board when the project was 
handed over to mainstream engineering. 
The identification of motion sickness as a consideration for future JLR vehicles and 
research was a significant contribution, where few people within the business were 
aware of the subject of motion sickness and there was limited knowledge across the 
human factors teams about the subject. This research was of great utility to JLR, 
through the contextualisation and clear argument for the subject of motion sickness 
both in initial reports, and through company meetings. The first experiment identified 
how simulator dropouts had significantly decreased performance in many areas 
including physical-visual, physical, cognitive-physical and cognitive performance. 
Identifying this as an issue helped JLR understand the nature of simulator 
transferability, where future trials could be assured for transferability (considering 
fundamental human performance) so long as motion sickness was not an issue. 
Further information was provided around the limitations of simulators for reaction-
time related studies. Although Submission 3 included all the in-depth information 
(which was available to JLR) a two-page summary of best practice for simulator trials 
was also created as a result of this experimentation and further reading (Appendix  2). 
No data has been collected on the utility of this best practice guide, but it is expected 
to help reduce simulator dropouts (saving time and money when running trials), 
inform on the ethics of running simulator trials where motion sickness is a risk and 
help in validating the data collected considering transferability.  
Another outcome of the first project was in the validation of the UK AutoDrive user 
trial data, where motion sickness was tracked and shown to not be a significant issue. 
This report was written up in Submission 5, but a one-page ‘industry friendly’ summary 
was also created. This is of use for the JLR owned project where they can be assured 
that human performance in their trials was not affected by motion sickness, adding to 
the validity of their study. 
One of the most exciting contributions and areas of impact made to the sponsoring 
company (considering its novelty) was in the creation of a method to reduce motion 
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sickness through visuospatial training. This method provided a solution to the issue of 
motion sickness within future vehicles, and if created into a consumer focused product 
could help in “Creating experiences people love for life” (Jaguar Land Rover, 2019) by 
helping reduce motion sickness discomfort for passengers in both traditional and 
future automated vehicles. Not only was this new knowledge created, but a workshop 
to explore exploitation methods was held and the results of this were handed over to 
JLR to inform them on possible areas of exploitation, and associated research 
questions that would help in product development. One of the outcomes of this 
research was in the creation of a JLR mobile app which this EngD research helped 
inform. This app was co-created to enable future testing and refinement of this 
method within JLR’s research division and, ultimately, would be considered for its 
applicability of being used as a consumer product. The development of this app, and 
JLR embargo of publications of this work to retain the IP is good evidence of the impact 
this research had on JLR. 
The concept for measuring motion sickness objectively through only the measures of 
skin temperature and EDA was being discussed within JLR and in response to the 
overall lack of conclusive information in the literature the third project of this EngD 
helped JLR to understand the utility of these physiological measures. This paper was 
taken by the head of JLR research and used to update the state of knowledge within 
the company about objective motion sickness measures. The impact this project had 
was one of prevention rather than addition, where this research prevented JLR 
spending time and money following these physiological measures as individual 
measures, although the impact to the wider field was greater in presenting real-time 
motion sickness physiology vs subjective measures for the first time. The conclusion of 
this research showed how there are many useful points of data that can be collected 
for future motion sickness measurement projects and this EngD provided an adapted 
model for data collection on which to inform a machine learning system to 
track/measure and perhaps predict motion sickness in the future.  
Considering other impacts created through this EngD, the detailed review of the 
literature and a strong understanding of the subject allowed for the creation of design 
recommendations for future automotive vehicles which will be useful for JLR to 
consider in the design of their future cars. Further to this, over the course of two 
workshops the information collected in this EngD was presented to the JLR automated 
vehicle interior design team where JLR staff were trained in the area of motion 
sickness countermeasures which was of great impact to the team. A letter from the 
manager of the user interface for automated driving team, written to the internal JLR 
EngD funder is shown in Appendix  5 as testament to the impact and contribution 
made. Further to this design project, the information and knowledge collected 
thought-out this EngD was used to inform JLR on future research strategies for motion 
sickness. Through multiple sessions JLR were advised on what areas of research should 
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be pursued, where the gaps in the knowledge are, the benefits of specific research 
projects and the impact to JLR for each research item. As testament to the utility of 
this information another letter has been included in Appendix  6, written by the lead 
engineer of interior sensing and sent to the JLR internal funder of this EngD.  
Overall the research conducted and the knowledge gained through this EngD has had 
many direct impacts on JLR as the project sponsor, and to the automotive industry as a 
whole. The impacts made to JLR speak well to the strengths of the EngD scope where 
creation of new knowledge, along with the innovation of this has shown to be of great 
benefit and success. There is still much more work to be done in this field, but JLR now 
have the understanding, tools and direction to tackle further motion sickness related 
issues, working towards their goal of creating experiences people love for life. 
9.3 LIMITATIONS OF THE RESEARCH  
 
Despite the many strengths of this research there are a few limitations that should be 
highlighted. Project specific limitations have been presented within the individual 
projects There are a few overarching limitations of the project overall. 
Given the geographical location of the experiments conducted, the vast number of 
participants were white, British participants. Given that motion sickness is known to 
vary between ethnicities this lack of diversity is considered a limitation for widespread 
representation. 
Throughout all user trials, and specifically relating to Projects A and C where the effect 
of motion sickness was being measured, a potential limitation of these studies was 
that the entire range of motion sickness was not experienced. As discussed, 
participants were free to end the study when they felt as if they were too 
uncomfortable to continue. This, although ethically advisable, limited the data set 
where little data was collected for severe motion sickness. 
Age is an often discussed characteristic of motion sickness. Motion sickness 
susceptibility variation is particularly observed in children (under 18s). The variance in 
susceptibility throughout the development of a child may be linked to developments of 
the brain, balance organs, familiarisation (habituation) and hormones. This research 
project has purposefully omitted the consideration of children within both 
experimental groups and discussions.  
Vehicle dynamics and vibration management is a popular area of research within 
motion sickness. This field was not discussed within this project, nor was data 
collected. The sponsoring company were already working in the field of dynamics so it 
was important for them that this project did not overlap. This does not limit the 
findings or results presented as part of this research, rather it limits the transferability 
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of data to other research. Particularly considering performance metrics in vibration 
environments (project A), and effectiveness of visuospatial training compared to 
vibration management (project B) 
9.4 OPPORTUNITIES FOR FURTHER RESEARCH 
 
Throughout the research projects presented, some ideas of further research have been 
highlighted. As a summary of these questions raised along the way, and considering 
wider aspects of the field, a few areas for further research have been highlighted: 
Project A: 
 How does motion sickness, and subsequent human performance 
degradation affect specific driving tasks in a simulator (simulation sickness) 
or in real world driving (considering automated vehicle control handover)? 
 How does motion sickness affect the various areas of visual performance 
(visual acuity, depth perception, target identification etc.)? 
 Is it possible to categorise motion sickness severity states using the SSQ or 
MSAQ? 
 What is the best method to measure at what level of sickness does 
performance (across individual categories) become significantly affected? 
 Does motion sickness affect the ability to regain control of a Level 3 or 4 
automated vehicle? (safety) 
 
Project B: 
 What is the most efficient way of training visuospatial ability (considering 
training duration and frequency)? 
 What tasks are most useful for training visuospatial skills? 
 What is the underlying mechanism through which motion sickness is related 
to visuospatial ability? 
 When training visuospatial ability, how long does the reduced motion 
sickness susceptibility affect last for? 
 How might the relationship between visuospatial training and car 
sickness/simulation sickness be applied to other fields where motion 
sickness is a concern? 
 What is the most acceptable method through which to train visuospatial 
skills and would automated vehicle users be willing to train? (also 
considerate of children as a stakeholder)  
 
Project C: 
 What key components affect the physiological measures of EDA and skin 
temperature and is it possible to filter the data to reduce the impact of 
variables other than motion sickness? 
 Can physiological data be analysed within specific time sections to give a 
better understanding of motion sickness state per specified timeframe? 
146 
 
 What data is most effective for a machine learning system to identify real-
time motion sickness state? 
General: 
 Considering the propensity for automated vehicles (and non-driving related 
tasks which they enable) what is the actual expected productivity gain of 
these vehicles? 
 How can automated vehicles be designed to enable productivity through 
managing motion comfort? 
 Considering how motion sickness severity varies between demographics, 
how can future vehicles be designed in an inclusive manner to ensure no 
demographic is designed out of utility due to motion sickness? 
 How acceptable are the many proposed solutions to minimise motion 
sickness (including vehicle designs, wearables, visuospatial training, 
habituation, route changes etc.) 
 
10 FINAL THOUGHT 
 
This EngD project has contextualised the issue of motion sickness within driving 
simulators and future automated vehicles. It has highlighted how motion sickness 
affects human performance, and discusses the impact this has on simulator trials and 
the utility of automated vehicles. A novel method of reducing motion sickness 
susceptibility has been developed, validated and discussed and further information 
around objective motion sickness measurement has been presented. Through the 
creation of new knowledge and the multiple innovations that this EngD generated, this 
research is of significance for academia, the sponsoring company (JLR) and the future 
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Appendix  2 Best Practice Guide for Simulator Trials 
Best Practice Guide for Simulator-




This best practice guide has been created to enable the most effective simulator-based user trials 
considering efficiency of user trials, participant wellbeing and reliability of user-collected data. All the 
recommendations made within this report are based on peer-reviewed findings from previous literature 
and original research collected in WMG’s 3xD simulator. It is recommended that all researchers using a 
simulator to collect data read understand and adhere to this guide. The guide has been split into six 
sections including scenario design, recruitment, pre-trial, during-trial, post-trial and data analysis. 
 
The most prevalent and accepted theory of why people become motion sick is ‘sensory conflict theory’, 
which states that “mismatches between (or within) the visual, vestibular, and somatosensory inputs” 
cause motion sickness [1] . That is to say a person can detect motion with their eyes (through sight), 
with their vestibular system (the inner ear) and through the somatosensory system (the brain area 
responsible for sensation of movement of limbs). If one or more of these senses conflicts with the other 
motion sickness can prevail. In a simulator, for example, the eyes will detect movement, but the 
vestibular system will detect none, so there is conflict and motion sickness is possible.  
 
Scenario design 
 Total user trial time should ideally be 15 minutes or less to minimise the chance of motion 
sickness. Multiple shorter runs separated by breaks are better than one long single run. 
 Routes should be mainly straight roads and minimal tight bends. Avoid multiple changes of 
speed and ensure any speed change happens on a straight road and not a bend. 
 Avoid roundabouts if possible, where making participants take the 3rd exit on a roundabout is 
perhaps the most disorientating action possible in a simulator. If roundabouts are needed the 
1st or 2nd exits are preferable. 
 Give all participants a 5 minute (at least) familiarisation run where they can drive at a steady 
slow speed on a straight road and are gradually introduced to speed and bends (if required). 
 Ensure the simulator is set up with no trip hazards if the participant has to exit quickly due to 
motion sickness. Provide a recovery space with plenty of water for unwell participants.  
 Reaction-time based user trials should be avoided, where Sopite Syndrome (a side effect of 
simulator use) is likely to induce fatigue and has been shown to significantly decrease reaction 
time. If reaction time is being measured it is recommended that Sopite Syndrome is also 
measured and pre and post simulator exposure reaction time is measured, where significant 
changes after simulator exposure indicate the user trial may be compromised.  
 
Recruitment 
 An exclusion criterion can be used if researchers need to minimalize the amount of people 
dropping out due to motion sickness. This should be used with caution considering excluding 
participants will not give a true representation of the general population. 
 Participants should be made aware of the risks of motion sickness upon recruitment, where the 
exclusion criteria can be provided (even if not being enforced) and participants made aware 
that if they meet any points they have an increased risk of motion sickness.  
 If participants are being paid to take part they should be made aware that they will receive the 
payment before simulator exposure and will receive payment even if they dropout.  
 Participants should be made aware at recruitment that motion sickness can affect human 
performance and they are advised not to operate heavy machinery (e.g. driving a car) for at 
least 2 hours after the simulator study – even if feeling subjectively well.  
 Participants should be advised not to consume caffeine directly before the user trial where this 
can increase the chance of motion sickness. 
 When recruiting be aware that around 25% of participants may dropout due to motion sickness 
(although some user trial have no dropouts) so recruit more participants than is required to 
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compensate. Females are more likely to drop out compared to males, so recruitment of more 
females may help ensure an equal demographic in the final data set.  
 
Pre-trial 
 Before taking part in the trial, make participants fully aware of the risks including subjective 
discomfort due to motion sickness. Ensure participants have signed a consent form. 
 Increasing self efficacy decreases motion sickness, so explain the simulator positively, where if 
the participant believes they will not get motion sickness, they are less likely to. 
 Acclimatise the participant for at least 5 minutes to the lighting conditions. If possible introduce 
the participant to the user trial inside the simulator so they have time to adapt.  
 The SSQ (Simulator Sickness Questionnaire) by [2] should be administered before the exposure 
to the simulator to capture any baseline feelings. Research has shown a pre SSQ. has no effect 
on likelihood of becoming motion sick and does not prime participants.  
 Participants should be reminded they are free to withdraw and end the study at any time. 
 
During-trial 
 The simulator should vent cold air to the participant, where increased airflow and lower 
temperatures are known to reduce motion sickness. 
 Remind participants to look ahead as much as possible – avoiding looking out the side or rear 
windows as much as possible.  
 The FMS (fast motion sickness questionnaire) can be administered by the researchers to 
capture subjective motion sickness in ‘real time’ [3]. 
 Ensure the intercom system is turned on and advise the participant they can contact the 
researcher at any time to end the study if they become motion sick. 
 Participants should be observed throughout the trial via the in-cabin cameras. Researchers 
should look out for signs of severe motion sickness so they can end the study. Anecdotal 
evidence of motion sickness onset highlights these actions: change in face pallor where 
participants can turn pale, increased sweating on the face, participants raising their hand to 
their mouth or brow, burping. A general ‘path’ to sickness is sweating – burping – vomiting. 
 
Post-trial  
 If participants dropout of the trial due to motion sickness their trial data should not be used. It 
has been shown that people who dropout due to motion sickness have impaired performance 
so their data is invalidated and non representative of their actual ability. Post-trial 
questionnaires relating to the user trial will also be invalidated so should not be used. 
 Participants should complete the SSQ  post-simulator exposure to measure new symptoms. 
 Participants should be welcomed to sit, drink water and recover fully before leaving. 
 Participants should be asked to not mention to any colleagues the nature of the user trial until 
the trial period is over. Discussing the trial with others may impact future results. 
 
Data analysis 
 SSQ scores should be evaluated looking at the difference between pre and post scores to 
eliminate prior conditions (such as a headache or fatigue) from affecting the SSQ scores. 
 If participants withdrew due to motion sickness, no performance data should be used and 
further questionnaires should not be given at risk of collecting unreliable data. 
 For those who don’t dropout due to motion sickness, human performance should be 
considered unaffected, however, transferability of simulator-collected data to ‘real-world’ 
applications is very much dependent on the trial specifics (e.g. risk perception of an AV) 
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method for quantifying simulator sickness,” International Journal of, pp. 203-220, 1993.  
[3] B. Keshavarz and H. Hecht , “Validating an Efficient Method to Quantify Motion Sickness,” Human Factors: The 





Appendix  3 UK AutoDrive One Page Summary 
Motion Sickness and Human Performance – A Follow-up Study with the UK Auto Drive Project ( Project Summary) 
Background: 
Previous research in this EngD has shown how motion sickness can affect various areas of human performance. 
Specifically - cognitive performance, physical performance, physical-visual performance and physical-
cognitive performance were all shown to be negatively affected by motion sickness. This impact may 
invalidate some user-collected data in future user trials where motion sickness is prevalent. Where it is thought 
that motion sickness is likely to affect the validity of user data if they are motion sick. It was important to see if 
effects observed in the 3xD simulator were similar to effects in the UK AutoDrive pods 
Method: 
Human performance can be broken down into a Venn diagram 
(right) considering performance skills needed to drive. Because 
time was a factor only two areas of performance were addressed 
- Cognitive performance, where driving cognitive performance 
is required for route planning, appraising danger, contextual 
awareness etc. In addition, Cognitive-Physical performance 
which is the intersection of cognitive skills (as mentioned) and 
physical skills which are required for dexterous interaction with 
HMI and physical manipulation of controls etc. The test used to assess cognitive performance was an N-back 
test - which relied on the participants cognitive ability to remember and add numbers in their head. The test 
used for assessing physical-cognitive skill was a reaction speed test where participants clicked a button when a 
light illuminated, thus depending on cognitive processing speed and subsequent physical response. Both tests 
are pre-validated representative of the specific areas without being impacted by other abilities. Motion sickness 
was measured using the Simulation Sickness Questionnaire (SSQ) so results were transferable to the previous 
simulator study. Participants completed the SSQ (to capture any pre-existing conditions) and completed both 
performance tests (in a random order) when they arrived at the facility. They were then exposed to the pods for 
a standardised time. After exposure participants completed the two tests again (randomised) and another SSQ. 
Results were analysed looking the change in motion sickness and comparing this to the change in task 
performance ability.  
Results: 
There was no statistically significant change between pre and post SSQ scores for the Nausea (N) subscale, 
Disorientation (D) subscale, Oculomotor (O) subscale and total SSQ scores where in all cases P>0.05. Looking 
at the difference between the pre and post cognitive scores there was no difference found (Z=-1.270, p=0.204). 
However, looking at the pre and post physical-cognitive test scores a significant difference was observed - 
t(16)= -0.251, p=0.039. Indicating that there was a significant increase in reaction time scores where the mean 
score pre exposure was 0.299 seconds and the mean post score was 0.317 seconds. There was no statistical 
significance observed between delta SSQ total (i.e., the change in total SSQ score) and delta reaction score as 
determined by the one-way ANOVA (F=0.967, p>0.05). Likewise, there was no significance shown between 
delta total SSQ and delta N-Back (F=1.1998, p=)0.05). 
Conclusion: 
Overall, motion sickness does not appear to be an issue for these UK Autodrive trials, where the design of the 
pod, test track and scenario are all designed in such a way that motion sickness onset likelihood is low. It is 
recommended that motion sickness is continued to be tracked whereby the Motion Sickness Assessment 
Questionnaire (MSAQ) by Gianaros et al. (Gianaros, et al. 2001) can be used in future studies. For real-time 
subjective scoring the Fast Motion Sickness Questionnaire (FMS) (Keshavarz and Hecht 2011) can be used. 
Previous EngD research has validated the effectiveness of the FMS (Pearson’s correlation = 0.620, p<0.001). If 
motion sickness does become more common in future trials then researchers are advised to consider if such 
motion sickness may affect the validity of results, where it is known motion sickness can affect performance. 
As for the performance scores, reaction time was significantly increased for participants. There is no evidence 
this was related to motion sickness, instead it is likely that cold test conditions impacted dexterity and motor 
control or Sopite Syndrome induced through the vehicle motion was a cause. If physical interaction is a 
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